archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,5.508e-06,1.7184,1.5009,1,1
1,GO BLEB ASSEMBLY,2.7578e-07,1.6202,1.4129,1,1
1,GO MEMBRANE RAFT ASSEMBLY,2.5774e-06,1.4257,1.574,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,1.349e-05,1.3467,1.1412,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,3.17e-07,1.2317,1.0873,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,8.4155e-08,1.1934,1.1896,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,2.4515e-08,1.1682,1.1164,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,2.9957e-08,1.1619,1.1056,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,7.013e-05,1.1571,1.0862,1,1
1,GO NEUTROPHIL HOMEOSTASIS,2.1831e-07,1.0953,1.0242,1,1
1,GO RESPONSE TO INTERFERON ALPHA,3.3202e-07,1.076,1.1515,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,1.725e-07,1.0692,1.0512,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.2971e-07,1.054,1.0019,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,4.6623e-06,1.0476,0.9885,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,9.389e-05,1.0416,0.80787,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,1.9873e-07,1.0286,1.0401,1,1
1,GO HYALURONAN CATABOLIC PROCESS,6.93e-08,1.0272,1.0615,1,1
1,GO REGULATION OF PLASMINOGEN ACTIVATION,4.4878e-05,1.0145,0.89651,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,2.3975e-07,0.99651,0.87839,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,6.2786e-05,0.99375,0.8563,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,1.4039e-05,0.9908,0.87926,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,2.2879e-07,0.98973,0.84912,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,4.2876e-06,0.98827,0.87997,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,3.6414e-07,0.9695,0.95482,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,5.0683e-06,0.94575,0.95524,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,3.8423e-08,0.93272,0.93407,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,3.17e-07,0.93268,0.99762,1,1
1,GO BONE TRABECULA FORMATION,1.4039e-05,0.92917,0.88071,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,2.9301e-06,0.92892,0.84687,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,6.4994e-06,0.92141,0.86984,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,2.8496e-08,0.92007,0.9877,1,1
1,GO TROPHOBLAST CELL MIGRATION,1.0311e-06,0.91684,0.86337,1,1
1,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00011241,0.91524,0.72381,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,2.0784e-06,0.90936,0.89304,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,3.9926e-07,0.90577,0.97577,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,8.628e-07,0.90321,0.81079,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,4.6623e-06,0.89158,1.0644,1,1
1,GO HEMIDESMOSOME ASSEMBLY,1.3441e-06,0.88821,1.2473,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,7.2756e-08,0.88753,0.92083,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,3.479e-08,0.87035,0.95484,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,3.6414e-07,0.86993,0.83986,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,1.2366e-07,0.8622,0.84804,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,7.2111e-07,0.86061,0.73218,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,4.2424e-08,0.85508,0.86684,1,1
1,GO MEMBRANE RAFT ORGANIZATION,2.4692e-06,0.85217,0.93814,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,2.0033e-05,0.83667,0.7734,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,5.6999e-08,0.83422,0.84731,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,2.1702e-06,0.83326,0.72633,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,4.5813e-07,0.83235,0.72335,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.2879e-07,0.83091,0.83929,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,2.6322e-07,0.82762,0.77824,1,1
1,GO CD40 SIGNALING PATHWAY,3.8131e-07,0.82693,0.76047,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,1.1237e-07,0.82175,0.79057,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,6.6003e-08,0.81999,0.79183,1,1
1,GO RESPONSE TO INTERFERON BETA,2.3654e-06,0.81918,0.96086,1,1
1,GO HIPPO SIGNALING,1.0311e-06,0.81736,0.66293,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,6.5896e-07,0.81364,0.88591,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,1.5201e-05,0.80448,0.81594,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,3.4772e-07,0.80446,0.68239,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,5.0194e-07,0.80137,0.70362,1,1
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,3.9926e-07,0.79819,0.77418,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,2.5308e-05,0.79748,0.71523,1,1
1,GO ZYMOGEN INHIBITION,3.3202e-07,0.79652,0.81438,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,7.5427e-07,0.79611,0.70191,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,1.725e-07,0.79161,0.77508,1,1
1,GO PLASMINOGEN ACTIVATION,5.2139e-05,0.79105,0.63467,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,3.1904e-06,0.7774,0.68572,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.0207e-07,0.77482,0.71761,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,8.6584e-06,0.77167,0.65882,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,9.7275e-08,0.76737,0.76016,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,1.8958e-07,0.76567,0.76789,1,1
1,GO ENDODERM FORMATION,4.6826e-08,0.76452,0.83948,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,2.7578e-07,0.75871,0.87318,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,3.7791e-06,0.7582,0.71576,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,1.104e-05,0.75427,0.68002,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,1.7118e-05,0.75255,0.63701,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,0.00079435,0.74994,0.54448,1,1
1,GO CYTIDINE TO URIDINE EDITING,0.00014935,0.74461,0.67938,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,1.2971e-07,0.74323,0.70837,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,6.0198e-07,0.74315,0.72966,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,1.1267e-06,0.73634,0.69929,1,1
1,GO EPIBOLY,8.8325e-08,0.73565,0.80908,1,1
1,GO LATERAL MESODERM DEVELOPMENT,4.8612e-06,0.73191,0.6384,1,1
1,GO GAP JUNCTION ASSEMBLY,1.0311e-06,0.73129,0.67255,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,5.986e-08,0.72952,0.70342,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,9.2696e-08,0.72741,0.6954,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,3.6228e-06,0.72536,0.74745,1,1
1,GO CELLULAR RESPONSE TO X RAY,1.9263e-05,0.72155,0.59077,1,1
1,GO BRANCH ELONGATION OF AN EPITHELIUM,0.00038934,0.72057,0.54763,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,5.1671e-08,0.71959,0.70783,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,7.0571e-06,0.71559,0.71371,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,5.2139e-05,0.71338,0.67383,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,9.4334e-07,0.71211,0.68399,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,6.6003e-08,0.71003,0.73512,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,2.4346e-05,0.70774,0.63065,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,2.0784e-06,0.70343,0.74778,1,1
1,GO LEUKOCYTE AGGREGATION,0.00011241,0.69722,0.60339,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,6.93e-08,0.69716,0.69103,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.6729e-06,0.69356,0.62259,1,1
1,GO BONE TRABECULA MORPHOGENESIS,0.00017186,0.69309,0.56826,1,1
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,6.0198e-07,0.69195,0.63481,1,1
1,GO NOTOCHORD DEVELOPMENT,2.5122e-07,0.68927,0.78584,1,1
1,GO T CELL MEDIATED CYTOTOXICITY,1.4039e-05,0.68836,0.6141,1,1
1,GO DENDRITIC CELL APOPTOTIC PROCESS,2.7343e-05,0.68761,0.55695,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,3.8131e-07,0.68664,0.84649,1,1
1,GO SALIVARY GLAND DEVELOPMENT,3.17e-07,0.68638,0.67602,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,5.986e-08,0.68278,0.66825,1,1
1,GO VASCULOGENESIS,2.8496e-08,0.68204,0.65965,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,9.4334e-07,0.67953,0.73999,1,1
1,GO FIBRINOLYSIS,1.0779e-06,0.67892,0.81607,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,4.5813e-07,0.67742,0.59491,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,3.3287e-06,0.67604,0.57416,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,2.3975e-07,0.67448,0.73294,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,4.1617e-05,0.67352,0.63404,1,1
1,GO BIOLOGICAL PHASE,0.00020448,0.67212,0.61919,1,1
1,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,9.8628e-07,0.67077,0.80045,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,3.4728e-06,0.66881,0.80018,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,5.2837e-06,0.66835,0.62614,1,1
1,GO CYSTEINE METABOLIC PROCESS,0.00021909,0.664,0.50011,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,3.4728e-06,0.66109,0.51158,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,9.4334e-07,0.6609,0.61441,1,1
1,GO RESPONSE TO INTERLEUKIN 18,0.0073363,0.66078,0.60706,1,1
1,GO T CELL EXTRAVASATION,7.0571e-06,0.66048,0.67233,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,1.3441e-06,0.65821,0.59943,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,5.9841e-06,0.65686,0.55414,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,1.3441e-06,0.65443,0.66436,1,1
1,GO REGULATION OF PINOCYTOSIS,4.8379e-05,0.65266,0.63654,1,1
1,GO SKIN MORPHOGENESIS,8.3127e-06,0.65191,0.80368,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,3.1888e-05,0.65072,0.62192,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,5.2837e-06,0.64875,0.6295,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,1.1267e-06,0.6482,0.70463,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00065623,0.64802,0.50733,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,9.3916e-06,0.64565,0.56948,1,1
1,GO APOPTOTIC CELL CLEARANCE,8.8325e-08,0.64512,0.73573,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,4.2876e-06,0.64479,0.57037,1,1
1,GO MUCUS SECRETION,0.0011199,0.64318,0.51538,1,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,5.2139e-05,0.64162,0.56673,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.5774e-06,0.64007,0.62719,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,7.889e-07,0.6392,0.60534,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,2.5308e-05,0.63898,0.55847,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,2.8077e-06,0.63626,0.74231,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,1.4963e-07,0.62926,0.67969,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,3.8423e-08,0.62907,0.62618,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,3.7791e-06,0.62864,0.55245,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,9.0221e-07,0.62737,0.74372,1,1
1,GO ENDODERM DEVELOPMENT,6.2859e-08,0.62469,0.69376,1,1
1,GO CELLULAR RESPONSE TO IRON ION,1.8084e-07,0.62306,0.63603,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,3.8131e-07,0.62179,0.63472,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,4.0375e-08,0.62011,0.63901,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,1.1776e-06,0.61767,0.65141,1,1
1,GO DNA DEAMINATION,5.7413e-06,0.61555,0.62226,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,6.7728e-06,0.61406,0.59624,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,2.3654e-06,0.61151,0.545,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,6.2786e-05,0.60729,0.43524,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,2.4692e-06,0.60628,0.71537,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,1.6455e-05,0.60417,0.56309,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,2.1702e-06,0.60305,0.66544,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,1.1267e-06,0.60224,0.66415,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,5.0194e-07,0.60223,0.62889,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.725e-07,0.60211,0.65678,1,1
1,GO COLLAGEN METABOLIC PROCESS,1.9873e-07,0.60033,0.61925,1,1
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,6.7728e-06,0.60027,0.59159,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,2.2879e-07,0.59871,0.51871,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.0037331,0.59725,0.37797,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,1.6729e-06,0.59693,0.67702,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,4.1617e-05,0.59676,0.56317,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,1.4044e-06,0.59621,0.50964,1,1
1,GO LIVER REGENERATION,2.2167e-08,0.59611,0.62435,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.00027832,0.59606,0.41536,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,1.0311e-06,0.59451,0.54487,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,5.508e-06,0.59393,0.69408,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0038387,0.59369,0.68239,1,1
1,GO REGULATION OF FIBRINOLYSIS,2.0033e-05,0.59308,0.60813,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,2.3418e-05,0.59277,0.51755,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.00011241,0.59186,0.49079,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,6.2985e-07,0.59159,0.66751,1,1
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.0073363,0.59057,0.48591,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,5.0683e-06,0.58951,0.60123,1,1
1,GO ELASTIC FIBER ASSEMBLY,4.8379e-05,0.58863,0.77004,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,3.4728e-06,0.58625,0.51544,1,1
1,GO RESPONSE TO X RAY,2.8496e-08,0.58533,0.6381,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,7.2754e-05,0.58363,0.46339,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,2.9301e-06,0.58286,0.52773,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.4963e-07,0.58243,0.59464,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,1.906e-06,0.58178,0.49143,1,1
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00022676,0.58103,0.49147,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,1.0604e-05,0.58028,0.54071,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,1.8084e-07,0.57919,0.61678,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,1.2971e-07,0.57918,0.63349,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,1.4039e-05,0.57865,0.5865,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,4.7955e-07,0.57823,0.54135,1,1
1,GO RESPONSE TO TYPE I INTERFERON,2.3418e-05,0.57683,0.64307,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,2.6902e-06,0.57606,0.64345,1,1
1,GO AORTIC VALVE DEVELOPMENT,1.4674e-06,0.57598,0.57178,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,3.7791e-06,0.57578,0.67583,1,1
1,GO AMYLOID BETA CLEARANCE,5.2533e-07,0.57467,0.502,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,1.104e-05,0.57423,0.60146,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,2.1663e-05,0.57321,0.53206,1,1
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,7.0571e-06,0.57217,0.59984,1,1
1,GO ENTRY INTO HOST,2.2879e-07,0.57198,0.59714,1,1
1,GO HEME METABOLIC PROCESS,2.0784e-06,0.57183,0.51518,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.6015e-06,0.57079,0.49733,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,0.00016023,0.57034,0.45126,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,3.9418e-06,0.56938,0.5261,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,1.0604e-05,0.56519,0.46787,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,3.0576e-06,0.56309,0.74151,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.7343e-05,0.56139,0.45568,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,3.4772e-07,0.56103,0.59418,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,1.104e-05,0.5601,0.53101,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,2.0033e-05,0.55988,0.47954,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,1.2308e-06,0.55959,0.51596,1,1
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,7.889e-07,0.55853,0.56302,1,1
1,GO TOLERANCE INDUCTION,0.00011241,0.55805,0.50511,1,1
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.019739,0.55727,0.38238,1,1
1,GO CELLULAR RESPONSE TO DSRNA,1.0207e-07,0.557,0.58626,1,1
1,GO PIGMENT GRANULE MATURATION,0.00014935,0.55681,0.4344,1,1
1,GO IMMUNE RESPONSE TO TUMOR CELL,5.0683e-06,0.5539,0.53795,1,1
1,GO REGULATION OF GLOMERULAR FILTRATION,0.00013917,0.5528,0.60879,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,5.2533e-07,0.55218,0.50396,1,1
1,GO TYPE 2 IMMUNE RESPONSE,5.508e-06,0.5506,0.56334,1,1
1,GO CYTOLYSIS,3.6228e-06,0.54962,0.48231,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,6.0198e-07,0.5484,0.59362,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.4963e-07,0.54697,0.53793,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0007696,0.54679,0.43161,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.0025083,0.5456,0.39081,1,1
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.0001165,0.54443,0.48453,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,3.7791e-06,0.54439,0.47906,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,4.4712e-06,0.54234,0.58473,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.00065623,0.54189,0.43228,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.4044e-06,0.54152,0.51795,1,1
1,GO INTERLEUKIN 1 PRODUCTION,4.1112e-06,0.53987,0.49721,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,1.4609e-05,0.53898,0.40458,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,9.3916e-06,0.53874,0.49543,1,1
1,GO COLLAGEN CATABOLIC PROCESS,5.4977e-07,0.53677,0.59561,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,1.2454e-05,0.53459,0.55137,1,1
1,GO MESODERMAL CELL DIFFERENTIATION,4.1802e-07,0.53434,0.49367,1,1
1,GO ZYMOGEN ACTIVATION,1.1964e-05,0.53383,0.54373,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.8131e-07,0.5333,0.58501,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,7.889e-07,0.53276,0.58372,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,7.3528e-06,0.53275,0.49209,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.0207e-07,0.53268,0.56439,1,1
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.00013433,0.53213,0.48009,1,1
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,9.0179e-06,0.53206,0.65343,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,5.8301e-05,0.5317,0.42431,1,1
1,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0046564,0.53123,0.35871,1,1
1,GO VAGINA DEVELOPMENT,1.5331e-06,0.53062,0.60296,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,6.2985e-07,0.53034,0.52662,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,7.2111e-07,0.52885,0.50215,1,1
1,GO RESPONSE TO INTERFERON GAMMA,2.0784e-06,0.52776,0.528,1,1
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,3.5759e-05,0.52653,0.46011,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,1.5691e-07,0.52641,0.60119,1,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.00090094,0.52614,0.55853,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,1.4268e-07,0.52534,0.48066,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,1.2454e-05,0.52479,0.53952,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,6.2859e-08,0.52372,0.53622,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.31e-08,0.52304,0.51984,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,1.6729e-06,0.52287,0.45135,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,5.0194e-07,0.52137,0.50984,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,6.5149e-05,0.52076,0.45961,1,1
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.00041602,0.51955,0.4455,1,1
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0019282,0.51884,0.38198,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,5.4977e-07,0.51825,0.46919,1,1
1,GO VIRAL GENOME REPLICATION,6.8936e-07,0.51779,0.47932,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,3.3202e-07,0.51749,0.47658,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,3.3287e-06,0.51692,0.53205,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,4.0073e-05,0.51528,0.50871,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.349e-05,0.51489,0.44234,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,2.1663e-05,0.51455,0.53631,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,1.4674e-06,0.51362,0.47492,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,1.725e-07,0.51143,0.54693,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,3.4421e-05,0.51102,0.50668,1,1
1,GO PULMONARY VALVE DEVELOPMENT,8.1192e-05,0.51006,0.51078,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,4.5813e-07,0.50975,0.75055,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,6.7596e-05,0.50867,0.44217,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,2.8077e-06,0.50831,0.45265,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,3.0576e-06,0.5083,0.53335,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,5.6999e-08,0.50793,0.52023,1,1
1,GO T CELL MEDIATED IMMUNITY,1.6729e-06,0.50765,0.49809,1,1
1,GO ENAMEL MINERALIZATION,6.7596e-05,0.5076,0.50329,1,1
1,GO OSTEOBLAST DEVELOPMENT,6.7596e-05,0.50516,0.46095,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0001165,0.50438,0.478,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,3.8583e-05,0.50344,0.39677,1,1
1,GO RESPONSE TO HYPEROXIA,1.0184e-05,0.50157,0.52224,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,1.2308e-06,0.50143,0.48073,1,1
1,GO EXTRACELLULAR MATRIX ASSEMBLY,0.00028792,0.50101,0.4917,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,2.9301e-06,0.50099,0.58244,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,9.0221e-07,0.5007,0.6274,1,1
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,7.8282e-05,0.4997,0.50542,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,4.7955e-07,0.49959,0.51994,1,1
1,GO MAMMARY GLAND MORPHOGENESIS,2.2658e-06,0.49926,0.49037,1,1
1,GO PEPTIDE CROSS LINKING,5.4121e-05,0.49844,0.5217,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,2.9532e-05,0.4983,0.52124,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,1.5331e-06,0.49778,0.54084,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,9.3916e-06,0.4976,0.43014,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,2.6322e-07,0.49739,0.56731,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.00041602,0.49693,0.47921,1,1
1,GO LYMPHANGIOGENESIS,2.5122e-07,0.49659,0.52339,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.00030804,0.49644,0.42953,1,1
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.001191,0.49603,0.42872,1,1
1,GO STORE OPERATED CALCIUM ENTRY,6.4994e-06,0.49539,0.4176,1,1
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.001662,0.49509,0.40113,1,1
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0010528,0.49409,0.40842,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,1.8251e-06,0.49401,0.46549,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,7.013e-05,0.49286,0.36739,1,1
1,GO GLAND MORPHOGENESIS,2.6902e-06,0.49221,0.47366,1,1
1,GO DETECTION OF BIOTIC STIMULUS,2.1702e-06,0.49201,0.50412,1,1
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.00084609,0.49094,0.46949,1,1
1,GO FOREGUT MORPHOGENESIS,7.0571e-06,0.49031,0.50204,1,1
1,GO FIBROBLAST ACTIVATION,0.00012512,0.48989,0.42295,1,1
1,GO ENDOTHELIAL CELL MORPHOGENESIS,0.0029794,0.48779,0.41499,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,9.8628e-07,0.48769,0.52434,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.011326,0.48596,0.40804,1,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00072223,0.48586,0.37189,1,1
1,GO PINOCYTOSIS,2.7578e-07,0.48579,0.61965,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,5.4272e-08,0.48568,0.50204,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,2.5308e-05,0.48508,0.39866,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00074557,0.48507,0.52123,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,5.2533e-07,0.48502,0.46893,1,1
1,GO PROTEIN OXIDATION,0.00031859,0.48447,0.47647,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,6.4994e-06,0.48286,0.47391,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.1493e-05,0.4825,0.39885,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,1.2962e-05,0.48197,0.52592,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,7.6603e-06,0.48118,0.48768,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,1.5201e-05,0.48084,0.4311,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00055855,0.48059,0.37338,1,1
1,GO PROGESTERONE METABOLIC PROCESS,0.007729,0.48008,0.26905,1,1
1,GO RESPONSE TO ANGIOTENSIN,9.4334e-07,0.47974,0.46273,1,1
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,5.7413e-06,0.47935,0.48012,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,2.1702e-06,0.47868,0.48843,1,1
1,GO VIRAL RNA GENOME REPLICATION,5.6999e-08,0.47778,0.47308,1,1
1,GO REGULATION OF TRANSPOSITION,1.5816e-05,0.47764,0.5152,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,3.1904e-06,0.47736,0.43811,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,3.3132e-05,0.47718,0.45458,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,3.9926e-07,0.4766,0.40141,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00013433,0.47632,0.39817,1,1
1,GO NIK NF KAPPAB SIGNALING,1.1788e-07,0.4751,0.44192,1,1
1,GO CYTOKINE METABOLIC PROCESS,1.7474e-06,0.47403,0.41172,1,1
1,GO BLOOD VESSEL REMODELING,4.8379e-05,0.47379,0.42356,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,5.2533e-07,0.47301,0.51739,1,1
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,4.4878e-05,0.47298,0.41503,1,1
1,GO HYALURONAN METABOLIC PROCESS,2.5122e-07,0.47297,0.50941,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,4.1802e-07,0.47221,0.49903,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.2524e-05,0.47181,0.44653,1,1
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,1.0184e-05,0.47136,0.49741,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,4.1112e-06,0.4713,0.48348,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,3.3287e-06,0.47005,0.50663,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00079435,0.46966,0.45714,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,2.9301e-06,0.46884,0.53929,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,2.1663e-05,0.46861,0.41337,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,1.1964e-05,0.46829,0.43867,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,3.8131e-07,0.46814,0.51002,1,1
1,GO REGULATION OF MYOBLAST FUSION,4.6597e-05,0.46731,0.53485,1,1
1,GO DEFENSE RESPONSE TO VIRUS,5.2837e-06,0.46678,0.43157,1,1
1,GO REGULATION OF HORMONE METABOLIC PROCESS,2.2524e-05,0.46674,0.45194,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,4.3763e-07,0.46666,0.51311,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.6729e-06,0.4665,0.42559,1,1
1,GO KERATAN SULFATE CATABOLIC PROCESS,1.6455e-05,0.46564,0.59884,1,1
1,GO DERMATAN SULFATE METABOLIC PROCESS,0.0019282,0.46498,0.59317,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,9.0551e-05,0.46484,0.39138,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,8.628e-07,0.46434,0.47518,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,1.0779e-06,0.46341,0.46979,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0018173,0.46336,0.38856,1,1
1,GO RESPONSE TO INTERLEUKIN 12,3.0264e-07,0.4632,0.44406,1,1
1,GO BONE GROWTH,1.1267e-06,0.4616,0.5596,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,3.7791e-06,0.46152,0.41941,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,6.0198e-07,0.46152,0.47516,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,4.6826e-08,0.46133,0.4494,1,1
1,GO MACROPHAGE PROLIFERATION,0.00057693,0.46034,0.46996,1,1
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00018427,0.46009,0.42487,1,1
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0060989,0.45999,0.32449,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,9.3916e-06,0.45962,0.41041,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,5.2837e-06,0.45935,0.44055,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,7.013e-05,0.45863,0.39536,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00034072,0.45763,0.41108,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,5.0683e-06,0.45696,0.45277,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.7791e-06,0.45695,0.41965,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,9.8628e-07,0.4567,0.40206,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,4.8612e-06,0.45662,0.41288,1,1
1,GO REPLICATIVE SENESCENCE,0.00036427,0.4566,0.45109,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,1.5201e-05,0.45603,0.53236,1,1
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0013457,0.45586,0.43816,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,7.0571e-06,0.45585,0.45832,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,7.5427e-07,0.45481,0.41386,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,5.508e-06,0.45459,0.41183,1,1
1,GO ANIMAL ORGAN REGENERATION,9.7275e-08,0.45455,0.51689,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,1.4268e-07,0.45439,0.40297,1,1
1,GO PROTEASOME ASSEMBLY,0.00017186,0.45437,0.31453,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,3.3132e-05,0.45359,0.69859,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,7.6603e-06,0.45257,0.49676,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,1.3605e-07,0.4525,0.51194,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,6.5896e-07,0.45234,0.48177,1,1
1,GO REGULATION OF RECEPTOR BINDING,0.0018173,0.45175,0.36868,1,1
1,GO TRABECULA FORMATION,0.00011241,0.4515,0.48904,1,1
1,GO MRNA TRANSCRIPTION,2.7343e-05,0.45148,0.37433,1,1
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.014486,0.45146,0.28393,1,1
1,GO MUSCLE CELL FATE COMMITMENT,3.1888e-05,0.45136,0.45821,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,2.7343e-05,0.45131,0.35745,1,1
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00052342,0.45123,0.32221,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.0311e-06,0.45052,0.41222,1,1
1,GO RESPONSE TO SALT STRESS,3.0264e-07,0.45042,0.41909,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.001191,0.45035,0.36474,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,1.3441e-06,0.45007,0.39798,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,3.17e-07,0.44967,0.52049,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,7.5427e-07,0.44963,0.42391,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,3.0264e-07,0.44781,0.42852,1,1
1,GO TONGUE MORPHOGENESIS,0.01282,0.44763,0.31539,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,3.3132e-05,0.44759,0.40291,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,3.9926e-07,0.44684,0.4321,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.00018427,0.44657,0.4854,1,1
1,GO HAIR FOLLICLE MATURATION,0.00087311,0.44653,0.36396,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.1663e-05,0.44636,0.36603,1,1
1,GO MATURATION OF LSU RRNA,0.00013917,0.4463,0.38091,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00027832,0.44597,0.36682,1,1
1,GO RESPONSE TO PROGESTERONE,0.0060989,0.44549,0.29835,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,5.4977e-07,0.44516,0.43554,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,2.6902e-06,0.44463,0.51177,1,1
1,GO ETHANOL OXIDATION,0.013798,0.44459,0.38118,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,6.8936e-07,0.44452,0.39721,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,3.0576e-06,0.44436,0.4461,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,2.7343e-05,0.44397,0.53568,1,1
1,GO REGULATION OF KIDNEY DEVELOPMENT,4.1112e-06,0.44386,0.39086,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,5.8301e-05,0.44368,0.32778,1,1
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.00013433,0.44332,0.39958,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,6.5896e-07,0.4425,0.41131,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,5.9841e-06,0.44232,0.47999,1,1
1,GO PROTEIN ACTIVATION CASCADE,1.1493e-05,0.44166,0.37722,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00081984,0.44133,0.33266,1,1
1,GO EMBRYO IMPLANTATION,3.0264e-07,0.44132,0.53216,1,1
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.00065623,0.44109,0.40692,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,1.7474e-06,0.44108,0.54439,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,7.6603e-06,0.43997,0.47511,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,2.1663e-05,0.43992,0.49914,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.00090094,0.43989,0.46246,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,9.8628e-07,0.43934,0.45692,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,1.349e-05,0.43912,0.41624,1,1
1,GO REGULATION OF HIPPO SIGNALING,5.4121e-05,0.43903,0.40661,1,1
1,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.023205,0.43896,0.27247,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,4.6597e-05,0.4387,0.35116,1,1
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00074557,0.43804,0.54122,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,9.0551e-05,0.43779,0.6396,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.0017641,0.43741,0.31401,1,1
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.00057693,0.4374,0.51477,1,1
1,GO VIRAL TRANSLATION,5.2837e-06,0.4367,0.41455,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,3.4421e-05,0.43643,0.41067,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,3.9418e-06,0.43604,0.45408,1,1
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00067758,0.43512,0.32015,1,1
1,GO DISTAL TUBULE DEVELOPMENT,0.012203,0.43499,0.34738,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,8.3127e-06,0.43469,0.41498,1,1
1,GO INTERLEUKIN 2 PRODUCTION,5.4977e-07,0.43407,0.45457,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,5.508e-06,0.43402,0.48004,1,1
1,GO CELL ADHESION MEDIATED BY INTEGRIN,2.2524e-05,0.434,0.4691,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,6.2786e-05,0.4337,0.39049,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,6.7596e-05,0.43294,0.35645,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,2.3418e-05,0.43243,0.31654,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,7.2754e-05,0.43216,0.3845,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.00057693,0.43181,0.35482,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,4.4878e-05,0.43171,0.37885,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0050528,0.43133,0.26081,1,1
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00084609,0.43072,0.46835,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.9263e-05,0.43051,0.47308,1,1
1,GO FOCAL ADHESION ASSEMBLY,3.3287e-06,0.4299,0.43249,1,1
1,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.0039469,0.42942,0.28778,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,2.1702e-06,0.42879,0.41876,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,1.5331e-06,0.42869,0.59202,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,9.0551e-05,0.42777,0.38098,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.0034322,0.42732,0.3936,1,1
1,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.0011549,0.42653,0.3326,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,6.2367e-06,0.42639,0.38131,1,1
1,GO FIBROBLAST MIGRATION,4.1802e-07,0.42632,0.44796,1,1
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.00059588,0.4263,0.49259,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,1.4963e-07,0.42609,0.45895,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,4.6623e-06,0.42585,0.46272,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,6.2985e-07,0.4255,0.41943,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,1.2862e-06,0.4253,0.43484,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,5.7413e-06,0.42502,0.39932,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,1.2971e-07,0.42501,0.39221,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,4.4712e-06,0.42487,0.37314,1,1
1,GO I KAPPAB PHOSPHORYLATION,5.0683e-06,0.42378,0.34683,1,1
1,GO RECEPTOR CATABOLIC PROCESS,4.8612e-06,0.42329,0.42185,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,5.753e-07,0.42324,0.39979,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,1.1776e-06,0.42312,0.46262,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,3.8583e-05,0.42129,0.34644,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00047456,0.42118,0.48173,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.2962e-05,0.4211,0.40813,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,4.4878e-05,0.42104,0.36792,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,4.1617e-05,0.42058,0.38039,1,1
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00010462,0.42,0.42627,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,1.2308e-06,0.41965,0.3758,1,1
1,GO CYTOPLASMIC TRANSLATION,0.00063551,0.41955,0.30059,1,1
1,GO VIRAL LIFE CYCLE,1.6452e-07,0.41928,0.43742,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,6.2985e-07,0.41881,0.36738,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,2.2658e-06,0.4188,0.40225,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00034072,0.41814,0.35916,1,1
1,GO TOOTH MINERALIZATION,0.00031859,0.41799,0.35106,1,1
1,GO VASCULAR TRANSPORT,0.0062634,0.41798,0.49423,1,1
1,GO IMMATURE T CELL PROLIFERATION,6.4994e-06,0.41788,0.47812,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,3.7791e-06,0.41779,0.44856,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,3.9418e-06,0.41743,0.36297,1,1
1,GO MULTI ORGANISM LOCALIZATION,6.6003e-08,0.41721,0.41753,1,1
1,GO PARAXIAL MESODERM DEVELOPMENT,8.7323e-05,0.41665,0.42495,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,1.2454e-05,0.41629,0.42609,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00016595,0.41575,0.34953,1,1
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.00029782,0.41551,0.33804,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.001986,0.41542,0.33184,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00013433,0.41503,0.39286,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,2.0833e-05,0.41442,0.39404,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,2.7343e-05,0.41398,0.4873,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,4.4712e-06,0.41343,0.40083,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,2.0829e-07,0.4132,0.41919,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,1.349e-05,0.4132,0.35796,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,9.2696e-08,0.41314,0.40922,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.00074557,0.41258,0.35594,1,1
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.0057817,0.41251,0.32307,1,1
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.0023671,0.4121,0.41985,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,4.4712e-06,0.41181,0.41574,1,1
1,GO LENS FIBER CELL DEVELOPMENT,7.8282e-05,0.41124,0.46027,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,1.5201e-05,0.41118,0.49195,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00095906,0.41106,0.31698,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0014299,0.41106,0.31566,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,8.2505e-07,0.41099,0.41056,1,1
1,GO PLATELET AGGREGATION,6.8936e-07,0.41073,0.39543,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00012074,0.41069,0.39557,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00025131,0.41067,0.40932,1,1
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0013872,0.4106,0.37924,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,1.7474e-06,0.41033,0.41669,1,1
1,GO COPPER ION HOMEOSTASIS,5.7413e-06,0.40959,0.49461,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00055855,0.40881,0.32476,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00031859,0.40821,0.38782,1,1
1,GO REGULATION OF MRNA BINDING,2.9532e-05,0.40814,0.35834,1,1
1,GO NEGATIVE REGULATION OF WOUND HEALING,7.3528e-06,0.40805,0.43756,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,2.1663e-05,0.40762,0.31474,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,6.7728e-06,0.40742,0.46673,1,1
1,GO INTERACTION WITH SYMBIONT,6.4994e-06,0.40735,0.35046,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,1.5201e-05,0.40725,0.60288,1,1
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,3.8583e-05,0.40714,0.40231,1,1
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0045306,0.4063,0.42698,1,1
1,GO RIBOSOME ASSEMBLY,0.00095906,0.40605,0.30983,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,1.8251e-06,0.40562,0.42348,1,1
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.0038387,0.40561,0.29002,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,5.2837e-06,0.4053,0.48023,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,6.8936e-07,0.40499,0.37879,1,1
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0064317,0.40495,0.45903,1,1
1,GO CARDIOBLAST DIFFERENTIATION,0.00013917,0.40493,0.41342,1,1
1,GO POSITIVE REGULATION OF CELL SIZE,0.03245,0.40476,0.24325,1,1
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.019283,0.40455,0.25412,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,2.2524e-05,0.40431,0.35948,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.00013917,0.40385,0.41031,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,9.3916e-06,0.40363,0.36413,1,1
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00038934,0.40356,0.3555,1,1
1,GO INTERLEUKIN 8 PRODUCTION,4.6623e-06,0.40344,0.40128,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,4.6597e-05,0.40231,0.48349,1,1
1,GO CELL SUBSTRATE ADHESION,3.3202e-07,0.40222,0.43433,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,4.8379e-05,0.40197,0.42985,1,1
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.00038934,0.40041,0.48014,1,1
1,GO HOMOCYSTEINE METABOLIC PROCESS,0.0030654,0.40023,0.29137,1,1
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00095906,0.40023,0.40711,1,1
1,GO REGULATION OF STEROL TRANSPORT,3.3287e-06,0.40018,0.3528,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,9.7801e-06,0.3998,0.47496,1,1
1,GO INTERFERON BETA PRODUCTION,2.4346e-05,0.39934,0.33089,1,1
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,5.0226e-05,0.39932,0.40259,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,4.7955e-07,0.39927,0.38815,1,1
1,GO SERTOLI CELL DEVELOPMENT,0.00026003,0.399,0.37255,1,1
1,GO GENITALIA MORPHOGENESIS,0.0014299,0.39898,0.34403,1,1
1,GO CERAMIDE CATABOLIC PROCESS,0.00014418,0.39898,0.36353,1,1
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,7.8282e-05,0.39853,0.40436,1,1
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00057693,0.3984,0.32299,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,5.2533e-07,0.39777,0.42665,1,1
1,GO SPROUTING ANGIOGENESIS,1.0311e-06,0.39741,0.39064,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,3.1904e-06,0.39685,0.35255,1,1
1,GO NEURAL CREST CELL MIGRATION,0.0025083,0.39675,0.27672,1,1
1,GO PRIMARY MIRNA PROCESSING,3.7145e-05,0.39624,0.39607,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,3.4728e-06,0.39609,0.39301,1,1
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.018398,0.39607,0.35906,1,1
1,GO TYPE I INTERFERON PRODUCTION,7.0571e-06,0.39558,0.34487,1,1
1,GO GALACTOSE METABOLIC PROCESS,0.00049035,0.39556,0.32527,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,1.7474e-06,0.39547,0.498,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,5.7413e-06,0.39516,0.44722,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.00023468,0.39484,0.5331,1,1
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0019282,0.39441,0.33315,1,1
1,GO PULMONARY VALVE MORPHOGENESIS,0.0036303,0.39434,0.48562,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,8.3127e-06,0.39367,0.44573,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.00049035,0.39326,0.33356,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.015574,0.39287,0.2673,1,1
1,GO CHONDROCYTE DEVELOPMENT,2.6307e-05,0.3927,0.42333,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,8.7323e-05,0.39213,0.36006,1,1
1,GO MYOBLAST DIFFERENTIATION,1.2308e-06,0.39197,0.37714,1,1
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.015574,0.39159,0.23633,1,1
1,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.00027832,0.39137,0.33663,1,1
1,GO OSTEOCLAST DEVELOPMENT,1.4674e-06,0.39084,0.4321,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,7.0571e-06,0.39081,0.37292,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,2.0033e-05,0.39063,0.44451,1,1
1,GO CARNITINE METABOLIC PROCESS,9.389e-05,0.39055,0.37277,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,7.3528e-06,0.39052,0.42323,1,1
1,GO CARDIAC MUSCLE CELL PROLIFERATION,1.2962e-05,0.39002,0.36923,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.013798,0.39,0.35536,1,1
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.00022676,0.38999,0.41384,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.1702e-06,0.38909,0.37049,1,1
1,GO URETER DEVELOPMENT,0.00041602,0.38905,0.36045,1,1
1,GO INTERACTION WITH HOST,4.3763e-07,0.38851,0.43804,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,1.3441e-06,0.38821,0.42304,1,1
1,GO ERBB2 SIGNALING PATHWAY,3.4728e-06,0.38782,0.35095,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.0028957,0.38744,0.36176,1,1
1,GO T CELL APOPTOTIC PROCESS,9.8628e-07,0.38743,0.37698,1,1
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00040247,0.38656,0.30366,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,6.2859e-08,0.38616,0.39678,1,1
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0007696,0.3861,0.3116,1,1
1,GO RESPONSE TO ESTROGEN,2.8891e-07,0.38605,0.40701,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.0033e-05,0.38539,0.34552,1,1
1,GO REGULATION OF GASTRULATION,4.5813e-07,0.38483,0.39684,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00040247,0.38479,0.40096,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,3.6228e-06,0.3847,0.35572,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.00012074,0.38339,0.31385,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0026572,0.38332,0.32862,1,1
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0021062,0.38304,0.28445,1,1
1,GO PHAGOCYTOSIS RECOGNITION,0.00016595,0.38198,0.52221,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,7.9801e-06,0.38186,0.34631,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00027832,0.3813,0.37827,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,1.1493e-05,0.38043,0.33234,1,1
1,GO PLATELET DEGRANULATION,9.3916e-06,0.37956,0.43397,1,1
1,GO TELOMERASE RNA LOCALIZATION,0.00030804,0.37929,0.31592,1,1
1,GO SMOOTH MUSCLE CELL MIGRATION,0.011326,0.37908,0.24689,1,1
1,GO MEMBRANE INVAGINATION,1.1267e-06,0.37863,0.37241,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,1.1267e-06,0.3785,0.47687,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00087311,0.37847,0.40253,1,1
1,GO MONONUCLEAR CELL DIFFERENTIATION,0.00013917,0.37812,0.34601,1,1
1,GO NEGATIVE REGULATION OF CELL SIZE,6.7728e-06,0.37795,0.3289,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,9.7801e-06,0.37792,0.48888,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,8.3127e-06,0.3776,0.31717,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,2.9301e-06,0.37758,0.44774,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,8.628e-07,0.37732,0.38043,1,1
1,GO MUSCLE FILAMENT SLIDING,2.1702e-06,0.37727,0.38353,1,1
1,GO REGULATION OF PHAGOCYTOSIS,3.0264e-07,0.37716,0.40933,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,1.1776e-06,0.37663,0.41177,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,0.00017186,0.37643,0.33811,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.0001547,0.37627,0.3262,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,1.6729e-06,0.37625,0.35319,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,8.1192e-05,0.37601,0.28929,1,1
1,GO REGULATION OF HEART MORPHOGENESIS,0.00026903,0.37583,0.35501,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,4.7955e-07,0.37582,0.52909,1,1
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.00026003,0.37515,0.31233,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.009256,0.37506,0.29688,1,1
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.00057693,0.37462,0.34686,1,1
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.00049035,0.37432,0.47491,1,1
1,GO T CELL CYTOKINE PRODUCTION,3.0576e-06,0.37391,0.43388,1,1
1,GO REGULATION OF LIPASE ACTIVITY,7.6603e-06,0.37269,0.29335,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,8.7323e-05,0.37205,0.29455,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,1.6015e-06,0.37192,0.40919,1,1
1,GO FIBROBLAST PROLIFERATION,2.0833e-05,0.37164,0.35526,1,1
1,GO REGULATION OF PROTEIN IMPORT,8.6584e-06,0.37155,0.3762,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,1.104e-05,0.37147,0.34969,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,0.00011241,0.37114,0.2928,1,1
1,GO MITRAL VALVE DEVELOPMENT,0.0039469,0.37088,0.43334,1,1
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00021909,0.37076,0.46051,1,1
1,GO MEMBRANE DISASSEMBLY,0.00017186,0.37042,0.30777,1,1
1,GO INTERLEUKIN 17 PRODUCTION,4.6623e-06,0.37025,0.45312,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0022332,0.36963,0.44343,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,2.1663e-05,0.36911,0.30242,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,5.2139e-05,0.36901,0.29275,1,1
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0013457,0.3688,0.25294,1,1
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0020453,0.36879,0.28683,1,1
1,GO CHEMOKINE PRODUCTION,0.00084609,0.36857,0.28433,1,1
1,GO RIG I SIGNALING PATHWAY,8.4205e-05,0.36825,0.35611,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,0.0017641,0.3679,0.3187,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00095906,0.36769,0.27998,1,1
1,GO CHONDROCYTE DIFFERENTIATION,2.3654e-06,0.36766,0.34635,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,9.389e-05,0.36731,0.30709,1,1
1,GO KERATINOCYTE MIGRATION,2.6307e-05,0.3672,0.36761,1,1
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.00034072,0.3671,0.36236,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.001872,0.36695,0.29009,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00095906,0.36639,0.28986,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,7.9801e-06,0.36626,0.3458,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00036427,0.36623,0.29937,1,1
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,4.0073e-05,0.36599,0.32294,1,1
1,GO GLIAL CELL ACTIVATION,0.00036427,0.36566,0.33333,1,1
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0083534,0.36563,0.38078,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0032441,0.36536,0.30037,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.00042998,0.36517,0.28183,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0012662,0.36504,0.33149,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,8.1192e-05,0.36502,0.44186,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,3.0689e-05,0.36479,0.31308,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.00044439,0.36451,0.30988,1,1
1,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.012203,0.36361,0.32982,1,1
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,1.6729e-06,0.36359,0.36797,1,1
1,GO TRANSLATIONAL INITIATION,0.00030804,0.36348,0.29944,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,2.9301e-06,0.36298,0.40298,1,1
1,GO MESODERM MORPHOGENESIS,2.0829e-07,0.36274,0.38813,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,6.2786e-05,0.36267,0.30401,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.9841e-06,0.36256,0.33475,1,1
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00045924,0.36245,0.36964,1,1
1,GO LYMPH VESSEL DEVELOPMENT,9.0551e-05,0.3623,0.41288,1,1
1,GO PROSTANOID BIOSYNTHETIC PROCESS,0.00021909,0.36224,0.3815,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00050664,0.36221,0.305,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0015653,0.36207,0.27075,1,1
1,GO PROSTANOID METABOLIC PROCESS,4.3218e-05,0.36201,0.38651,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,3.7145e-05,0.36163,0.34897,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.013798,0.36073,0.34667,1,1
1,GO MUSCLE CELL MIGRATION,0.0032441,0.36066,0.26953,1,1
1,GO VASCULATURE DEVELOPMENT,1.0311e-06,0.36033,0.33505,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,3.8131e-07,0.36015,0.34958,1,1
1,GO RESPONSE TO CORTICOSTEROID,8.4205e-05,0.36013,0.2709,1,1
1,GO GASTRULATION,1.4268e-07,0.35998,0.39661,1,1
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00019079,0.35981,0.31965,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.1888e-05,0.3595,0.33992,1,1
1,GO RETINAL METABOLIC PROCESS,0.010245,0.35945,0.31067,1,1
1,GO RESPONSE TO VIRUS,3.0576e-06,0.3591,0.37023,1,1
1,GO MATURATION OF 5 8S RRNA,0.00067758,0.35875,0.26412,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,0.0001165,0.35868,0.29248,1,1
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,2.0033e-05,0.35847,0.2988,1,1
1,GO FOREBRAIN MORPHOGENESIS,0.036164,0.35829,0.18538,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,2.1663e-05,0.35821,0.28555,1,1
1,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.010506,0.35819,0.24596,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.2962e-05,0.35757,0.39017,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00065623,0.35754,0.31708,1,1
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0097392,0.35747,0.29219,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,7.9801e-06,0.35743,0.37553,1,1
1,GO HYPOTONIC RESPONSE,0.00022676,0.35712,0.32167,1,1
1,GO WOUND HEALING,3.3287e-06,0.35685,0.34761,1,1
1,GO SERTOLI CELL DIFFERENTIATION,0.00040247,0.35657,0.31584,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,1.7118e-05,0.35633,0.33618,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.00030804,0.35629,0.30948,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,2.3654e-06,0.35555,0.38151,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.6452e-07,0.35527,0.39832,1,1
1,GO REGULATION OF SPROUTING ANGIOGENESIS,3.7791e-06,0.35527,0.37698,1,1
1,GO REGULATION OF PROTEIN MATURATION,1.0311e-06,0.35515,0.37907,1,1
1,GO SKELETAL MUSCLE CELL PROLIFERATION,0.00074557,0.35474,0.33669,1,1
1,GO MATERNAL PLACENTA DEVELOPMENT,1.0604e-05,0.35434,0.39998,1,1
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,3.8583e-05,0.35427,0.33478,1,1
1,GO ENDOTHELIAL CELL MIGRATION,2.8077e-06,0.35421,0.36021,1,1
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.7118e-05,0.35415,0.34044,1,1
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00013433,0.35402,0.2949,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,8.6584e-06,0.35398,0.35815,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,9.0179e-06,0.35377,0.37693,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,4.4712e-06,0.35336,0.37131,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,9.2696e-08,0.35322,0.37305,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,5.7413e-06,0.35291,0.33919,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,2.5774e-06,0.35283,0.34003,1,1
1,GO CHONDROCYTE PROLIFERATION,0.00067758,0.35273,0.47315,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,3.9418e-06,0.35213,0.41541,1,1
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0013872,0.35078,0.24248,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,3.7145e-05,0.35072,0.33176,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00010845,0.35045,0.33658,1,1
1,GO B CELL MEDIATED IMMUNITY,9.0179e-06,0.35039,0.32256,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,1.9904e-06,0.35015,0.34875,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,4.3218e-05,0.34992,0.28461,1,1
1,GO ERAD PATHWAY,1.5816e-05,0.34991,0.2649,1,1
1,GO BASEMENT MEMBRANE ASSEMBLY,0.00013433,0.34985,0.53882,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,2.8418e-05,0.34969,0.27193,1,1
1,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00037661,0.34967,0.3816,1,1
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.00034072,0.34936,0.41664,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,7.2754e-05,0.34888,0.4205,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,2.9532e-05,0.34883,0.37954,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,5.2139e-05,0.34844,0.38134,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,6.4994e-06,0.34652,0.35534,1,1
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.00055855,0.34579,0.314,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,2.4692e-06,0.34515,0.38039,1,1
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.00081984,0.34498,0.2687,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0049174,0.34434,0.24962,1,1
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0006154,0.34418,0.3643,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0024367,0.34378,0.32105,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.001191,0.34376,0.31282,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,1.5201e-05,0.34369,0.30267,1,1
1,GO TISSUE MIGRATION,5.9841e-06,0.34364,0.33071,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0067808,0.3431,0.28886,1,1
1,GO VIRAL GENE EXPRESSION,5.0226e-05,0.34305,0.33472,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,7.5427e-07,0.34289,0.33847,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.8077e-06,0.34281,0.38271,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00013917,0.34245,0.25611,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.00031859,0.34226,0.36283,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00012074,0.34205,0.45551,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,2.0033e-05,0.34183,0.34739,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,2.6307e-05,0.34159,0.31082,1,1
1,GO TRACHEA DEVELOPMENT,0.00087311,0.34132,0.30734,1,1
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00010092,0.34126,0.33201,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,5.0226e-05,0.3411,0.37569,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,4.4878e-05,0.34108,0.35422,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,2.8077e-06,0.34067,0.34491,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,6.5896e-07,0.34036,0.43025,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00037661,0.34028,0.42126,1,1
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0021689,0.33988,0.36928,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,4.6597e-05,0.33981,0.31344,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,5.2139e-05,0.3398,0.3566,1,1
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.00044439,0.3396,0.34908,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,2.0033e-05,0.33957,0.40821,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,6.4994e-06,0.33933,0.33087,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00026903,0.33911,0.3873,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00087311,0.33898,0.3122,1,1
1,GO REGULATION OF TOLERANCE INDUCTION,0.0022992,0.33887,0.32333,1,1
1,GO CELLULAR RESPONSE TO RETINOIC ACID,0.00030804,0.33869,0.31819,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.0006154,0.33851,0.45396,1,1
1,GO NATURAL KILLER CELL ACTIVATION,1.0311e-06,0.33817,0.34937,1,1
1,GO DECIDUALIZATION,0.0012662,0.33798,0.41675,1,1
1,GO L GLUTAMATE IMPORT,0.0039469,0.33789,0.28867,1,1
1,GO CARTILAGE DEVELOPMENT,4.2876e-06,0.33751,0.31029,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,5.508e-06,0.33746,0.29246,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,3.1904e-06,0.33729,0.39959,1,1
1,GO PROTEIN HYDROXYLATION,0.007729,0.33717,0.36629,1,1
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.00031859,0.33694,0.56942,1,1
1,GO REGULATION OF PROTEIN FOLDING,0.00028792,0.33692,0.26,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00038934,0.33691,0.31374,1,1
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,6.5149e-05,0.33688,0.34884,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00023468,0.33684,0.33748,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,1.8958e-07,0.33631,0.3641,1,1
1,GO INTERFERON ALPHA PRODUCTION,0.00047456,0.33612,0.27297,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,2.7343e-05,0.33554,0.36556,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,7.0571e-06,0.3351,0.31242,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,8.4205e-05,0.3345,0.24353,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,7.3528e-06,0.33443,0.4164,1,1
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00013433,0.33435,0.32518,1,1
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.023205,0.3342,0.1934,1,1
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,3.0689e-05,0.33416,0.28992,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,3.4421e-05,0.3341,0.27906,1,1
1,GO REGULATION OF CALCIUM ION IMPORT,0.00067758,0.33395,0.21679,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,5.2837e-06,0.33393,0.3391,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,1.349e-05,0.33372,0.46564,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,5.2837e-06,0.33369,0.33207,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,5.2533e-07,0.33348,0.4048,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,0.00016023,0.33311,0.43196,1,1
1,GO CELL MATRIX ADHESION,3.3287e-06,0.33299,0.36709,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,7.013e-05,0.33296,0.35892,1,1
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,9.389e-05,0.33279,0.37146,1,1
1,GO ENDOCARDIAL CUSHION FORMATION,0.0083534,0.3324,0.25428,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,3.8131e-07,0.33206,0.34353,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00032948,0.33181,0.33723,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,1.906e-06,0.33124,0.32594,1,1
1,GO GLOMERULUS DEVELOPMENT,2.7343e-05,0.33113,0.41455,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,5.0683e-06,0.33076,0.32029,1,1
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00084609,0.33076,0.24147,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00084609,0.33051,0.29838,1,1
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00010845,0.33042,0.262,1,1
1,GO RESPONSE TO WOUNDING,2.3654e-06,0.33042,0.30397,1,1
1,GO RESPONSE TO MANGANESE ION,1.5201e-05,0.3302,0.31716,1,1
1,GO PROTEIN TARGETING TO VACUOLE,7.8282e-05,0.33016,0.26638,1,1
1,GO TISSUE REGENERATION,1.7806e-05,0.32996,0.3383,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,2.3654e-06,0.32971,0.31148,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,8.1192e-05,0.32953,0.29167,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,3.4728e-06,0.3294,0.40405,1,1
1,GO NADPH REGENERATION,0.00036427,0.32921,0.30185,1,1
1,GO REGULATION OF BMP SIGNALING PATHWAY,3.3132e-05,0.32891,0.30439,1,1
1,GO ACTIVATION OF MAPKK ACTIVITY,6.2367e-06,0.32887,0.33631,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0028957,0.32879,0.31063,1,1
1,GO AMYLOID FIBRIL FORMATION,0.022165,0.32847,0.26309,1,1
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0017123,0.32836,0.36234,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00079435,0.32824,0.25527,1,1
1,GO REGENERATION,1.2971e-07,0.32782,0.33217,1,1
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0017641,0.32774,0.22786,1,1
1,GO MACROPHAGE MIGRATION,1.1267e-06,0.3277,0.38329,1,1
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.0025817,0.32766,0.33896,1,1
1,GO REGULATION OF HEART GROWTH,6.7728e-06,0.32763,0.29731,1,1
1,GO MACROPHAGE DIFFERENTIATION,8.6584e-06,0.32739,0.37734,1,1
1,GO MUSCLE CELL PROLIFERATION,6.2985e-07,0.32726,0.3483,1,1
1,GO PIGMENT ACCUMULATION,0.00028792,0.32724,0.30868,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.00025131,0.32704,0.2921,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00018427,0.327,0.32984,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,1.4044e-06,0.32652,0.35994,1,1
1,GO PEPTIDE CATABOLIC PROCESS,7.547e-05,0.32645,0.26176,1,1
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,9.0551e-05,0.3263,0.29501,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,0.00035231,0.3263,0.36867,1,1
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00019079,0.32555,0.36693,1,1
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00038934,0.32549,0.35457,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,6.4994e-06,0.32525,0.32283,1,1
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00019079,0.32491,0.29078,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,7.3528e-06,0.32487,0.29303,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0025817,0.32434,0.26089,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,8.2505e-07,0.32407,0.29046,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,9.0221e-07,0.324,0.3143,1,1
1,GO MATURATION OF SSU RRNA,0.0006154,0.32345,0.29832,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.00010845,0.3227,0.28532,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.00022676,0.32251,0.30849,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.017549,0.32249,0.19299,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.6307e-05,0.32243,0.40398,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.00035231,0.32241,0.29484,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00016595,0.32237,0.31355,1,1
1,GO RESPONSE TO INTERLEUKIN 1,1.0311e-06,0.32236,0.36946,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,4.2876e-06,0.32235,0.30915,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,4.6623e-06,0.32205,0.35115,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,5.9841e-06,0.322,0.35441,1,1
1,GO RESPONSE TO DEXAMETHASONE,0.0014299,0.32189,0.27618,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.5331e-06,0.32185,0.33129,1,1
1,GO TETRAPYRROLE METABOLIC PROCESS,0.00013433,0.32172,0.22954,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0025817,0.32141,0.23581,1,1
1,GO NECROTIC CELL DEATH,4.0073e-05,0.32109,0.40332,1,1
1,GO CYTOKINETIC PROCESS,2.6902e-06,0.32024,0.32384,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,8.1192e-05,0.31984,0.27394,1,1
1,GO KERATINOCYTE PROLIFERATION,0.0039469,0.31971,0.36279,1,1
1,GO SYNCYTIUM FORMATION,1.0184e-05,0.31957,0.3487,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00016595,0.31928,0.26441,1,1
1,GO ASTROCYTE ACTIVATION,9.0551e-05,0.31904,0.35246,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,4.3763e-07,0.31874,0.3538,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,1.9904e-06,0.31858,0.35186,1,1
1,GO HISTONE PHOSPHORYLATION,3.9926e-07,0.31819,0.31884,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,0.00025131,0.31814,0.34164,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,2.5308e-05,0.31805,0.39551,1,1
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00036427,0.31799,0.32963,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,7.5427e-07,0.31778,0.3424,1,1
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,1.4609e-05,0.31755,0.3962,1,1
1,GO VIRAL RELEASE FROM HOST CELL,7.2754e-05,0.31754,0.2805,1,1
1,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.00090094,0.31733,0.27638,1,1
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.0015653,0.3172,0.23568,1,1
1,GO SNRNA PROCESSING,0.001986,0.31672,0.5482,1,1
1,GO REGULATION OF CELL KILLING,0.00095906,0.3167,0.23408,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,3.5759e-05,0.31668,0.30788,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,7.889e-07,0.31659,0.35953,1,1
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.8379e-05,0.31656,0.34451,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0001165,0.31639,0.2824,1,1
1,GO ETHER BIOSYNTHETIC PROCESS,0.0050528,0.31628,0.34057,1,1
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.00044439,0.31617,0.30669,1,1
1,GO REGULATION OF ORGAN GROWTH,2.0829e-07,0.31608,0.34289,1,1
1,GO PROTEIN DEGLYCOSYLATION,0.00021167,0.31509,0.30841,1,1
1,GO RENAL FILTRATION,0.0050528,0.31496,0.37967,1,1
1,GO IRON ION HOMEOSTASIS,4.6623e-06,0.3149,0.27564,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,7.2756e-08,0.3146,0.32672,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,3.0689e-05,0.31442,0.26702,1,1
1,GO INNATE IMMUNE RESPONSE,8.6584e-06,0.31441,0.28882,1,1
1,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0062634,0.31427,0.45453,1,1
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0097392,0.31416,0.23587,1,1
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00010845,0.314,0.27587,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0001547,0.31363,0.28863,1,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.00095906,0.31356,0.40301,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,7.8282e-05,0.31341,0.30256,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00019753,0.31318,0.30409,1,1
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00031859,0.31284,0.29268,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.00018427,0.31264,0.35992,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0010206,0.31251,0.23892,1,1
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.00052342,0.31232,0.29881,1,1
1,GO LIPOPROTEIN LOCALIZATION,0.0001547,0.31231,0.39588,1,1
1,GO REGULATION OF VIRAL TRANSCRIPTION,2.0033e-05,0.31221,0.26598,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,4.0073e-05,0.31209,0.35194,1,1
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.00010845,0.31172,0.28948,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.001191,0.31156,0.20843,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,3.3132e-05,0.31143,0.38887,1,1
1,GO VESICLE CARGO LOADING,0.00012512,0.31075,0.28125,1,1
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,6.0504e-05,0.31036,0.30161,1,1
1,GO OSTEOBLAST DIFFERENTIATION,1.6015e-06,0.31013,0.32627,1,1
1,GO ALPHA BETA T CELL ACTIVATION,0.00011241,0.31,0.24847,1,1
1,GO C21 STEROID HORMONE METABOLIC PROCESS,0.00024286,0.30971,0.34122,1,1
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,5.0226e-05,0.30967,0.28641,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.6603e-06,0.30918,0.30546,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,1.104e-05,0.30911,0.28582,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,7.9801e-06,0.30905,0.41325,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,6.5149e-05,0.30894,0.41687,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.00026903,0.30892,0.2929,1,1
1,GO REGULATION OF CELL MATRIX ADHESION,1.7806e-05,0.30885,0.37349,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,1.7474e-06,0.30865,0.35557,1,1
1,GO MACROPHAGE CHEMOTAXIS,1.9263e-05,0.30858,0.35615,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,2.7578e-07,0.30854,0.33426,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.00065623,0.30823,0.2854,1,1
1,GO RESPONSE TO PROTOZOAN,0.00017186,0.30772,0.31899,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,2.9301e-06,0.30765,0.28173,1,1
1,GO OLIGOPEPTIDE TRANSPORT,0.00065623,0.30728,0.41601,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00072223,0.30639,0.2643,1,1
1,GO NEURAL TUBE PATTERNING,0.00092958,0.30636,0.25352,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0017123,0.3054,0.32425,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,8.7323e-05,0.30525,0.25046,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,7.3528e-06,0.30464,0.2858,1,1
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.00025131,0.30439,0.2987,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.00018427,0.304,0.22811,1,1
1,GO MESENCHYME MORPHOGENESIS,0.0011549,0.30372,0.33791,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,1.3441e-06,0.30344,0.23737,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,3.5759e-05,0.30279,0.30688,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0014738,0.30263,0.29383,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,2.1702e-06,0.30251,0.44319,1,1
1,GO NEURAL CREST CELL DIFFERENTIATION,0.0054795,0.30223,0.22642,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,1.7118e-05,0.3022,0.27805,1,1
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,9.389e-05,0.30201,0.29465,1,1
1,GO PIGMENT METABOLIC PROCESS,1.6455e-05,0.30198,0.26703,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00049035,0.30195,0.28375,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.00016595,0.30194,0.31737,1,1
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.0087944,0.30191,0.35138,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,1.6015e-06,0.30179,0.28198,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,2.1702e-06,0.30171,0.37943,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.00025131,0.30164,0.27413,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00012964,0.3015,0.28746,1,1
1,GO RRNA PSEUDOURIDINE SYNTHESIS,0.020205,0.30131,0.22145,1,1
1,GO SELECTIVE AUTOPHAGY,1.6729e-06,0.30121,0.29974,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,4.3218e-05,0.30117,0.29474,1,1
1,GO PLASMA MEMBRANE TUBULATION,6.4994e-06,0.30096,0.34669,1,1
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,7.9801e-06,0.30055,0.32719,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.349e-05,0.30038,0.27366,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,1.906e-06,0.30032,0.33949,1,1
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0010859,0.30023,0.26164,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.0075304,0.29989,0.22155,1,1
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.03245,0.2998,0.27523,1,1
1,GO POSITIVE REGULATION OF CELL ADHESION,1.1493e-05,0.29941,0.31055,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010845,0.29918,0.28576,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,2.0033e-05,0.29899,0.23336,1,1
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.0017123,0.29871,0.30857,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,5.7413e-06,0.29853,0.26885,1,1
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,7.8282e-05,0.29845,0.38103,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0021689,0.29829,0.23479,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.024288,0.29828,0.31289,1,1
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0013457,0.29826,0.25989,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00011241,0.29798,0.20307,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,2.7343e-05,0.29795,0.31879,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,7.0571e-06,0.29783,0.29025,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0023671,0.29761,0.30454,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,6.5149e-05,0.29726,0.28649,1,1
1,GO PODOSOME ASSEMBLY,7.2754e-05,0.2969,0.37578,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,5.7413e-06,0.2969,0.36236,1,1
1,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.0007696,0.29653,0.38364,1,1
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.00057693,0.29649,0.29969,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00019753,0.29605,0.30434,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,1.2308e-06,0.296,0.28361,1,1
1,GO TRABECULA MORPHOGENESIS,0.00013917,0.29589,0.31048,1,1
1,GO AMEBOIDAL TYPE CELL MIGRATION,1.7474e-06,0.29555,0.30055,1,1
1,GO CORONARY VASCULATURE DEVELOPMENT,1.5816e-05,0.29552,0.35078,1,1
1,GO TRANSPOSITION,0.001662,0.29552,0.28455,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,3.5759e-05,0.29543,0.27013,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.014841,0.29542,0.23032,1,1
1,GO RESPONSE TO CYTOKINE,4.2876e-06,0.29539,0.31178,1,1
1,GO RESPONSE TO RETINOIC ACID,2.5308e-05,0.29505,0.2842,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00047456,0.29502,0.2337,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,1.8251e-06,0.29489,0.25889,1,1
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0014299,0.29486,0.27412,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,2.1702e-06,0.2947,0.31701,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0019282,0.29469,0.34333,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00017796,0.29444,0.35979,1,1
1,GO TONGUE DEVELOPMENT,0.00055855,0.29437,0.37263,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.00098941,0.29414,0.25104,1,1
1,GO CYTOKINE PRODUCTION,9.0179e-06,0.2941,0.27399,1,1
1,GO REGULATION OF CELL AGING,1.9873e-07,0.29407,0.33221,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.001191,0.29401,0.22511,1,1
1,GO SPERM EGG RECOGNITION,1.349e-05,0.29394,0.25495,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,3.5759e-05,0.29377,0.25879,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,4.0073e-05,0.29373,0.24818,1,1
1,GO POSITIVE CHEMOTAXIS,0.0012662,0.29362,0.25041,1,1
1,GO SNRNA METABOLIC PROCESS,0.00059588,0.29348,0.43984,1,1
1,GO TRACHEA MORPHOGENESIS,0.00026003,0.29325,0.2967,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,3.3132e-05,0.29324,0.31984,1,1
1,GO MEMBRANE LIPID CATABOLIC PROCESS,0.0029794,0.29308,0.19773,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00024286,0.29295,0.33106,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0037331,0.29266,0.25563,1,1
1,GO RESPONSE TO DSRNA,3.4728e-06,0.29261,0.35998,1,1
1,GO COAGULATION,3.7791e-06,0.29223,0.3057,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00040247,0.29219,0.24676,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,7.9801e-06,0.29206,0.29555,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0041716,0.29199,0.22628,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00022676,0.29186,0.29323,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,6.5149e-05,0.29172,0.25076,1,1
1,GO GONADOTROPIN SECRETION,0.019739,0.29148,0.23541,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,2.8077e-06,0.29105,0.31887,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.018836,0.29093,0.24037,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,1.9904e-06,0.2906,0.23951,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,1.2862e-06,0.29037,0.30295,1,1
1,GO RESPONSE TO UV B,0.036164,0.29036,0.2277,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,0.00035231,0.29032,0.27157,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00023468,0.29,0.25329,1,1
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0042883,0.28967,0.28732,1,1
1,GO NCRNA PROCESSING,0.00012964,0.28872,0.24901,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00021167,0.2886,0.26168,1,1
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00025131,0.28853,0.26949,1,1
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,8.4205e-05,0.28779,0.31816,1,1
1,GO MYOBLAST FUSION,6.5149e-05,0.28771,0.35071,1,1
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,2.4346e-05,0.28766,0.27792,1,1
1,GO T CELL CHEMOTAXIS,6.5149e-05,0.28754,0.24611,1,1
1,GO REGULATION OF RNA BINDING,1.104e-05,0.28722,0.28958,1,1
1,GO RESPONSE TO BACTERIUM,1.8521e-05,0.2872,0.26653,1,1
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,3.0576e-06,0.28709,0.26919,1,1
1,GO SYMBIOTIC PROCESS,1.5691e-07,0.28705,0.28733,1,1
1,GO LIPID IMPORT INTO CELL,0.0067808,0.28695,0.23656,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,3.0264e-07,0.28687,0.27271,1,1
1,GO STEROL TRANSPORT,0.0001547,0.28642,0.22613,1,1
1,GO ACUTE INFLAMMATORY RESPONSE,7.547e-05,0.28628,0.3471,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,8.7323e-05,0.28627,0.28864,1,1
1,GO ARTERY DEVELOPMENT,0.00042998,0.28608,0.30981,1,1
1,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.023741,0.28599,0.18652,1,1
1,GO REGULATION OF CELLULAR EXTRAVASATION,0.0016129,0.28595,0.27698,1,1
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.012203,0.28592,0.23012,1,1
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00014935,0.28584,0.25273,1,1
1,GO NEGATIVE REGULATION OF OSSIFICATION,3.1888e-05,0.28583,0.2813,1,1
1,GO CELL CELL RECOGNITION,1.2308e-06,0.28569,0.28905,1,1
1,GO ASTROCYTE DEVELOPMENT,2.2524e-05,0.28566,0.34615,1,1
1,GO BONE MORPHOGENESIS,4.0073e-05,0.2853,0.30585,1,1
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.014841,0.2853,0.19944,1,1
1,GO CELLULAR RESPONSE TO VIRUS,0.00027832,0.28499,0.27219,1,1
1,GO MACROPHAGE APOPTOTIC PROCESS,0.0007696,0.28445,0.37107,1,1
1,GO PLACENTA DEVELOPMENT,9.7346e-05,0.28417,0.24456,1,1
1,GO AMINOGLYCAN METABOLIC PROCESS,2.5308e-05,0.28405,0.29741,1,1
1,GO REGULATION OF PEPTIDASE ACTIVITY,0.00067758,0.28405,0.20614,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,2.6902e-06,0.28401,0.26802,1,1
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2962e-05,0.28384,0.34917,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,8.3127e-06,0.2838,0.27605,1,1
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,1.4039e-05,0.28378,0.25396,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0059384,0.28353,0.20022,1,1
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,3.9418e-06,0.28344,0.23832,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00044439,0.28341,0.24429,1,1
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.00020448,0.28297,0.3166,1,1
1,GO REGULATION OF LEUKOCYTE MIGRATION,1.7118e-05,0.28291,0.28086,1,1
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.00045924,0.28272,0.22747,1,1
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.0013872,0.28271,0.27102,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,2.0784e-06,0.28244,0.26693,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,6.7728e-06,0.28234,0.29194,1,1
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00020448,0.28227,0.40919,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,1.6455e-05,0.28227,0.29371,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,7.2754e-05,0.28222,0.23035,1,1
1,GO RNA 5 END PROCESSING,0.001191,0.28201,0.24118,1,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.0073363,0.2819,0.20986,1,1
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.0045306,0.2815,0.4372,1,1
1,GO HISTONE H4 DEACETYLATION,0.0029794,0.28093,0.27769,1,1
1,GO CELLULAR HYPEROSMOTIC RESPONSE,0.00067758,0.28063,0.33651,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,6.2786e-05,0.28061,0.367,1,1
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.042857,0.28057,0.1818,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.019283,0.28044,0.23299,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,9.7346e-05,0.28031,0.21748,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00059588,0.28015,0.24508,1,1
1,GO REGULATION OF GENE SILENCING,1.906e-06,0.28012,0.25829,1,1
1,GO RESPONSE TO IONIZING RADIATION,1.5331e-06,0.2792,0.29396,1,1
1,GO CHOLESTEROL EFFLUX,4.6597e-05,0.27905,0.27208,1,1
1,GO TISSUE REMODELING,0.00020448,0.27882,0.26781,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,3.7145e-05,0.27862,0.31563,1,1
1,GO NUCLEOSIDE SALVAGE,0.0019282,0.27852,0.40917,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,6.7596e-05,0.27852,0.45626,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,3.0576e-06,0.27834,0.30938,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,1.0184e-05,0.27826,0.22138,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,7.547e-05,0.27737,0.2725,1,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.0028141,0.27715,0.1955,1,1
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.018836,0.27707,0.22399,1,1
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.024288,0.27702,0.20516,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,2.4346e-05,0.27695,0.28518,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.023741,0.27687,0.22191,1,1
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00081984,0.2768,0.20867,1,1
1,GO MESENCHYME DEVELOPMENT,1.7118e-05,0.27658,0.25865,1,1
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.019283,0.27642,0.21389,1,1
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.013139,0.27636,0.20499,1,1
1,GO RESPONSE TO OXYGEN RADICAL,7.547e-05,0.27635,0.21509,1,1
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.01282,0.27612,0.24158,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,1.8521e-05,0.27595,0.2436,1,1
1,GO ERK1 AND ERK2 CASCADE,4.1112e-06,0.27594,0.2625,1,1
1,GO RRNA METABOLIC PROCESS,0.00054072,0.27593,0.24076,1,1
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.00084609,0.27574,0.28123,1,1
1,GO TRNA 5 LEADER REMOVAL,0.00036427,0.27553,0.29987,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,2.7343e-05,0.27534,0.27607,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00019079,0.27517,0.25607,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,9.7801e-06,0.27511,0.23816,1,1
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,6.2786e-05,0.27492,0.2892,1,1
1,GO CELLULAR RESPONSE TO LIPID,4.1617e-05,0.27488,0.21772,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.01282,0.27483,0.46088,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,8.6584e-06,0.27461,0.26384,1,1
1,GO T CELL MIGRATION,0.00014935,0.27459,0.27706,1,1
1,GO CELL REDOX HOMEOSTASIS,4.8379e-05,0.27437,0.27323,1,1
1,GO ALPHA BETA T CELL PROLIFERATION,0.024288,0.27378,0.22604,1,1
1,GO ACUTE PHASE RESPONSE,0.0034322,0.27373,0.27708,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,2.6902e-06,0.2732,0.24281,1,1
1,GO FACE DEVELOPMENT,3.7145e-05,0.27319,0.29234,1,1
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,4.3218e-05,0.27309,0.33784,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,1.1267e-06,0.27301,0.25721,1,1
1,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.027803,0.27274,0.24614,1,1
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00059588,0.27266,0.3078,1,1
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0069616,0.27212,0.28256,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,2.4346e-05,0.27192,0.26024,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00013433,0.27188,0.21454,1,1
1,GO MESODERM DEVELOPMENT,4.1112e-06,0.27184,0.2408,1,1
1,GO DNA LIGATION,0.00011241,0.27181,0.30211,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.0013054,0.27174,0.27647,1,1
1,GO RESPONSE TO OSMOTIC STRESS,0.00017186,0.27149,0.22086,1,1
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.0001165,0.27146,0.21707,1,1
1,GO COMPLEMENT ACTIVATION,7.0571e-06,0.27136,0.29459,1,1
1,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.0032441,0.27135,0.26312,1,1
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,2.3418e-05,0.27127,0.31394,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0083534,0.27115,0.23253,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,6.8936e-07,0.27113,0.27984,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.0604e-05,0.27041,0.3078,1,1
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00028792,0.27038,0.27467,1,1
1,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.027803,0.27019,0.21006,1,1
1,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00012964,0.27019,0.23496,1,1
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0012662,0.27018,0.30552,1,1
1,GO DETECTION OF OTHER ORGANISM,0.0012662,0.27011,0.32779,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0011549,0.27009,0.28314,1,1
1,GO TUBE MORPHOGENESIS,1.349e-05,0.26996,0.24183,1,1
1,GO METANEPHRIC NEPHRON DEVELOPMENT,0.00018427,0.26994,0.28228,1,1
1,GO ASTROCYTE DIFFERENTIATION,0.00074557,0.26975,0.21137,1,1
1,GO RIBOSOME BIOGENESIS,0.00041602,0.26974,0.2562,1,1
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00013917,0.26973,0.29802,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.001228,0.26924,0.25561,1,1
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.0013054,0.26909,0.30565,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00027832,0.26873,0.29176,1,1
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0034322,0.26864,0.25376,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0011199,0.26858,0.23295,1,1
1,GO PHAGOCYTOSIS,6.8936e-07,0.26827,0.33898,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.0833e-05,0.26815,0.26917,1,1
1,GO NCRNA 3 END PROCESSING,0.018398,0.26797,0.34733,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0032441,0.26796,0.28997,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,7.6603e-06,0.26748,0.26385,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,3.4772e-07,0.26747,0.27359,1,1
1,GO REGULATION OF LIGASE ACTIVITY,0.0031536,0.26747,0.24447,1,1
1,GO SEQUESTERING OF METAL ION,0.001191,0.26745,0.24946,1,1
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.007729,0.2673,0.19503,1,1
1,GO RESPONSE TO TUMOR CELL,0.011612,0.2672,0.21902,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,1.3441e-06,0.26716,0.27067,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00038934,0.2671,0.2179,1,1
1,GO RESPONSE TO REDOX STATE,0.012203,0.2669,0.22639,1,1
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.016339,0.26674,0.2591,1,1
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00079435,0.26622,0.22936,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,2.4346e-05,0.2662,0.28044,1,1
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0071468,0.26593,0.33779,1,1
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.5816e-05,0.2657,0.27122,1,1
1,GO MIDGUT DEVELOPMENT,0.043763,0.26564,0.20965,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,4.4878e-05,0.26542,0.22717,1,1
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.0016129,0.2653,0.35709,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0026572,0.26523,0.30048,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,3.17e-07,0.26522,0.27484,1,1
1,GO RNA CATABOLIC PROCESS,2.0784e-06,0.26513,0.25257,1,1
1,GO NCRNA METABOLIC PROCESS,0.00026903,0.26492,0.21954,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00067758,0.26473,0.28537,1,1
1,GO REGULATION OF PROTEOLYSIS,1.4609e-05,0.26473,0.20941,1,1
1,GO RESPONSE TO OXYGEN LEVELS,0.00027832,0.2647,0.20119,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0042883,0.26457,0.23402,1,1
1,GO CELL AGING,4.8612e-06,0.26455,0.22253,1,1
1,GO MACROPHAGE CYTOKINE PRODUCTION,0.00098941,0.26451,0.43728,1,1
1,GO CELLULAR RESPONSE TO ETHANOL,0.0028957,0.26448,0.28119,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0027346,0.2644,0.22926,1,1
1,GO VIRION ASSEMBLY,6.0504e-05,0.26433,0.21113,1,1
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0066042,0.26425,0.20845,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,2.1702e-06,0.2642,0.26294,1,1
1,GO TOXIN TRANSPORT,0.0029794,0.26416,0.17846,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00050664,0.26416,0.28707,1,1
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.027188,0.26392,0.18094,1,1
1,GO CARDIAC SEPTUM DEVELOPMENT,9.389e-05,0.26377,0.26546,1,1
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.015203,0.26359,0.20967,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.00040247,0.26345,0.24733,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00055855,0.26343,0.23979,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,9.7801e-06,0.26321,0.38129,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0057817,0.26317,0.26312,1,1
1,GO PROTEIN KINASE B SIGNALING,4.4712e-06,0.26305,0.23763,1,1
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.001228,0.26304,0.18421,1,1
1,GO CELLULAR KETONE METABOLIC PROCESS,2.0833e-05,0.26289,0.21133,1,1
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,8.6584e-06,0.26241,0.24509,1,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,3.3132e-05,0.2621,0.25039,1,1
1,GO HEART VALVE DEVELOPMENT,0.00016023,0.26197,0.31117,1,1
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00069957,0.26187,0.22488,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.00011241,0.26154,0.23751,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,6.7728e-06,0.26154,0.28503,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.00026003,0.26143,0.24139,1,1
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.0018173,0.26131,0.34176,1,1
1,GO REGULATION OF STEM CELL PROLIFERATION,0.018398,0.26096,0.14652,1,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.00041602,0.2609,0.23322,1,1
1,GO AUTOPHAGOSOME MATURATION,8.4205e-05,0.26078,0.25791,1,1
1,GO FATTY ACID BETA OXIDATION,0.00028792,0.26068,0.24757,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,9.7801e-06,0.26068,0.22634,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,2.2658e-06,0.26056,0.33255,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0051916,0.26052,0.2117,1,1
1,GO ATP BIOSYNTHETIC PROCESS,0.0042883,0.2604,0.21414,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,5.8301e-05,0.25998,0.23987,1,1
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0062634,0.25973,0.21081,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,7.547e-05,0.25962,0.20759,1,1
1,GO RESPONSE TO TESTOSTERONE,2.1663e-05,0.25954,0.28266,1,1
1,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0059384,0.25944,0.22938,1,1
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.0021062,0.25933,0.24494,1,1
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.00028792,0.2593,0.27413,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.00045924,0.25927,0.23846,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,6.4994e-06,0.25923,0.3464,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,4.8612e-06,0.25921,0.26233,1,1
1,GO ETHANOL METABOLIC PROCESS,0.0059384,0.25921,0.279,1,1
1,GO MESENCHYMAL CELL DIFFERENTIATION,0.0001165,0.25908,0.23883,1,1
1,GO RNA DESTABILIZATION,3.0689e-05,0.25884,0.2522,1,1
1,GO T CELL PROLIFERATION,0.00032948,0.25878,0.21627,1,1
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.00027832,0.25858,0.24164,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,2.0033e-05,0.25824,0.22355,1,1
1,GO IMMUNE EFFECTOR PROCESS,7.0571e-06,0.25819,0.28504,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,6.0504e-05,0.25806,0.26873,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,2.3654e-06,0.25792,0.31376,1,1
1,GO RESPONSE TO VITAMIN A,0.014138,0.25784,0.19917,1,1
1,GO PROTEIN FOLDING,8.4205e-05,0.25772,0.2204,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.9301e-06,0.2576,0.28521,1,1
1,GO EMBRYONIC EYE MORPHOGENESIS,0.0031536,0.25748,0.25602,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.7343e-05,0.25738,0.31123,1,1
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.0001547,0.25732,0.2487,1,1
1,GO NUCLEAR PORE ORGANIZATION,0.00049035,0.25727,0.25089,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,1.5816e-05,0.25722,0.2565,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,7.2754e-05,0.25674,0.33627,1,1
1,GO TRNA 5 END PROCESSING,0.00029782,0.25637,0.27623,1,1
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00074557,0.25617,0.31142,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00017796,0.25562,0.22705,1,1
1,GO STRESS FIBER ASSEMBLY,0.0007696,0.25553,0.23735,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.00095906,0.25546,0.1819,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.01282,0.25533,0.18868,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,1.2308e-06,0.25531,0.24738,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.00010092,0.25529,0.27071,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2962e-05,0.2547,0.29806,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00029782,0.25459,0.19909,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,1.104e-05,0.2544,0.25618,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,3.0689e-05,0.25431,0.2312,1,1
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.02068,0.25355,0.19067,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,5.508e-06,0.25329,0.27255,1,1
1,GO RESPONSE TO BIOTIC STIMULUS,7.9801e-06,0.25303,0.254,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,6.0198e-07,0.25298,0.24698,1,1
1,GO LEUKOCYTE CELL CELL ADHESION,7.013e-05,0.25279,0.24207,1,1
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,6.2786e-05,0.25276,0.28574,1,1
1,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.01282,0.25264,0.27943,1,1
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00026003,0.25262,0.20319,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,3.0689e-05,0.25242,0.21137,1,1
1,GO LYMPHOCYTE MIGRATION,9.0551e-05,0.25196,0.22897,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00063551,0.25158,0.26698,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,2.4692e-06,0.25132,0.2362,1,1
1,GO INFLAMMATORY RESPONSE,6.7596e-05,0.25125,0.24954,1,1
1,GO REGULATION OF VASOCONSTRICTION,0.00018427,0.25096,0.25556,1,1
1,GO FIBROBLAST APOPTOTIC PROCESS,0.017137,0.25051,0.23408,1,1
1,GO LIPID OXIDATION,0.0015189,0.2504,0.19167,1,1
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00047456,0.25035,0.24009,1,1
1,GO OSTEOCLAST DIFFERENTIATION,1.9904e-06,0.25017,0.24218,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,0.0028957,0.25013,0.21101,1,1
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0019282,0.24999,0.30159,1,1
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,5.8301e-05,0.2499,0.29269,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,2.0833e-05,0.24952,0.21807,1,1
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0029794,0.24942,0.21488,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,1.5816e-05,0.24918,0.29605,1,1
1,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0028957,0.24892,0.2482,1,1
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.010245,0.24891,0.28982,1,1
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00017186,0.24818,0.21648,1,1
1,GO RRNA TRANSCRIPTION,0.0019282,0.24808,0.19882,1,1
1,GO NUCLEUS LOCALIZATION,0.0073363,0.24791,0.16321,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,2.8418e-05,0.24744,0.21394,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,9.389e-05,0.24708,0.23038,1,1
1,GO SEQUESTERING OF TRIGLYCERIDE,0.0028957,0.24704,0.33249,1,1
1,GO GTP METABOLIC PROCESS,0.00052342,0.24681,0.28293,1,1
1,GO T CELL ACTIVATION,3.7145e-05,0.24678,0.2242,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,1.6455e-05,0.24651,0.25956,1,1
1,GO AMELOGENESIS,0.009256,0.24648,0.24992,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,4.8612e-06,0.24637,0.24519,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00016023,0.24627,0.20578,1,1
1,GO SMOOTHENED SIGNALING PATHWAY,0.00057693,0.24626,0.17812,1,1
1,GO CARDIOLIPIN METABOLIC PROCESS,0.036948,0.24609,0.12711,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,7.6603e-06,0.24599,0.29026,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,8.4205e-05,0.24585,0.22292,1,1
1,GO P38MAPK CASCADE,2.4346e-05,0.24581,0.33779,1,1
1,GO NEGATIVE REGULATION OF DNA REPLICATION,0.023205,0.24469,0.17117,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00013433,0.24461,0.22382,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0042883,0.24436,0.3828,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,1.1493e-05,0.24432,0.24978,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,7.3528e-06,0.24408,0.21467,1,1
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00028792,0.244,0.27341,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.00042998,0.24347,0.22118,1,1
1,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.046579,0.24318,0.16755,1,1
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0013872,0.24315,0.21731,1,1
1,GO AORTA DEVELOPMENT,0.0033369,0.24311,0.29162,1,1
1,GO NATURAL KILLER CELL PROLIFERATION,0.0042883,0.24301,0.34396,1,1
1,GO RESPONSE TO STEROID HORMONE,0.00021167,0.24275,0.20022,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,3.1888e-05,0.24259,0.21215,1,1
1,GO REGULATION OF IMMUNE RESPONSE,1.0184e-05,0.24247,0.2257,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.023205,0.24242,0.15661,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,3.6228e-06,0.24234,0.24713,1,1
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0006154,0.24227,0.22492,1,1
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00027832,0.24223,0.23301,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,0.00014935,0.24204,0.26179,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0013054,0.24196,0.18179,1,1
1,GO RRNA MODIFICATION,0.012203,0.24195,0.1653,1,1
1,GO LEUKOCYTE MEDIATED IMMUNITY,1.349e-05,0.24185,0.28526,1,1
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00055855,0.24174,0.19226,1,1
1,GO REGULATION OF MITOPHAGY,0.019739,0.24166,0.19067,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0069616,0.24149,0.15923,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00054072,0.24144,0.1851,1,1
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,1.4039e-05,0.24117,0.2362,1,1
1,GO NADP METABOLIC PROCESS,0.037747,0.24105,0.16528,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,2.4346e-05,0.24064,0.21189,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.00049035,0.24034,0.27216,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,1.4044e-06,0.24034,0.22714,1,1
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00022676,0.24023,0.2237,1,1
1,GO PEPTIDE METABOLIC PROCESS,8.6584e-06,0.24018,0.20283,1,1
1,GO OSSIFICATION,5.0226e-05,0.24013,0.23337,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00057693,0.24008,0.22153,1,1
1,GO AUTOPHAGY OF NUCLEUS,0.0015653,0.24005,0.22822,1,1
1,GO PLATELET ACTIVATION,6.7596e-05,0.23998,0.24849,1,1
1,GO SCHWANN CELL DIFFERENTIATION,0.00012074,0.23988,0.21572,1,1
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.4421e-05,0.23948,0.36188,1,1
1,GO REGULATION OF CELL ADHESION,0.00045924,0.23935,0.20896,1,1
1,GO DEFENSE RESPONSE,2.8418e-05,0.2391,0.23251,1,1
1,GO MITOTIC CELL CYCLE ARREST,0.0099891,0.23909,0.19715,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0034322,0.23905,0.18963,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.0028141,0.23891,0.20424,1,1
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.014138,0.23889,0.25244,1,1
1,GO MEMBRANE BIOGENESIS,0.011047,0.23859,0.21032,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,0.0007696,0.23846,0.19006,1,1
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.2524e-05,0.23845,0.3011,1,1
1,GO EPITHELIAL CELL PROLIFERATION,0.00026903,0.23821,0.21377,1,1
1,GO CELLULAR DEFENSE RESPONSE,0.0017641,0.23782,0.28637,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00032948,0.2378,0.18826,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0017123,0.23778,0.25366,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00025131,0.23778,0.33391,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0062634,0.23754,0.2021,1,1
1,GO ANIMAL ORGAN FORMATION,0.00095906,0.23742,0.21853,1,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,1.2454e-05,0.23739,0.21833,1,1
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.00041602,0.23711,0.2014,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,1.8521e-05,0.23703,0.27174,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00063551,0.23651,0.23134,1,1
1,GO HEAD MORPHOGENESIS,0.00072223,0.23645,0.26753,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,0.00072223,0.23614,0.22916,1,1
1,GO MYOTUBE DIFFERENTIATION,0.0066042,0.23595,0.16044,1,1
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.00054072,0.23585,0.25146,1,1
1,GO ORGAN GROWTH,5.0226e-05,0.23549,0.24024,1,1
1,GO DNA DEALKYLATION,0.0011199,0.23537,0.224,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0020453,0.23516,0.21539,1,1
1,GO HYPEROSMOTIC RESPONSE,0.00092958,0.23488,0.24565,1,1
1,GO HISTONE H2B UBIQUITINATION,0.007729,0.23483,0.1696,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00013433,0.23444,0.20871,1,1
1,GO LIPID STORAGE,0.00032948,0.23358,0.23996,1,1
1,GO CELLULAR IRON ION HOMEOSTASIS,5.8301e-05,0.23317,0.20343,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,9.8628e-07,0.2331,0.27221,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,8.1192e-05,0.23293,0.26472,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00036427,0.23282,0.23798,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,1.1964e-05,0.23268,0.35232,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0007696,0.23266,0.27671,1,1
1,GO NEGATIVE REGULATION OF DNA REPAIR,1.1964e-05,0.23235,0.24826,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.547e-05,0.23229,0.24429,1,1
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.014486,0.23228,0.2219,1,1
1,GO LEUKOCYTE PROLIFERATION,0.0011549,0.23221,0.18435,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,9.3916e-06,0.23214,0.21486,1,1
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0010859,0.23208,0.25865,1,1
1,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0059384,0.23172,0.17069,1,1
1,GO MYELOID CELL HOMEOSTASIS,2.9301e-06,0.23169,0.23265,1,1
1,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.018836,0.23134,0.15806,1,1
1,GO CELLULAR EXTRAVASATION,9.7346e-05,0.23119,0.22768,1,1
1,GO CELLULAR OXIDANT DETOXIFICATION,0.0019282,0.23117,0.18135,1,1
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00034072,0.23093,0.26455,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00012512,0.23091,0.19516,1,1
1,GO POSITIVE REGULATION OF CELL ACTIVATION,3.1888e-05,0.23062,0.23412,1,1
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.00029782,0.23044,0.20567,1,1
1,GO TRNA METHYLATION,0.0012662,0.23037,0.18249,1,1
1,GO REGULATION OF PROTON TRANSPORT,0.0024367,0.23037,0.21071,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0029794,0.23004,0.30007,1,1
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.0013054,0.23001,0.23649,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,1.6729e-06,0.22991,0.2337,1,1
1,GO REGULATION OF HEMOPOIESIS,4.1112e-06,0.22985,0.22174,1,1
1,GO STEROL IMPORT,0.00029782,0.22965,0.4251,1,1
1,GO RNA 3 END PROCESSING,0.00069957,0.22924,0.17783,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,2.3654e-06,0.22913,0.20771,1,1
1,GO DE NOVO PROTEIN FOLDING,0.0085714,0.22912,0.15997,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.0019282,0.22889,0.2447,1,1
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,7.2754e-05,0.22864,0.25798,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,1.4044e-06,0.22854,0.23009,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0013457,0.22842,0.19926,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.001986,0.22801,0.19141,1,1
1,GO CERAMIDE TRANSPORT,0.0075304,0.22783,0.2135,1,1
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0030654,0.22732,0.19223,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.00019753,0.22728,0.23402,1,1
1,GO POSITIVE REGULATION OF HEMOPOIESIS,8.4205e-05,0.22711,0.22781,1,1
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,3.7145e-05,0.22703,0.26137,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,2.1663e-05,0.22691,0.22672,1,1
1,GO AGING,2.1663e-05,0.22677,0.19722,1,1
1,GO POSITIVE REGULATION OF CELL KILLING,0.014138,0.22677,0.16809,1,1
1,GO MITOPHAGY,0.0010206,0.22669,0.22377,1,1
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,2.1663e-05,0.22657,0.24154,1,1
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00041602,0.22647,0.22662,1,1
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,2.4346e-05,0.22606,0.22339,1,1
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00012964,0.226,0.24294,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00014418,0.22585,0.21157,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00014418,0.22555,0.35716,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,2.9532e-05,0.2255,0.23577,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,7.5427e-07,0.2252,0.20175,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00035231,0.22519,0.27492,1,1
1,GO REGULATION OF BODY FLUID LEVELS,8.7323e-05,0.22516,0.20614,1,1
1,GO KINETOCHORE ASSEMBLY,0.033894,0.22504,0.17756,1,1
1,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.0021689,0.22479,0.29095,1,1
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,6.7596e-05,0.22465,0.18459,1,1
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.0014299,0.22433,0.17241,1,1
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,2.3418e-05,0.22415,0.21293,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0026572,0.22404,0.19728,1,1
1,GO RESPONSE TO GONADOTROPIN,0.0032441,0.2238,0.28977,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00042998,0.22367,0.22375,1,1
1,GO PERICARDIUM DEVELOPMENT,0.0013054,0.2236,0.2806,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,1.9263e-05,0.22333,0.28046,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0069616,0.2233,0.20609,1,1
1,GO CELL KILLING,0.0023671,0.22321,0.16413,1,1
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0056288,0.22304,0.22693,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE,0.00090094,0.22304,0.19288,1,1
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00026903,0.22294,0.23449,1,1
1,GO PLATELET MORPHOGENESIS,0.00041602,0.22279,0.22896,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0017123,0.22265,0.21737,1,1
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0007696,0.22254,0.23043,1,1
1,GO LEUKOCYTE HOMEOSTASIS,9.389e-05,0.22209,0.20622,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,4.1112e-06,0.22209,0.24222,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00019753,0.22208,0.32803,1,1
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.011326,0.22193,0.1673,1,1
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.001191,0.22185,0.21192,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0025083,0.22171,0.2781,1,1
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,2.4692e-06,0.22127,0.21364,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,0.0045306,0.22116,0.19011,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00012074,0.22115,0.22921,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,2.6307e-05,0.22078,0.19256,1,1
1,GO REGULATION OF MUSCLE HYPERTROPHY,0.020205,0.22062,0.15277,1,1
1,GO REGULATION OF URINE VOLUME,9.389e-05,0.22054,0.25475,1,1
1,GO MITOCHONDRIAL DNA REPLICATION,0.001662,0.22028,0.17466,1,1
1,GO REPLACEMENT OSSIFICATION,0.0014299,0.22015,0.32086,1,1
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.6597e-05,0.21995,0.21261,1,1
1,GO OVULATION,0.031059,0.21987,0.22934,1,1
1,GO BODY FLUID SECRETION,0.00036427,0.21983,0.20859,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00031859,0.21961,0.23222,1,1
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.00038934,0.21958,0.20983,1,1
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,1.4609e-05,0.21957,0.2041,1,1
1,GO NCRNA EXPORT FROM NUCLEUS,0.001986,0.21939,0.19961,1,1
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.031059,0.21936,0.15708,1,1
1,GO TISSUE MORPHOGENESIS,3.0689e-05,0.21928,0.197,1,1
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0050528,0.21909,0.19272,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.5816e-05,0.21904,0.2348,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,1.5201e-05,0.21884,0.22275,1,1
1,GO HEMOGLOBIN METABOLIC PROCESS,0.011904,0.2188,0.17683,1,1
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.00024286,0.21859,0.20796,1,1
1,GO INTERFERON GAMMA PRODUCTION,5.2139e-05,0.21747,0.26436,1,1
1,GO REGULATION OF CENTRIOLE REPLICATION,0.004408,0.21699,0.16796,1,1
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0017123,0.2169,0.18389,1,1
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.0014299,0.21687,0.21787,1,1
1,GO POSITIVE REGULATION OF NEURON MIGRATION,0.042857,0.21642,0.16515,1,1
1,GO MORPHOGENESIS OF AN EPITHELIUM,2.8418e-05,0.21603,0.20201,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00026903,0.216,0.19705,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,1.0604e-05,0.216,0.18088,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.001228,0.21583,0.18594,1,1
1,GO TRANSEPITHELIAL TRANSPORT,0.0010528,0.21566,0.22342,1,1
1,GO PORE COMPLEX ASSEMBLY,0.0050528,0.21566,0.17833,1,1
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.0062634,0.21546,0.20174,1,1
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.00098941,0.21528,0.23103,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,7.0571e-06,0.21526,0.19502,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,1.4674e-06,0.21471,0.20647,1,1
1,GO REGULATION OF CELL ACTIVATION,5.4121e-05,0.21463,0.20738,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.0071468,0.21454,0.28688,1,1
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.00027832,0.21444,0.22214,1,1
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0038387,0.2141,0.15056,1,1
1,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.02268,0.21399,0.24884,1,1
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0011199,0.21397,0.24272,1,1
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.00092958,0.21394,0.23137,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0032441,0.21379,0.21339,1,1
1,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0033369,0.21359,0.13852,1,1
1,GO BONE DEVELOPMENT,3.5759e-05,0.21353,0.24032,1,1
1,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.022165,0.21345,0.2021,1,1
1,GO SPINDLE LOCALIZATION,3.3287e-06,0.21337,0.2116,1,1
1,GO TRANSITION METAL ION HOMEOSTASIS,0.00012512,0.21324,0.20425,1,1
1,GO NEURAL TUBE DEVELOPMENT,0.00084609,0.21322,0.20908,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.0017641,0.21315,0.19176,1,1
1,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.042857,0.21291,0.12547,1,1
1,GO TRNA MODIFICATION,0.0036303,0.21222,0.14837,1,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.0079323,0.21153,0.26754,1,1
1,GO RNA MODIFICATION,0.00069957,0.21144,0.16051,1,1
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00016023,0.21143,0.19185,1,1
1,GO CELL ACTIVATION,1.4039e-05,0.21138,0.23614,1,1
1,GO REGULATION OF DEFENSE RESPONSE,8.4205e-05,0.21122,0.20466,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,2.2658e-06,0.21113,0.24401,1,1
1,GO RESPONSE TO LIPID,0.00032948,0.21105,0.17802,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0015189,0.21091,0.18545,1,1
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,2.4346e-05,0.21087,0.23069,1,1
1,GO MITOTIC CYTOKINESIS,0.00014418,0.21071,0.22298,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0081404,0.21035,0.25722,1,1
1,GO LYMPHOCYTE ACTIVATION,2.8418e-05,0.21024,0.20422,1,1
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,1.7806e-05,0.21022,0.21866,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,2.6307e-05,0.20992,0.18093,1,1
1,GO PROTEIN TARGETING TO MEMBRANE,0.0083534,0.20978,0.17206,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,0.00025131,0.20959,0.19766,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00013917,0.20958,0.19798,1,1
1,GO RRNA METHYLATION,0.018398,0.20936,0.13963,1,1
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0040578,0.20936,0.18476,1,1
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0067808,0.20905,0.18836,1,1
1,GO REGULATION OF T CELL ACTIVATION,0.00017796,0.20885,0.19896,1,1
1,GO TRNA PROCESSING,0.0025083,0.20879,0.14846,1,1
1,GO TETRAHYDROFOLATE INTERCONVERSION,0.0085714,0.20848,0.21244,1,1
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.019739,0.20847,0.24045,1,1
1,GO FATTY ACID CATABOLIC PROCESS,0.0024367,0.20847,0.16859,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,6.7728e-06,0.20827,0.2102,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.001228,0.20827,0.19278,1,1
1,GO MYELOID CELL DIFFERENTIATION,4.2876e-06,0.20806,0.19327,1,1
1,GO RESPONSE TO ISCHEMIA,0.00079435,0.20766,0.19136,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,4.4712e-06,0.20749,0.23372,1,1
1,GO CAMP METABOLIC PROCESS,0.02843,0.20744,0.21666,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,1.104e-05,0.20742,0.25151,1,1
1,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.0071468,0.20731,0.2454,1,1
1,GO SUPEROXIDE METABOLIC PROCESS,0.0020453,0.20702,0.17657,1,1
1,GO MYELOID LEUKOCYTE ACTIVATION,5.0226e-05,0.20697,0.27355,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00038934,0.20654,0.18097,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,1.7118e-05,0.20651,0.22746,1,1
1,GO LEUKOCYTE MIGRATION,0.0016129,0.20628,0.19458,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0073363,0.20604,0.1813,1,1
1,GO GLIAL CELL APOPTOTIC PROCESS,0.0090226,0.20574,0.2971,1,1
1,GO PROTEIN ADP RIBOSYLATION,0.012508,0.20567,0.16538,1,1
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.00353,0.20564,0.17078,1,1
1,GO POSITIVE REGULATION OF PROTEIN BINDING,0.00013917,0.20545,0.19083,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.00042998,0.2054,0.22312,1,1
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0037331,0.2054,0.22591,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.0028957,0.20534,0.22461,1,1
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0022992,0.20503,0.20466,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,8.3127e-06,0.20499,0.2006,1,1
1,GO RUFFLE ORGANIZATION,0.001986,0.20481,0.1557,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00041602,0.2047,0.1791,1,1
1,GO REGULATION OF LIPID LOCALIZATION,0.00034072,0.20436,0.16897,1,1
1,GO RESPONSE TO KETONE,0.0038387,0.20427,0.15619,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,1.8251e-06,0.20376,0.23503,1,1
1,GO CELLULAR RESPONSE TO ATP,0.0007696,0.20366,0.19658,1,1
1,GO MIDBODY ABSCISSION,0.0094949,0.2034,0.20782,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,1.9263e-05,0.20319,0.21673,1,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,6.5149e-05,0.20293,0.15689,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00037661,0.20272,0.17302,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.2786e-05,0.20259,0.25004,1,1
1,GO REGULATION OF LIPID STORAGE,0.00069957,0.2024,0.23966,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0060989,0.20239,0.23577,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.009256,0.20209,0.19572,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0007696,0.20208,0.18926,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.00026903,0.20205,0.17786,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0017641,0.20204,0.18437,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.00013917,0.20189,0.1684,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,4.6623e-06,0.20184,0.19624,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.001228,0.20164,0.16341,1,1
1,GO SECRETION BY TISSUE,0.029068,0.20161,0.14299,1,1
1,GO HEART GROWTH,0.00057693,0.20136,0.1967,1,1
1,GO TRNA METABOLIC PROCESS,0.0030654,0.20095,0.14574,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,1.0311e-06,0.20085,0.1923,1,1
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.010245,0.2008,0.22092,1,1
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0032441,0.20054,0.20109,1,1
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,1.906e-06,0.20027,0.18125,1,1
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.011326,0.20021,0.16208,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00032948,0.20009,0.19356,1,1
1,GO NEUROINFLAMMATORY RESPONSE,0.025414,0.19991,0.2154,1,1
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,9.7346e-05,0.19988,0.17125,1,1
1,GO PROTEIN PROCESSING,0.00023468,0.19977,0.20209,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,0.00069957,0.19966,0.20027,1,1
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.00090094,0.19931,0.23381,1,1
1,GO CARNITINE SHUTTLE,0.042857,0.19902,0.15634,1,1
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00065623,0.19887,0.16878,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,5.2533e-07,0.19884,0.16616,1,1
1,GO NUCLEAR EXPORT,8.3127e-06,0.19868,0.20204,1,1
1,GO TUBE DEVELOPMENT,0.00010462,0.19846,0.19742,1,1
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.02268,0.19825,0.20528,1,1
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.013139,0.19799,0.13373,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0026572,0.19748,0.20278,1,1
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.013798,0.1974,0.15479,1,1
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,6.2786e-05,0.19708,0.18961,1,1
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.033894,0.19694,0.091015,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.010245,0.19672,0.19274,1,1
1,GO NEURAL TUBE FORMATION,0.001986,0.19646,0.20077,1,1
1,GO HEART TRABECULA MORPHOGENESIS,0.0053338,0.19631,0.20348,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,9.7801e-06,0.19627,0.22044,1,1
1,GO PROTEOGLYCAN METABOLIC PROCESS,0.0026572,0.19597,0.22768,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,3.1888e-05,0.1959,0.17572,1,1
1,GO VESICLE TARGETING,0.00049035,0.19585,0.19756,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.011326,0.1958,0.20103,1,1
1,GO STEM CELL DIFFERENTIATION,2.2524e-05,0.19562,0.20305,1,1
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.031748,0.19555,0.15749,1,1
1,GO TRNA WOBBLE BASE MODIFICATION,0.0087944,0.19538,0.1661,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,0.00014418,0.19521,0.16457,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,6.7728e-06,0.19489,0.18352,1,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,4.4878e-05,0.19428,0.2027,1,1
1,GO TRANSLATIONAL ELONGATION,0.007729,0.19408,0.16328,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.010773,0.19402,0.12874,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,1.5816e-05,0.19354,0.19428,1,1
1,GO ALDITOL METABOLIC PROCESS,0.0013872,0.19338,0.20366,1,1
1,GO TRANSLATIONAL TERMINATION,0.0029794,0.19295,0.19824,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,0.00019753,0.19255,0.17619,1,1
1,GO RESPONSE TO GAMMA RADIATION,6.7596e-05,0.19175,0.23926,1,1
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00034072,0.19172,0.29373,1,1
1,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.044685,0.19165,0.16492,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,2.0033e-05,0.19162,0.19654,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,9.0551e-05,0.1916,0.23249,1,1
1,GO RESPONSE TO UV,2.9532e-05,0.19128,0.19393,1,1
1,GO PROTEIN TARGETING,0.00034072,0.19024,0.16372,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,9.389e-05,0.19012,0.16057,1,1
1,GO ENDOTHELIAL CELL PROLIFERATION,0.00032948,0.19008,0.2029,1,1
1,GO SULFUR COMPOUND METABOLIC PROCESS,6.7596e-05,0.19004,0.18236,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00025131,0.19004,0.19606,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.00035231,0.19003,0.16092,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.00074557,0.19001,0.18505,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,4.4878e-05,0.18989,0.1941,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.001228,0.18987,0.16965,1,1
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00010092,0.18966,0.19574,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00067758,0.18957,0.16348,1,1
1,GO NEGATIVE REGULATION OF MAPK CASCADE,0.0006154,0.18945,0.14596,1,1
1,GO CARDIAC CHAMBER MORPHOGENESIS,0.013139,0.1894,0.17167,1,1
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.004408,0.18937,0.14175,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,6.0504e-05,0.18895,0.20022,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00024286,0.1889,0.20944,1,1
1,GO PEPTIDYL ARGININE MODIFICATION,0.00067758,0.18864,0.15066,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.0029794,0.18839,0.13876,1,1
1,GO IMMUNE SYSTEM DEVELOPMENT,1.1964e-05,0.18834,0.16972,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0025083,0.18806,0.18791,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,0.00041602,0.18757,0.19532,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00098941,0.18753,0.1846,1,1
1,GO GLIAL CELL MIGRATION,0.017549,0.18746,0.1878,1,1
1,GO APOPTOTIC SIGNALING PATHWAY,0.00019079,0.18744,0.17768,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,3.6414e-07,0.18718,0.1792,1,1
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,2.0033e-05,0.18716,0.15696,1,1
1,GO RESPONSE TO GROWTH FACTOR,8.7323e-05,0.18714,0.178,1,1
1,GO HISTONE DEACETYLATION,0.00052342,0.18712,0.1312,1,1
1,GO ORGANELLE INHERITANCE,0.0013054,0.18635,0.17319,1,1
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.031748,0.18628,0.1327,1,1
1,GO CELLULAR RESPONSE TO UV,0.00025131,0.18588,0.18047,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0013054,0.18588,0.22103,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,3.1904e-06,0.18517,0.1544,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,6.5149e-05,0.18497,0.18282,1,1
1,GO POSITIVE REGULATION OF CELL AGING,0.0054795,0.18468,0.26426,1,1
1,GO BIOLOGICAL ADHESION,0.0054795,0.18456,0.13772,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,5.2139e-05,0.18445,0.15923,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.00054072,0.18442,0.16693,1,1
1,GO PROTEIN LOCALIZATION TO ENDOSOME,0.023205,0.18388,0.16966,1,1
1,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.033894,0.18372,0.19789,1,1
1,GO RNA METHYLATION,0.0024367,0.18327,0.15141,1,1
1,GO REGULATION OF AMYLOID BETA FORMATION,0.026586,0.18289,0.16963,1,1
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0073363,0.18289,0.15852,1,1
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00045924,0.18284,0.15845,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,7.2754e-05,0.18279,0.17373,1,1
1,GO SKELETAL SYSTEM DEVELOPMENT,0.00092958,0.18265,0.1753,1,1
1,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.024846,0.18262,0.13464,1,1
1,GO CELLULAR RESPONSE TO HEAT,0.001986,0.18255,0.16681,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,3.6228e-06,0.18255,0.184,1,1
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0039469,0.18224,0.12844,1,1
1,GO HISTONE MRNA METABOLIC PROCESS,0.011326,0.18222,0.1246,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.04854,0.182,0.15516,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,4.0073e-05,0.18161,0.1616,1,1
1,GO RESPONSE TO INTERLEUKIN 4,0.001986,0.18153,0.16156,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00021167,0.18152,0.16634,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0013872,0.18143,0.14652,1,1
1,GO CHYLOMICRON ASSEMBLY,0.038561,0.18109,0.1737,1,1
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.029719,0.1806,0.21274,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.007729,0.18033,0.20721,1,1
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.00055855,0.18021,0.17218,1,1
1,GO CARDIAC CHAMBER DEVELOPMENT,0.0049174,0.18001,0.16127,1,1
1,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.033894,0.17995,0.23596,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.031059,0.17981,0.12261,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,4.3763e-07,0.17974,0.17823,1,1
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00027832,0.17948,0.15484,1,1
1,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.036164,0.17914,0.1784,1,1
1,GO POSITIVE REGULATION OF DNA REPLICATION,0.0081404,0.17905,0.11172,1,1
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.0040578,0.17899,0.15288,1,1
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.00041602,0.1787,0.16371,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.00069957,0.17842,0.17965,1,1
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.00017796,0.17811,0.1754,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.00020448,0.17808,0.15762,1,1
1,GO XENOBIOTIC TRANSPORT,0.0022332,0.17807,0.23296,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,9.0179e-06,0.17749,0.1777,1,1
1,GO MITOTIC SPINDLE ORGANIZATION,0.00030804,0.17717,0.17856,1,1
1,GO MEIOTIC SPINDLE ORGANIZATION,0.0017641,0.17712,0.18556,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00090094,0.17681,0.20695,1,1
1,GO SULFUR COMPOUND TRANSPORT,0.00024286,0.17648,0.16499,1,1
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00016023,0.17599,0.16591,1,1
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0067808,0.17584,0.13437,1,1
1,GO TRNA TRANSPORT,0.0097392,0.17573,0.14978,1,1
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00023468,0.17564,0.19278,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,3.4728e-06,0.17557,0.16743,1,1
1,GO AUTOPHAGOSOME ORGANIZATION,0.00013917,0.17476,0.2001,1,1
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.0047853,0.17469,0.16813,1,1
1,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0099891,0.17462,0.17046,1,1
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.0036303,0.17454,0.14473,1,1
1,GO MULTIVESICULAR BODY ORGANIZATION,0.0053338,0.17437,0.13567,1,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.00087311,0.17435,0.16124,1,1
1,GO GOLGI VESICLE TRANSPORT,2.3418e-05,0.17426,0.16258,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.0011549,0.17419,0.1829,1,1
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.0028957,0.17392,0.14811,1,1
1,GO SCHWANN CELL DEVELOPMENT,0.0021062,0.17384,0.1709,1,1
1,GO CENTRIOLE ASSEMBLY,0.007729,0.17344,0.12327,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0040578,0.17324,0.12996,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00049035,0.17309,0.17282,1,1
1,GO MITOCHONDRIAL TRANSLATION,0.0075304,0.17296,0.15636,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,2.6902e-06,0.17273,0.16172,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.013139,0.17266,0.17177,1,1
1,GO REGULATION OF MAPK CASCADE,8.4205e-05,0.17259,0.16851,1,1
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0013872,0.17233,0.18664,1,1
1,GO DEFENSE RESPONSE TO BACTERIUM,0.0018173,0.17231,0.16897,1,1
1,GO RESPONSE TO CHEMOKINE,0.016339,0.17226,0.18439,1,1
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.021165,0.1722,0.13754,1,1
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.0075304,0.17211,0.17531,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,1.906e-06,0.17186,0.16152,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0021062,0.17184,0.15173,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00069957,0.17181,0.17894,1,1
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.04854,0.1717,0.19297,1,1
1,GO LYSOSOMAL TRANSPORT,0.00057693,0.17139,0.16816,1,1
1,GO TRANSLESION SYNTHESIS,0.00034072,0.17119,0.17023,1,1
1,GO POSITIVE REGULATION OF CELL DIVISION,0.030383,0.17116,0.13323,1,1
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.0033369,0.17095,0.16982,1,1
1,GO REGULATION OF RESPONSE TO STRESS,2.6307e-05,0.17084,0.16534,1,1
1,GO COENZYME A METABOLIC PROCESS,0.013139,0.17074,0.15407,1,1
1,GO LEUKOCYTE DIFFERENTIATION,0.00014418,0.17039,0.17214,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0017641,0.17018,0.14282,1,1
1,GO REGULATION OF NUCLEAR DIVISION,2.7343e-05,0.17003,0.14911,1,1
1,GO RESPONSE TO MINERALOCORTICOID,0.0056288,0.1699,0.2433,1,1
1,GO BLASTOCYST GROWTH,0.0025083,0.16955,0.24007,1,1
1,GO REGULATION OF CATABOLIC PROCESS,7.889e-07,0.1695,0.1623,1,1
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0001547,0.16919,0.13964,1,1
1,GO REGULATION OF CELL SHAPE,0.0030654,0.16902,0.18732,1,1
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.041093,0.16883,0.10593,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.001228,0.16866,0.24956,1,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0053338,0.16863,0.19901,1,1
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0038387,0.16858,0.19841,1,1
1,GO MUSCLE ORGAN MORPHOGENESIS,0.047551,0.16848,0.13367,1,1
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0075304,0.16841,0.12716,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0039469,0.16818,0.14856,1,1
1,GO DENDRITIC CELL CHEMOTAXIS,0.036164,0.16812,0.20338,1,1
1,GO IMPORT INTO NUCLEUS,0.00028792,0.16798,0.13799,1,1
1,GO COPII COATED VESICLE CARGO LOADING,0.0016129,0.16756,0.18402,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,3.7791e-06,0.16748,0.15617,1,1
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.00353,0.16744,0.17834,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.026586,0.16734,0.1768,1,1
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0011199,0.16726,0.13087,1,1
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00026003,0.16683,0.18679,1,1
1,GO RESPONSE TO BMP,0.021165,0.16642,0.13928,1,1
1,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.016339,0.16632,0.13615,1,1
1,GO AMYLOID BETA METABOLIC PROCESS,0.016339,0.16626,0.15872,1,1
1,GO LAMELLIPODIUM ORGANIZATION,0.00052342,0.1659,0.21976,1,1
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.041093,0.16577,0.13426,1,1
1,GO REGULATION OF OSSIFICATION,0.00025131,0.16574,0.23308,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0019282,0.16567,0.1888,1,1
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,6.5149e-05,0.16563,0.14963,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0021689,0.16556,0.13085,1,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,9.7346e-05,0.16554,0.13758,1,1
1,GO NEGATIVE REGULATION OF JNK CASCADE,0.0083534,0.16545,0.13942,1,1
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.011612,0.16518,0.17322,1,1
1,GO PROTEIN KINASE A SIGNALING,0.00020448,0.16514,0.20909,1,1
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.00034072,0.16511,0.20207,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.004408,0.16504,0.17076,1,1
1,GO POSITIVE REGULATION OF CELL DEATH,0.00055855,0.16459,0.14039,1,1
1,GO LAMELLIPODIUM ASSEMBLY,0.00067758,0.16451,0.21238,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,4.2876e-06,0.16447,0.16909,1,1
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00018427,0.16445,0.18211,1,1
1,GO REGULATION OF MYELINATION,0.011612,0.16445,0.14145,1,1
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.011326,0.16437,0.17336,1,1
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0026572,0.16378,0.12129,1,1
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.027188,0.16357,0.21513,1,1
1,GO RESPONSE TO PH,0.025994,0.16335,0.17198,1,1
1,GO RESPONSE TO ANTIBIOTIC,0.0016129,0.16316,0.19236,1,1
1,GO RNA DECAPPING,0.00041602,0.16313,0.19151,1,1
1,GO POSITIVE REGULATION OF BINDING,0.00016595,0.16287,0.15988,1,1
1,GO REGULATION OF MUSCLE ADAPTATION,0.044685,0.16286,0.099072,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,6.4994e-06,0.16278,0.14523,1,1
1,GO HEART MORPHOGENESIS,0.0034322,0.16235,0.16245,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.02843,0.16233,0.11369,1,1
1,GO REGULATION OF SPINDLE ORGANIZATION,0.00081984,0.16213,0.15755,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00041602,0.16211,0.20325,1,1
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00074557,0.16209,0.15972,1,1
1,GO VACUOLE ORGANIZATION,0.00030804,0.16206,0.14107,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0025083,0.16198,0.148,1,1
1,GO RRNA 3 END PROCESSING,0.0036303,0.16195,0.1766,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,8.1192e-05,0.16169,0.18276,1,1
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.0047853,0.16141,0.18005,1,1
1,GO RECEPTOR RECYCLING,0.016339,0.16122,0.11988,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.030383,0.16117,0.13923,1,1
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0020453,0.16108,0.12252,1,1
1,GO PROTEIN POLYUBIQUITINATION,2.2524e-05,0.161,0.1564,1,1
1,GO THYROID HORMONE METABOLIC PROCESS,0.02268,0.161,0.14363,1,1
1,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.014841,0.16093,0.17832,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.017549,0.16073,0.14857,1,1
1,GO MUSCLE ADAPTATION,0.013465,0.1606,0.11489,1,1
1,GO REGULATION OF GLIAL CELL MIGRATION,0.0027346,0.16042,0.19923,1,1
1,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0051916,0.16023,0.098224,1,1
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.013139,0.16022,0.13386,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0014738,0.16001,0.20788,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS,4.1617e-05,0.15981,0.16332,1,1
1,GO PLASMA MEMBRANE ORGANIZATION,0.009256,0.15957,0.14197,1,1
1,GO PROTEOLYSIS,1.7806e-05,0.15947,0.14516,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0081404,0.15933,0.19789,1,1
1,GO ERYTHROCYTE HOMEOSTASIS,4.8379e-05,0.15925,0.19057,1,1
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.013465,0.15898,0.17564,1,1
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0087944,0.15839,0.16827,1,1
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0031536,0.15826,0.13885,1,1
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.00036427,0.15794,0.20364,1,1
1,GO POSTREPLICATION REPAIR,0.00026903,0.15789,0.14927,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.010245,0.15752,0.15917,1,1
1,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00057693,0.15742,0.2235,1,1
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00353,0.15736,0.14973,1,1
1,GO INOSITOL LIPID MEDIATED SIGNALING,0.00011241,0.15708,0.19563,1,1
1,GO CELL CELL SIGNALING BY WNT,0.0010528,0.15697,0.14163,1,1
1,GO PROTEIN IMPORT,0.0001165,0.15671,0.15442,1,1
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0054795,0.15665,0.19456,1,1
1,GO MAINTENANCE OF LOCATION,9.0551e-05,0.156,0.16337,1,1
1,GO MITOCHONDRIAL GENE EXPRESSION,0.011612,0.15594,0.14298,1,1
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0006154,0.1558,0.15242,1,1
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.00044439,0.15577,0.14245,1,1
1,GO LYMPHOCYTE COSTIMULATION,0.0069616,0.15512,0.14122,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.00098941,0.15497,0.15627,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.041967,0.15493,0.1302,1,1
1,GO PROTEIN CATABOLIC PROCESS,3.1904e-06,0.15492,0.14536,1,1
1,GO RESPONSE TO HEAT,0.00034072,0.15478,0.17555,1,1
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.033894,0.15425,0.1424,1,1
1,GO ORGANIC ACID CATABOLIC PROCESS,0.0034322,0.15422,0.1491,1,1
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.00028792,0.15417,0.16766,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.00041602,0.15401,0.18536,1,1
1,GO PROTEIN STABILIZATION,6.5149e-05,0.15372,0.15513,1,1
1,GO CENTRIOLE CENTRIOLE COHESION,0.0039469,0.15345,0.19305,1,1
1,GO RESPONSE TO DRUG,0.0094949,0.15335,0.11519,1,1
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,3.5759e-05,0.15332,0.18274,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,1.2962e-05,0.15305,0.18414,1,1
1,GO CELL MOTILITY,0.0040578,0.15291,0.12094,1,1
1,GO MUSCLE ORGAN DEVELOPMENT,0.00059588,0.1528,0.14423,1,1
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0042883,0.15267,0.1551,1,1
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0064317,0.15266,0.10873,1,1
1,GO TELOMERE ORGANIZATION,0.0011549,0.15251,0.12291,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,3.5759e-05,0.1523,0.13415,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,7.3528e-06,0.15189,0.15562,1,1
1,GO REGULATION OF CELL DEATH,7.547e-05,0.15169,0.14259,1,1
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.030383,0.15166,0.10566,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.001228,0.15159,0.11503,1,1
1,GO B CELL ACTIVATION,0.001228,0.15151,0.14117,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00031859,0.15137,0.13575,1,1
1,GO REGULATION OF BINDING,0.00018427,0.15112,0.14291,1,1
1,GO RESPONSE TO NUTRIENT,0.023741,0.15094,0.13752,1,1
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.00019753,0.15091,0.1491,1,1
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,2.0833e-05,0.15067,0.16434,1,1
1,GO PIGMENT GRANULE ORGANIZATION,0.010773,0.15056,0.1985,1,1
1,GO LACTATION,0.0083534,0.15046,0.1752,1,1
1,GO REGULATION OF ERAD PATHWAY,0.00057693,0.1504,0.14562,1,1
1,GO RESPONSE TO LEPTIN,0.02166,0.15038,0.18643,1,1
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0012662,0.15034,0.16853,1,1
1,GO GOLGI VESICLE BUDDING,0.0026572,0.14979,0.1623,1,1
1,GO CELLULAR LIPID CATABOLIC PROCESS,0.0047853,0.14958,0.12363,1,1
1,GO HEART DEVELOPMENT,0.00026003,0.14936,0.16167,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0099891,0.14936,0.12219,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,0.0019282,0.14929,0.20351,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0042883,0.14927,0.12862,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.00052342,0.14921,0.13892,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00057693,0.14897,0.13662,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,2.7343e-05,0.14888,0.15111,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.00014935,0.14842,0.19145,1,1
1,GO REGULATION OF CHROMOSOME SEPARATION,0.00081984,0.14805,0.18477,1,1
1,GO REGULATION OF PROTEIN BINDING,0.00024286,0.14769,0.15781,1,1
1,GO DNA BIOSYNTHETIC PROCESS,1.4674e-06,0.14764,0.16582,1,1
1,GO ESTABLISHMENT OF CELL POLARITY,0.0023671,0.1476,0.11515,1,1
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.00017186,0.14706,0.12228,1,1
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0079323,0.14699,0.11904,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0053338,0.14694,0.14833,1,1
1,GO POSITIVE REGULATION OF DNA BINDING,0.020205,0.14691,0.12296,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0040578,0.14631,0.18715,1,1
1,GO REGULATION OF MAP KINASE ACTIVITY,0.00055855,0.14608,0.13845,1,1
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.02843,0.14584,0.09765,1,1
1,GO CHROMOSOME LOCALIZATION,0.022165,0.14565,0.11807,1,1
1,GO AEROBIC RESPIRATION,0.038561,0.14559,0.094552,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.00012074,0.14545,0.12204,1,1
1,GO ORGANIC ACID METABOLIC PROCESS,0.00052342,0.1454,0.12297,1,1
1,GO MITOTIC RECOMBINATION,0.018836,0.14529,0.16391,1,1
1,GO RECEPTOR METABOLIC PROCESS,0.0013457,0.14472,0.13601,1,1
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0045306,0.14472,0.16678,1,1
1,GO NUCLEAR TRANSPORT,5.4121e-05,0.14458,0.14747,1,1
1,GO REGULATION OF CELL DIVISION,0.0075304,0.14453,0.10529,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00010092,0.14448,0.14527,1,1
1,GO CELLULAR RESPONSE TO RADIATION,0.00026003,0.14447,0.14938,1,1
1,GO REGULATION OF DNA BINDING,0.018836,0.14437,0.089188,1,1
1,GO RNA LOCALIZATION,0.00035231,0.14429,0.17298,1,1
1,GO CELL CYCLE PHASE TRANSITION,0.00021167,0.14391,0.12443,1,1
1,GO VACUOLAR ACIDIFICATION,0.0060989,0.14387,0.15795,1,1
1,GO REGULATION OF SENSORY PERCEPTION,0.010773,0.14368,0.15257,1,1
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.011612,0.14339,0.14595,1,1
1,GO REGULATION OF PHOSPHORYLATION,0.00023468,0.14318,0.12769,1,1
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.031059,0.14317,0.14727,1,1
1,GO POSITIVE REGULATION OF URINE VOLUME,0.012508,0.14311,0.23337,1,1
1,GO RNA PROCESSING,0.00030804,0.14295,0.14859,1,1
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0039469,0.14253,0.10982,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00035231,0.14245,0.18739,1,1
1,GO COPII COATED VESICLE BUDDING,0.0051916,0.14234,0.16085,1,1
1,GO RNA CAPPING,0.001662,0.14165,0.14068,1,1
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.013798,0.14134,0.11431,1,1
1,GO PROTEIN NEDDYLATION,0.0046564,0.14116,0.16595,1,1
1,GO REGULATION OF CARTILAGE DEVELOPMENT,0.027803,0.14074,0.16823,1,1
1,GO SMALL MOLECULE CATABOLIC PROCESS,0.00090094,0.1406,0.12916,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,6.2786e-05,0.14057,0.13341,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.00011241,0.14043,0.13928,1,1
1,GO CYTOKINESIS,0.00084609,0.13949,0.12969,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00029782,0.13896,0.16921,1,1
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,2.6307e-05,0.13892,0.15048,1,1
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00018427,0.13874,0.16295,1,1
1,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.0064317,0.13807,0.12252,1,1
1,GO ENDOSOME ORGANIZATION,0.00047456,0.13765,0.15976,1,1
1,GO SPINDLE ORGANIZATION,0.00059588,0.13731,0.13477,1,1
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0075304,0.13726,0.12022,1,1
1,GO APOPTOTIC PROCESS,7.547e-05,0.13719,0.13407,1,1
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00012964,0.13711,0.14077,1,1
1,GO REGULATION OF ENDOCYTOSIS,0.0059384,0.13709,0.11533,1,1
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.0032441,0.13703,0.17041,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.0066042,0.13702,0.18703,1,1
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.00023468,0.13645,0.16829,1,1
1,GO NUCLEUS ORGANIZATION,0.0031536,0.13624,0.11874,1,1
1,GO GENE SILENCING,9.389e-05,0.13576,0.13397,1,1
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.01282,0.13522,0.1106,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00021167,0.13508,0.13112,1,1
1,GO FAT CELL DIFFERENTIATION,0.0034322,0.13495,0.1279,1,1
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0039469,0.13485,0.10686,1,1
1,GO PROTEIN MONOUBIQUITINATION,0.0085714,0.13419,0.092766,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,0.00021909,0.13395,0.15154,1,1
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0071468,0.13392,0.19536,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.015953,0.13331,0.19639,1,1
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.00031859,0.13267,0.14978,1,1
1,GO OXALATE TRANSPORT,0.044685,0.13224,0.096043,1,1
1,GO VIRAL BUDDING,0.0046564,0.13218,0.13868,1,1
1,GO REGULATION OF CENTROSOME DUPLICATION,0.004408,0.13215,0.14936,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0013872,0.13127,0.13589,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00055855,0.13116,0.13708,1,1
1,GO ANIMAL ORGAN MORPHOGENESIS,0.0051916,0.13114,0.11846,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00067758,0.13107,0.17764,1,1
1,GO CHROMOSOME CONDENSATION,0.0027346,0.13093,0.13786,1,1
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.00353,0.1305,0.12038,1,1
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0016129,0.12993,0.13255,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.0097392,0.1297,0.096545,1,1
1,GO CELL DIVISION,0.00027832,0.12918,0.12456,1,1
1,GO G2 DNA DAMAGE CHECKPOINT,0.013139,0.1291,0.11961,1,1
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0020453,0.12889,0.14908,1,1
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.00036427,0.12876,0.13773,1,1
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,4.0073e-05,0.1286,0.14635,1,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,0.00014935,0.12824,0.13755,1,1
1,GO MRNA METABOLIC PROCESS,7.547e-05,0.12795,0.14857,1,1
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0024367,0.12782,0.11782,1,1
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.0014299,0.12768,0.19351,1,1
1,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0064317,0.12767,0.15354,1,1
1,GO RESPONSE TO ABIOTIC STIMULUS,0.0017641,0.12762,0.11201,1,1
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.023741,0.12753,0.10933,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00063551,0.12744,0.12114,1,1
1,GO REGULATION OF DNA REPAIR,0.0075304,0.1273,0.097303,1,1
1,GO LIPID CATABOLIC PROCESS,0.004408,0.12669,0.095345,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00024286,0.12654,0.11295,1,1
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00038934,0.12649,0.14089,1,1
1,GO REGULATION OF HYDROLASE ACTIVITY,0.0019282,0.12643,0.11157,1,1
1,GO NON RECOMBINATIONAL REPAIR,0.0019282,0.12626,0.13215,1,1
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00059588,0.12616,0.10988,1,1
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00081984,0.12615,0.11659,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.03939,0.1261,0.16067,1,1
1,GO PROTEIN LOCALIZATION TO ORGANELLE,7.0571e-06,0.12604,0.12122,1,1
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00050664,0.12601,0.12139,1,1
1,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.035393,0.12563,0.097927,1,1
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00017186,0.12559,0.21519,1,1
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.004408,0.12541,0.11332,1,1
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.011326,0.12507,0.097991,1,1
1,GO CELLULAR RESPIRATION,0.02268,0.12505,0.10078,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.00069957,0.12468,0.12999,1,1
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.004408,0.12466,0.1094,1,1
1,GO MEMBRANE ORGANIZATION,0.0027346,0.12443,0.10151,1,1
1,GO MITOTIC CELL CYCLE,0.00016023,0.1243,0.12277,1,1
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,3.3132e-05,0.12394,0.12685,1,1
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00353,0.12356,0.1176,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00049035,0.12336,0.12878,1,1
1,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.02068,0.12309,0.15501,1,1
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.016339,0.12303,0.098804,1,1
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.00065623,0.12286,0.14005,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.0030654,0.12269,0.1348,1,1
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.009256,0.12254,0.089169,1,1
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00023468,0.12208,0.10341,1,1
1,GO ACTIN FILAMENT ORGANIZATION,0.033166,0.12171,0.099949,1,1
1,GO NEGATIVE REGULATION OF SIGNALING,4.8379e-05,0.12119,0.13265,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00045924,0.12117,0.1705,1,1
1,GO CELLULAR SENESCENCE,0.0027346,0.12096,0.12477,1,1
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.02843,0.12043,0.088165,1,1
1,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.031748,0.12038,0.076634,1,1
1,GO BLASTOCYST FORMATION,0.015953,0.12014,0.12905,1,1
1,GO ENDOCYTOSIS,0.00095906,0.11991,0.13217,1,1
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.0018173,0.11989,0.1627,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.00012964,0.11974,0.11378,1,1
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.00353,0.1197,0.11694,1,1
1,GO FLUID TRANSPORT,0.0046564,0.11895,0.15022,1,1
1,GO REGULATION OF DNA REPLICATION,0.0013054,0.11843,0.11621,1,1
1,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.027803,0.11822,0.096605,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,5.6174e-05,0.11802,0.13885,1,1
1,GO CHROMOSOME SEPARATION,0.0071468,0.11668,0.13798,1,1
1,GO REGULATION OF ACTIN FILAMENT LENGTH,0.018836,0.11649,0.090456,1,1
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0013872,0.1163,0.11478,1,1
1,GO GOLGI ORGANIZATION,0.0046564,0.11613,0.11633,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.00017796,0.11605,0.13622,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.001986,0.11582,0.12664,1,1
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0047853,0.11574,0.12475,1,1
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.0062634,0.11558,0.094557,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE,0.018836,0.11523,0.094847,1,1
1,GO AUTOPHAGY OF MITOCHONDRION,0.0011199,0.11502,0.13863,1,1
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00084609,0.11494,0.1192,1,1
1,GO RESPONSE TO HORMONE,0.001228,0.11492,0.12158,1,1
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.0024367,0.11489,0.12106,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.010506,0.11482,0.11863,1,1
1,GO REGULATION OF REPRODUCTIVE PROCESS,0.015574,0.11446,0.080023,1,1
1,GO REGULATION OF AUTOPHAGY,5.8301e-05,0.11411,0.13587,1,1
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.0013457,0.11376,0.11618,1,1
1,GO ORGANELLE FISSION,0.0014738,0.11369,0.098494,1,1
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.00012512,0.11368,0.12567,1,1
1,GO REGULATION OF ATP METABOLIC PROCESS,0.021165,0.11367,0.093388,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.0053338,0.11364,0.086034,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.031059,0.11323,0.12129,1,1
1,GO MITOTIC NUCLEAR DIVISION,0.00072223,0.11293,0.11902,1,1
1,GO RNA SURVEILLANCE,0.0030654,0.11283,0.16482,1,1
1,GO REGULATION OF TRANSFERASE ACTIVITY,0.0001547,0.11267,0.11329,1,1
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.023205,0.11234,0.081032,1,1
1,GO APOPTOTIC DNA FRAGMENTATION,0.0026572,0.11233,0.10475,1,1
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.00038934,0.11221,0.11171,1,1
1,GO MACROAUTOPHAGY,5.6174e-05,0.11204,0.13267,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.0021062,0.11193,0.098696,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0047853,0.11169,0.09179,1,1
1,GO FEMALE GAMETE GENERATION,0.0025083,0.11153,0.099842,1,1
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0024367,0.11144,0.11354,1,1
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.02166,0.1111,0.10296,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.00067758,0.11092,0.12495,1,1
1,GO METAPHASE PLATE CONGRESSION,0.015203,0.11086,0.11512,1,1
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.017969,0.10967,0.090435,1,1
1,GO MRNA TRANSPORT,0.00072223,0.10949,0.1556,1,1
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,1.8521e-05,0.10925,0.12536,1,1
1,GO ORGANELLE DISASSEMBLY,0.00074557,0.10897,0.11714,1,1
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0006154,0.10845,0.10094,1,1
1,GO CYTOSKELETON ORGANIZATION,0.02843,0.10832,0.073862,1,1
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00054072,0.1082,0.1135,1,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,2.2524e-05,0.10751,0.11314,1,1
1,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.01282,0.10742,0.098388,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0067808,0.10647,0.1066,1,1
1,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.044685,0.10621,0.14105,1,1
1,GO SULFATE TRANSPORT,0.0031536,0.10612,0.11352,1,1
1,GO CARDIOCYTE DIFFERENTIATION,0.0036303,0.10576,0.1797,1,1
1,GO HORMONE MEDIATED SIGNALING PATHWAY,0.030383,0.10568,0.073984,1,1
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0062634,0.10564,0.16601,1,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.0006154,0.10542,0.1258,1,1
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.001662,0.10406,0.12773,1,1
1,GO PEPTIDYL THREONINE MODIFICATION,0.0083534,0.10385,0.097964,1,1
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.0083534,0.1038,0.12848,1,1
1,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.024288,0.10367,0.14078,1,1
1,GO CELL CYCLE PROCESS,0.00030804,0.10353,0.10072,1,1
1,GO MRNA CLEAVAGE,0.010245,0.10301,0.095414,1,1
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.027188,0.10203,0.075965,1,1
1,GO NEGATIVE REGULATION OF BINDING,0.0051916,0.10135,0.11124,1,1
1,GO DNA INTEGRITY CHECKPOINT,0.030383,0.10104,0.086549,1,1
1,GO REGULATION OF CELL CYCLE,0.00042998,0.10084,0.088985,1,1
1,GO CELLULAR RESPONSE TO DRUG,0.035393,0.099759,0.10347,1,1
1,GO PROTEIN TETRAMERIZATION,0.0083534,0.099286,0.10184,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0028957,0.098743,0.095974,1,1
1,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.042857,0.098423,0.11141,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0062634,0.096813,0.18237,1,1
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.036948,0.09675,0.091883,1,1
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0010528,0.09651,0.10507,1,1
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.0083534,0.096042,0.09663,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0006154,0.095805,0.076897,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0027346,0.095001,0.088013,1,1
1,GO MACROMOLECULE DEACYLATION,0.018398,0.094987,0.074363,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0064317,0.094858,0.12223,1,1
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.00045924,0.094263,0.087248,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0018173,0.093935,0.10508,1,1
1,GO MRNA 3 END PROCESSING,0.022165,0.093093,0.098174,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE III,0.011612,0.092858,0.080535,1,1
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.0030654,0.092091,0.12969,1,1
1,GO MULTI ORGANISM PROCESS,0.0047853,0.092018,0.068931,1,1
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.018398,0.091715,0.088866,1,1
1,GO REGULATION OF CHROMOSOME SEGREGATION,0.016734,0.09145,0.11259,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0066042,0.091401,0.14546,1,1
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.012203,0.091334,0.078173,1,1
1,GO CELL CYCLE,0.00050664,0.09073,0.08412,1,1
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0028141,0.090629,0.10261,1,1
1,GO REGULATION OF ATPASE ACTIVITY,0.017969,0.090262,0.08705,1,1
1,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.0051916,0.089693,0.093786,1,1
1,GO IRON ION TRANSPORT,0.0081404,0.08938,0.094071,1,1
1,GO REGULATION OF CYTOKINESIS,0.037747,0.089267,0.074076,1,1
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.01282,0.088978,0.08993,1,1
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.029719,0.088833,0.068501,1,1
1,GO REGULATION OF CENTROSOME CYCLE,0.0085714,0.08844,0.11339,1,1
1,GO RESPONSE TO ACID CHEMICAL,0.046579,0.088233,0.11721,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00035231,0.087704,0.092213,1,1
1,GO MUSCLE CELL DIFFERENTIATION,0.03245,0.087516,0.10749,1,1
1,GO ACTIN FILAMENT BASED PROCESS,0.014138,0.087492,0.10299,1,1
1,GO SPINDLE ASSEMBLY,0.0049174,0.086935,0.097064,1,1
1,GO DNA METABOLIC PROCESS,0.00034072,0.086822,0.094615,1,1
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.0033369,0.086683,0.12624,1,1
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.00031859,0.085656,0.088966,1,1
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.0037331,0.085483,0.098986,1,1
1,GO NEGATIVE REGULATION OF TRANSPORT,0.0099891,0.085441,0.087363,1,1
1,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.019739,0.085254,0.077934,1,1
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00044439,0.084405,0.10058,1,1
1,GO POSITIVE REGULATION OF SIGNALING,0.011326,0.084129,0.076112,1,1
1,GO REGULATION OF DNA METABOLIC PROCESS,0.00034072,0.083888,0.10582,1,1
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0046564,0.083293,0.065301,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00025131,0.083088,0.093344,1,1
1,GO RESPONSE TO RADIATION,0.007729,0.081098,0.069949,1,1
1,GO CELL CYCLE CHECKPOINT,0.0047853,0.079292,0.088715,1,1
1,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.024846,0.077082,0.072086,1,1
1,GO ELECTRON TRANSPORT CHAIN,0.037747,0.076105,0.083723,1,1
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.0028957,0.075382,0.13985,1,1
1,GO PEPTIDYL SERINE MODIFICATION,0.029719,0.074445,0.065094,1,1
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.041093,0.074211,0.082131,1,1
1,GO MITOTIC SISTER CHROMATID SEGREGATION,0.038561,0.073357,0.086039,1,1
1,GO DNA CATABOLIC PROCESS,0.012203,0.073105,0.069313,1,1
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.015574,0.07194,0.088852,1,1
1,GO CHROMOSOME SEGREGATION,0.022165,0.071793,0.087507,1,1
1,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0066042,0.071599,0.094573,1,1
1,GO T CELL LINEAGE COMMITMENT,0.043763,0.071521,0.10918,1,1
1,GO PROTEIN LOCALIZATION TO MEMBRANE,0.0099891,0.071049,0.066936,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.023741,0.070728,0.11404,1,1
1,GO NUCLEAR CHROMOSOME SEGREGATION,0.030383,0.07063,0.078195,1,1
1,GO REGULATION OF ORGANELLE ORGANIZATION,0.011326,0.068697,0.055381,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.035393,0.065358,0.059211,1,1
1,GO DNA REPAIR,0.0071468,0.06391,0.07903,1,1
1,GO DOUBLE STRAND BREAK REPAIR,0.01282,0.063461,0.09106,1,1
1,GO INTRACELLULAR TRANSPORT,0.0038387,0.063372,0.067539,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.03245,0.061943,0.046634,1,1
1,GO MITOCHONDRION ORGANIZATION,0.010245,0.061687,0.066657,1,1
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.014486,0.06149,0.052455,1,1
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.019739,0.060453,0.060427,1,1
1,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.020205,0.059805,0.067687,1,1
1,GO REGULATION OF MACROAUTOPHAGY,0.0046564,0.058212,0.1191,1,1
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.023741,0.050345,0.072492,1,1
1,GO DNA REPLICATION,0.047551,0.049182,0.062098,1,1
1,GO ORGANELLE ASSEMBLY,0.013798,0.040663,0.062271,1,1
2,GO ETHER BIOSYNTHETIC PROCESS,2.3975e-07,1.2188,0.98077,1,1
2,GO ETHANOL OXIDATION,6.8936e-07,1.0574,0.91957,1,1
2,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.00025131,0.96721,0.71972,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,3.6414e-07,0.82551,0.76751,1,1
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.00049035,0.82084,0.6559,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,3.7791e-06,0.80051,0.61412,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00024286,0.79234,0.65233,1,1
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.4963e-07,0.77703,0.7163,1,1
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.00012074,0.75668,0.61402,1,1
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.0001547,0.7414,0.61311,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00067758,0.73434,0.48717,1,1
2,GO RESPONSE TO INTERLEUKIN 18,8.4205e-05,0.71907,0.69033,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,9.7801e-06,0.70935,0.70201,1,1
2,GO T HELPER 2 CELL DIFFERENTIATION,0.00021909,0.69788,0.51912,1,1
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,4.2876e-06,0.68144,0.51662,1,1
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,3.8131e-07,0.68021,0.52836,1,1
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,3.3202e-07,0.67989,0.64115,1,1
2,GO T HELPER 1 CELL DIFFERENTIATION,2.0833e-05,0.67581,0.59002,1,1
2,GO BIOLOGICAL PHASE,5.8301e-05,0.67252,0.64455,1,1
2,GO MUCUS SECRETION,0.00041602,0.66447,0.62258,1,1
2,GO T CELL MEDIATED CYTOTOXICITY,0.00014418,0.66081,0.48671,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00012512,0.65356,0.55602,1,1
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0032441,0.64671,0.46843,1,1
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.00079435,0.63924,0.56895,1,1
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0067808,0.63783,0.41816,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,8.1192e-05,0.62672,0.54969,1,1
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00026903,0.62238,0.47929,1,1
2,GO PROSTANOID BIOSYNTHETIC PROCESS,7.9801e-06,0.61743,0.54446,1,1
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00079435,0.6163,0.43915,1,1
2,GO MYOBLAST MIGRATION,0.012203,0.61214,0.48969,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,1.9904e-06,0.61141,0.58141,1,1
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0006154,0.60615,0.39289,1,1
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,2.8077e-06,0.59842,0.53565,1,1
2,GO INFLAMMATORY RESPONSE TO WOUNDING,7.013e-05,0.59822,0.57271,1,1
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0050528,0.59403,0.40774,1,1
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,3.4421e-05,0.59241,0.56255,1,1
2,GO BARBED END ACTIN FILAMENT CAPPING,0.001662,0.5892,0.41026,1,1
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.0037331,0.58809,0.38473,1,1
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0014738,0.58398,0.48389,1,1
2,GO PROSTATE GLAND GROWTH,2.6902e-06,0.58277,0.66094,1,1
2,GO PROSTANOID METABOLIC PROCESS,1.2454e-05,0.57692,0.50387,1,1
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0036303,0.57617,0.5243,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00072223,0.5746,0.41042,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,4.8612e-06,0.5727,0.41492,1,1
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,8.3127e-06,0.57002,0.51339,1,1
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.00054072,0.56861,0.49296,1,1
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,5.0226e-05,0.56849,0.50487,1,1
2,GO HAIR FOLLICLE MATURATION,5.0226e-05,0.56535,0.46299,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,4.8379e-05,0.56446,0.5591,1,1
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,7.547e-05,0.56443,0.52748,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,6.0504e-05,0.5639,0.50941,1,1
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.00029782,0.55977,0.55728,1,1
2,GO ETHER METABOLIC PROCESS,2.2658e-06,0.55969,0.52151,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00041602,0.55842,0.38525,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.00057693,0.54504,0.45648,1,1
2,GO LYSINE METABOLIC PROCESS,0.00027832,0.54427,0.50937,1,1
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.5331e-06,0.53953,0.52941,1,1
2,GO OTIC VESICLE DEVELOPMENT,0.00035231,0.53863,0.44538,1,1
2,GO GLYCEROL ETHER METABOLIC PROCESS,5.2533e-07,0.5381,0.50383,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,1.1493e-05,0.53748,0.58244,1,1
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00035231,0.53501,0.54111,1,1
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0014299,0.53424,0.37862,1,1
2,GO PSEUDOPODIUM ORGANIZATION,0.0085714,0.53404,0.37151,1,1
2,GO RETINAL METABOLIC PROCESS,0.011612,0.52399,0.33519,1,1
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,1.5201e-05,0.52013,0.45297,1,1
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,8.1192e-05,0.50824,0.40378,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00040247,0.50678,0.4586,1,1
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0023671,0.50474,0.3476,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00045924,0.50334,0.43411,1,1
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,1.0184e-05,0.50221,0.42961,1,1
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00012964,0.50121,0.46953,1,1
2,GO CARDIOLIPIN METABOLIC PROCESS,2.8418e-05,0.50099,0.40463,1,1
2,GO REGULATION OF GASTRIC ACID SECRETION,0.00013433,0.49905,0.45815,1,1
2,GO HEPATOCYTE DIFFERENTIATION,0.0034322,0.49763,0.40906,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0014299,0.49496,0.35548,1,1
2,GO CYCLOOXYGENASE PATHWAY,0.0073363,0.49416,0.4227,1,1
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.00037661,0.49345,0.43814,1,1
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0010206,0.48643,0.35473,1,1
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.00034072,0.48059,0.47727,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.4692e-06,0.47901,0.43059,1,1
2,GO ACTIN FILAMENT SEVERING,0.03939,0.47803,0.31778,1,1
2,GO IMMUNE RESPONSE TO TUMOR CELL,0.00011241,0.47764,0.43602,1,1
2,GO OXYGEN TRANSPORT,0.0097392,0.47714,0.44234,1,1
2,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,6.7728e-06,0.47699,0.47013,1,1
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,5.2139e-05,0.4752,0.43857,1,1
2,GO ETHANOL METABOLIC PROCESS,3.9418e-06,0.47423,0.53454,1,1
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0094949,0.47382,0.31455,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,1.7806e-05,0.47187,0.42891,1,1
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.043763,0.47024,0.31162,1,1
2,GO RESPONSE TO INTERFERON BETA,0.014841,0.46842,0.33406,1,1
2,GO MUSCLE ATROPHY,0.0056288,0.46832,0.35363,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00074557,0.46758,0.36777,1,1
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,2.8077e-06,0.46665,0.46345,1,1
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.017969,0.46374,0.33599,1,1
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0039469,0.46115,0.3362,1,1
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.00010092,0.45356,0.32321,1,1
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,5.0683e-06,0.45162,0.44542,1,1
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0025083,0.45013,0.35679,1,1
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,5.2139e-05,0.44985,0.38143,1,1
2,GO NEPHRON TUBULE FORMATION,0.0051916,0.44818,0.29165,1,1
2,GO SKELETAL MUSCLE TISSUE REGENERATION,1.8521e-05,0.44531,0.36481,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.2139e-05,0.44416,0.39268,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,3.4421e-05,0.44402,0.44861,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00038934,0.4434,0.31054,1,1
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.00079435,0.44175,0.41148,1,1
2,GO OTIC VESICLE MORPHOGENESIS,0.00065623,0.43886,0.40518,1,1
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.0012662,0.43534,0.28381,1,1
2,GO PSEUDOURIDINE SYNTHESIS,0.00065623,0.43487,0.32608,1,1
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0037331,0.43454,0.36136,1,1
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.021165,0.4339,0.38552,1,1
2,GO DENDRITIC CELL MIGRATION,0.00023468,0.43328,0.35887,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0013054,0.43308,0.34556,1,1
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0014738,0.43185,0.41882,1,1
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00054072,0.43045,0.34009,1,1
2,GO HEME METABOLIC PROCESS,0.0001165,0.43026,0.36397,1,1
2,GO HOMOCYSTEINE METABOLIC PROCESS,0.0042883,0.42078,0.35767,1,1
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0099891,0.41912,0.31179,1,1
2,GO LABYRINTHINE LAYER MORPHOGENESIS,0.03245,0.41769,0.28844,1,1
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.00081984,0.41675,0.40011,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,8.7323e-05,0.41199,0.35263,1,1
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,7.6603e-06,0.41126,0.34496,1,1
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.00095906,0.40983,0.34481,1,1
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.00067758,0.40915,0.3631,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.013798,0.40864,0.36164,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0013872,0.40716,0.36921,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.036948,0.40538,0.21569,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.00059588,0.40313,0.31314,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00024286,0.40309,0.35282,1,1
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0021689,0.40206,0.36819,1,1
2,GO PIGMENT GRANULE MATURATION,0.0064317,0.40113,0.28935,1,1
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,5.8301e-05,0.39563,0.37481,1,1
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0007696,0.39535,0.36431,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00084609,0.39496,0.37627,1,1
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.012508,0.39302,0.25517,1,1
2,GO MONONUCLEAR CELL DIFFERENTIATION,1.4609e-05,0.39275,0.36363,1,1
2,GO NEURAL CREST FORMATION,0.001986,0.39274,0.31258,1,1
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.00010462,0.39259,0.33245,1,1
2,GO PORE COMPLEX ASSEMBLY,1.5331e-06,0.39017,0.3861,1,1
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00012512,0.39002,0.30019,1,1
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0036303,0.38886,0.24956,1,1
2,GO NEUTROPHIL HOMEOSTASIS,0.0056288,0.38851,0.34701,1,1
2,GO CELLULAR RESPONSE TO SALT STRESS,0.0021062,0.38673,0.39568,1,1
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00024286,0.38641,0.33182,1,1
2,GO CYSTEINE METABOLIC PROCESS,0.00052342,0.38428,0.45613,1,1
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0071468,0.3838,0.34373,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,3.6228e-06,0.38376,0.3767,1,1
2,GO GAS TRANSPORT,0.0027346,0.38344,0.3948,1,1
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00047456,0.38307,0.29409,1,1
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00034072,0.38284,0.29717,1,1
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.0085714,0.38202,0.30739,1,1
2,GO RRNA PSEUDOURIDINE SYNTHESIS,0.010506,0.38191,0.27894,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,0.00013917,0.37995,0.34824,1,1
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,5.2139e-05,0.3795,0.44891,1,1
2,GO FATTY ACID HOMEOSTASIS,0.0060989,0.37871,0.24295,1,1
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.0059384,0.37771,0.34512,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0022992,0.3771,0.31748,1,1
2,GO LIMB BUD FORMATION,0.004408,0.37637,0.45708,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,3.6228e-06,0.37556,0.3522,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,7.9801e-06,0.37499,0.34095,1,1
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00081984,0.37398,0.26276,1,1
2,GO LEFT RIGHT AXIS SPECIFICATION,0.00020448,0.3725,0.44521,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00019753,0.37234,0.31057,1,1
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,1.6015e-06,0.37228,0.38208,1,1
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00059588,0.37187,0.25297,1,1
2,GO MYELOID CELL APOPTOTIC PROCESS,0.001986,0.37038,0.27804,1,1
2,GO VESICLE CARGO LOADING,7.6603e-06,0.36955,0.32422,1,1
2,GO LAMELLIPODIUM MORPHOGENESIS,0.00079435,0.36948,0.30425,1,1
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.00017186,0.36863,0.3066,1,1
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.011612,0.36735,0.27613,1,1
2,GO REGULATION OF RESPONSE TO TUMOR CELL,8.1192e-05,0.36734,0.34248,1,1
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,3.4421e-05,0.36571,0.30276,1,1
2,GO ACETYL COA METABOLIC PROCESS,0.00050664,0.36557,0.26279,1,1
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.042857,0.36536,0.1533,1,1
2,GO POSITIVE REGULATION OF CELL MATURATION,0.015574,0.36517,0.32126,1,1
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0015189,0.36464,0.39153,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0025083,0.3632,0.3316,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0099891,0.36188,0.30721,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0007696,0.36136,0.28495,1,1
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.00013433,0.36053,0.30139,1,1
2,GO PENTOSE METABOLIC PROCESS,9.389e-05,0.36036,0.36299,1,1
2,GO REGULATION OF RIBOSOME BIOGENESIS,2.5308e-05,0.35899,0.36324,1,1
2,GO ERYTHROCYTE MATURATION,0.0032441,0.35683,0.33047,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00055855,0.3557,0.30435,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,5.4121e-05,0.35549,0.35851,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0011199,0.35417,0.25943,1,1
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.044685,0.35396,0.22261,1,1
2,GO I KAPPAB PHOSPHORYLATION,0.0040578,0.35337,0.21368,1,1
2,GO SENSORY PERCEPTION OF BITTER TASTE,4.4878e-05,0.35275,0.36296,1,1
2,GO INTERLEUKIN 13 PRODUCTION,0.00079435,0.35091,0.3868,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0013872,0.35069,0.28011,1,1
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0006154,0.35048,0.29794,1,1
2,GO TYPE 2 IMMUNE RESPONSE,0.00037661,0.34998,0.27938,1,1
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,3.7791e-06,0.3499,0.32381,1,1
2,GO HEMOGLOBIN METABOLIC PROCESS,6.5149e-05,0.34977,0.29849,1,1
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,4.8379e-05,0.34956,0.49294,1,1
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.0011199,0.34881,0.38049,1,1
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.020205,0.34859,0.23365,1,1
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00029782,0.34843,0.37059,1,1
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0001165,0.34839,0.33558,1,1
2,GO TETRAPYRROLE METABOLIC PROCESS,8.7323e-05,0.34835,0.24901,1,1
2,GO PROTEIN DEMANNOSYLATION,0.0015653,0.34824,0.25943,1,1
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00042998,0.34749,0.40917,1,1
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.00017796,0.34744,0.30255,1,1
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.016734,0.34708,0.26331,1,1
2,GO GLYCINE METABOLIC PROCESS,0.0010859,0.34597,0.28162,1,1
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.017969,0.34567,0.21733,1,1
2,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.020205,0.34249,0.23351,1,1
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.0028957,0.34167,0.22797,1,1
2,GO PRE MIRNA PROCESSING,0.0024367,0.34144,0.21951,1,1
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.015953,0.34087,0.33089,1,1
2,GO REGULATION OF PROTEIN IMPORT,0.0001165,0.33992,0.29113,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0022992,0.33906,0.28396,1,1
2,GO REGULATION OF DNA METHYLATION,0.00049035,0.3388,0.242,1,1
2,GO NEUROBLAST DIVISION,0.00072223,0.33846,0.37127,1,1
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.017969,0.33702,0.30073,1,1
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00057693,0.33599,0.28252,1,1
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.038561,0.3359,0.18055,1,1
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0019282,0.33542,0.26919,1,1
2,GO NOTOCHORD DEVELOPMENT,0.00017186,0.3353,0.50849,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.021165,0.33524,0.21581,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.027803,0.3351,0.19838,1,1
2,GO RESPONSE TO STEROL DEPLETION,0.00011241,0.33447,0.3165,1,1
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0033369,0.3344,0.33026,1,1
2,GO RNA DECAPPING,1.1493e-05,0.33388,0.25129,1,1
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00035231,0.3336,0.25115,1,1
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,1.6455e-05,0.33295,0.37286,1,1
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.00353,0.33197,0.20721,1,1
2,GO REGULATION OF PODOSOME ASSEMBLY,0.001662,0.33102,0.3149,1,1
2,GO ERBB2 SIGNALING PATHWAY,0.00074557,0.33092,0.25496,1,1
2,GO TONGUE MORPHOGENESIS,0.019283,0.33071,0.29047,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.001228,0.33066,0.33854,1,1
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,2.5308e-05,0.33032,0.35008,1,1
2,GO RETINOL METABOLIC PROCESS,8.1192e-05,0.33001,0.34236,1,1
2,GO FIBROBLAST ACTIVATION,0.00032948,0.32998,0.33966,1,1
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0018173,0.32972,0.32863,1,1
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.001662,0.32941,0.2276,1,1
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00031859,0.32938,0.3004,1,1
2,GO POSITIVE REGULATION OF CELL KILLING,0.0087944,0.32827,0.20394,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00084609,0.32825,0.27999,1,1
2,GO MICROVILLUS ASSEMBLY,0.010506,0.32748,0.307,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0062634,0.3265,0.22607,1,1
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0067808,0.32616,0.21725,1,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.017969,0.32523,0.24907,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00063551,0.32312,0.24574,1,1
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0057817,0.32299,0.26181,1,1
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,9.7801e-06,0.32178,0.32829,1,1
2,GO FIBROBLAST APOPTOTIC PROCESS,0.0011199,0.32154,0.29743,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0010528,0.32145,0.2392,1,1
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.0036303,0.32106,0.27455,1,1
2,GO FOREGUT MORPHOGENESIS,0.001228,0.32032,0.36484,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0073363,0.3201,0.28901,1,1
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.0066042,0.3199,0.31447,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00022676,0.31757,0.28225,1,1
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,2.4692e-06,0.31751,0.26071,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,4.3218e-05,0.31731,0.30741,1,1
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.024288,0.31666,0.21477,1,1
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0012662,0.31647,0.25098,1,1
2,GO REGULATION OF TELOMERASE ACTIVITY,6.2985e-07,0.31647,0.29308,1,1
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.0053338,0.31633,0.24956,1,1
2,GO RESPONSE TO NITROSATIVE STRESS,0.014486,0.31618,0.27754,1,1
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0013054,0.31594,0.27754,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00011241,0.31574,0.2736,1,1
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00013917,0.31551,0.29973,1,1
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0034322,0.31543,0.26202,1,1
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00021909,0.31514,0.27835,1,1
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.012203,0.31502,0.22058,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,2.6902e-06,0.31497,0.33393,1,1
2,GO PHAGOCYTOSIS RECOGNITION,0.0075304,0.31489,0.24774,1,1
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0081404,0.31474,0.29061,1,1
2,GO REGULATION OF MAST CELL ACTIVATION,0.00050664,0.3143,0.2573,1,1
2,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.02268,0.31397,0.26268,1,1
2,GO MIDDLE EAR MORPHOGENESIS,0.011326,0.31389,0.23893,1,1
2,GO RESPONSE TO ANGIOTENSIN,0.00017186,0.3137,0.29961,1,1
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.00027832,0.31301,0.28947,1,1
2,GO CARNITINE SHUTTLE,4.4878e-05,0.31298,0.32458,1,1
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0069616,0.31284,0.29225,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.0022992,0.31212,0.25508,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0073363,0.31211,0.22347,1,1
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.001228,0.31164,0.26226,1,1
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,3.6228e-06,0.3115,0.30406,1,1
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,1.0604e-05,0.31107,0.26557,1,1
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0040578,0.31092,0.30449,1,1
2,GO HISTONE SERINE PHOSPHORYLATION,0.00087311,0.31004,0.25051,1,1
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00050664,0.30986,0.21472,1,1
2,GO REGULATION OF LIPASE ACTIVITY,1.6455e-05,0.3096,0.24778,1,1
2,GO AMP METABOLIC PROCESS,0.0083534,0.30824,0.24605,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.015953,0.30823,0.22793,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0013872,0.30794,0.20978,1,1
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.0025817,0.30789,0.24625,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00017186,0.3076,0.27318,1,1
2,GO OVULATION,7.547e-05,0.30732,0.34627,1,1
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.00055855,0.30703,0.26567,1,1
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.0097392,0.30686,0.26815,1,1
2,GO LEUKOTRIENE METABOLIC PROCESS,0.0028957,0.30673,0.22582,1,1
2,GO DNA LIGATION,0.0013872,0.30662,0.22916,1,1
2,GO THYMOCYTE APOPTOTIC PROCESS,0.0087944,0.30646,0.24362,1,1
2,GO MONOCYTE CHEMOTAXIS,0.00059588,0.30575,0.26266,1,1
2,GO MONONUCLEAR CELL MIGRATION,5.4121e-05,0.3057,0.27806,1,1
2,GO INTERLEUKIN 2 PRODUCTION,5.8301e-05,0.30565,0.2589,1,1
2,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00072223,0.30557,0.27088,1,1
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.014138,0.305,0.3023,1,1
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.019283,0.30472,0.30503,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0010528,0.30438,0.22548,1,1
2,GO CHONDROCYTE PROLIFERATION,0.0016129,0.30433,0.37661,1,1
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.0087944,0.30363,0.18653,1,1
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0090226,0.30346,0.27204,1,1
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0010859,0.30308,0.29313,1,1
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0010528,0.30198,0.25207,1,1
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.00016595,0.29938,0.32981,1,1
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00072223,0.29931,0.23673,1,1
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.0020453,0.2993,0.2478,1,1
2,GO PROTEIN DEGLYCOSYLATION,0.0020453,0.2992,0.25235,1,1
2,GO PHOSPHOLIPID CATABOLIC PROCESS,2.3418e-05,0.29884,0.2868,1,1
2,GO CELLULAR OXIDANT DETOXIFICATION,0.00010092,0.29871,0.25627,1,1
2,GO RESPONSE TO GONADOTROPIN,0.0030654,0.29827,0.2272,1,1
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0064317,0.29801,0.21124,1,1
2,GO INTERLEUKIN 8 PRODUCTION,0.00040247,0.29755,0.24907,1,1
2,GO RESPONSE TO TUMOR CELL,0.001228,0.29688,0.2561,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00012512,0.29589,0.29569,1,1
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0001165,0.29584,0.32224,1,1
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0028141,0.29582,0.18248,1,1
2,GO NUCLEAR PORE ORGANIZATION,5.9841e-06,0.29577,0.36087,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0010859,0.29556,0.20829,1,1
2,GO ENTRY INTO HOST,0.0021689,0.29495,0.21752,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00010092,0.29466,0.24138,1,1
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0012662,0.29446,0.24354,1,1
2,GO REGULATION OF VIRAL TRANSCRIPTION,7.2111e-07,0.29425,0.2659,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0046564,0.2937,0.26234,1,1
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00022676,0.29315,0.29834,1,1
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.0010206,0.29304,0.23921,1,1
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.0097392,0.29273,0.26839,1,1
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.00032948,0.29162,0.30054,1,1
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,7.013e-05,0.29107,0.24873,1,1
2,GO HISTONE H4 DEACETYLATION,4.4878e-05,0.29103,0.3279,1,1
2,GO ZYMOGEN INHIBITION,0.010245,0.29042,0.24546,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0032441,0.29041,0.22435,1,1
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0001547,0.29001,0.29361,1,1
2,GO PODOSOME ASSEMBLY,0.0022332,0.28995,0.25805,1,1
2,GO GRANULOCYTE DIFFERENTIATION,0.0034322,0.28871,0.23378,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.0038387,0.28853,0.27612,1,1
2,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0010859,0.28853,0.22523,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.00022676,0.28845,0.29004,1,1
2,GO MRNA MODIFICATION,0.001191,0.28832,0.21786,1,1
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00017796,0.28826,0.26875,1,1
2,GO GASTRIC ACID SECRETION,0.0024367,0.28823,0.22976,1,1
2,GO RIG I SIGNALING PATHWAY,9.389e-05,0.2881,0.25117,1,1
2,GO VIRAL TRANSLATION,0.00029782,0.2879,0.3207,1,1
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.023741,0.28738,0.34516,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00027832,0.28729,0.27398,1,1
2,GO PEPTIDE CROSS LINKING,0.0021689,0.28685,0.26412,1,1
2,GO FRUCTOSE METABOLIC PROCESS,0.020205,0.28525,0.3749,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0060989,0.28503,0.23448,1,1
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00018427,0.28472,0.21719,1,1
2,GO IRON ION TRANSMEMBRANE TRANSPORT,0.00032948,0.28463,0.2552,1,1
2,GO TELOMERASE RNA LOCALIZATION,0.001872,0.28431,0.27043,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,3.1888e-05,0.28428,0.28014,1,1
2,GO RESPONSE TO INTERLEUKIN 12,0.00012074,0.28381,0.26318,1,1
2,GO BLASTODERM SEGMENTATION,0.027803,0.28377,0.28331,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0054795,0.28375,0.24407,1,1
2,GO DETOXIFICATION,0.00023468,0.28367,0.25648,1,1
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.037747,0.28284,0.2367,1,1
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0001547,0.28128,0.25224,1,1
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.00065623,0.28103,0.19887,1,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0037331,0.28095,0.2198,1,1
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00016023,0.28011,0.24105,1,1
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.00050664,0.27965,0.2655,1,1
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00023468,0.27964,0.36523,1,1
2,GO EPITHELIAL CELL CELL ADHESION,0.001228,0.27896,0.4369,1,1
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00031859,0.27855,0.2719,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00054072,0.27659,0.25955,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0017641,0.27646,0.20075,1,1
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,2.0033e-05,0.27471,0.25233,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,4.3218e-05,0.27462,0.37623,1,1
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.0013457,0.27447,0.17784,1,1
2,GO PROSTATE GLAND DEVELOPMENT,0.0059384,0.27414,0.33267,1,1
2,GO REGULATION OF CELL KILLING,0.0036303,0.27402,0.19491,1,1
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.001872,0.27392,0.26244,1,1
2,GO ARACHIDONIC ACID SECRETION,0.00029782,0.27323,0.27101,1,1
2,GO HIPPO SIGNALING,0.0017123,0.27315,0.33362,1,1
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.029719,0.27292,0.33387,1,1
2,GO CHROMATIN DISASSEMBLY,0.0033369,0.27261,0.19177,1,1
2,GO TETRAHYDROFOLATE INTERCONVERSION,0.00052342,0.2726,0.39055,1,1
2,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.0038387,0.27242,0.24319,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0015189,0.27208,0.20134,1,1
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00072223,0.27153,0.26824,1,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0036303,0.27045,0.252,1,1
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0013457,0.26947,0.21333,1,1
2,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.0032441,0.26892,0.23371,1,1
2,GO MIRNA METABOLIC PROCESS,2.7343e-05,0.26846,0.21557,1,1
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,7.013e-05,0.2683,0.23074,1,1
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,8.1192e-05,0.26805,0.24199,1,1
2,GO L PHENYLALANINE METABOLIC PROCESS,0.0017641,0.26734,0.28463,1,1
2,GO GTP METABOLIC PROCESS,0.0021689,0.26711,0.27004,1,1
2,GO REGULATION OF MACROPHAGE ACTIVATION,0.00047456,0.26689,0.19917,1,1
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00031859,0.26667,0.23997,1,1
2,GO VIRAL GENE EXPRESSION,0.0013872,0.26609,0.24196,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00049035,0.2655,0.24123,1,1
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.009256,0.26545,0.19744,1,1
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.046579,0.26516,0.14257,1,1
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0017123,0.26478,0.19242,1,1
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.0064317,0.26433,0.24907,1,1
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.0019282,0.26309,0.20352,1,1
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.026586,0.263,0.21919,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.0020453,0.26282,0.18821,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0057817,0.26253,0.26756,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.017549,0.26251,0.14963,1,1
2,GO RESPONSE TO CADMIUM ION,0.04854,0.26217,0.18851,1,1
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.004408,0.26155,0.19522,1,1
2,GO MOVEMENT IN HOST ENVIRONMENT,0.001986,0.26104,0.19359,1,1
2,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.0040578,0.26074,0.30895,1,1
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.00092958,0.26067,0.25007,1,1
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.017969,0.25969,0.15241,1,1
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.00017186,0.25959,0.22385,1,1
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00035231,0.25894,0.24524,1,1
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0067808,0.25804,0.21197,1,1
2,GO T CELL CHEMOTAXIS,0.00018427,0.25766,0.2468,1,1
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0016129,0.25764,0.2328,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0024367,0.25744,0.20189,1,1
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.029719,0.25735,0.17793,1,1
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.04854,0.25722,0.18507,1,1
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.00069957,0.2569,0.2449,1,1
2,GO MATURATION OF SSU RRNA,0.00084609,0.25673,0.29059,1,1
2,GO AMINE CATABOLIC PROCESS,0.0036303,0.25667,0.29734,1,1
2,GO LINOLEIC ACID METABOLIC PROCESS,0.00081984,0.25639,0.41676,1,1
2,GO CELL REDOX HOMEOSTASIS,0.00019079,0.25586,0.23492,1,1
2,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.021165,0.25578,0.2371,1,1
2,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0047853,0.25545,0.30462,1,1
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.0014738,0.25496,0.20245,1,1
2,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.010773,0.25458,0.16782,1,1
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,1.7118e-05,0.2542,0.27672,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0021689,0.2539,0.28436,1,1
2,GO HYPEROSMOTIC RESPONSE,0.0015653,0.25339,0.25632,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.011047,0.2531,0.31198,1,1
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0040578,0.25298,0.25278,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.0013457,0.25295,0.22878,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,4.8379e-05,0.25284,0.22507,1,1
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.0041716,0.25283,0.28006,1,1
2,GO AMINO SUGAR METABOLIC PROCESS,0.0013054,0.25253,0.19678,1,1
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.0062634,0.25197,0.248,1,1
2,GO HISTONE H3 K9 ACETYLATION,7.2754e-05,0.25194,0.23856,1,1
2,GO NUCLEAR MIGRATION,0.015203,0.25191,0.17003,1,1
2,GO LAMELLIPODIUM ORGANIZATION,0.00014418,0.25118,0.24104,1,1
2,GO CELLULAR RESPONSE TO ETHANOL,0.0024367,0.25058,0.24338,1,1
2,GO OSTEOBLAST DEVELOPMENT,0.0007696,0.25012,0.29923,1,1
2,GO TRNA METHYLATION,0.00032948,0.25004,0.22206,1,1
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0010206,0.24986,0.17177,1,1
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.044685,0.24969,0.14031,1,1
2,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.016734,0.24912,0.22943,1,1
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00026003,0.24904,0.27761,1,1
2,GO MITOCHONDRIAL TRANSLATION,0.00063551,0.24882,0.23474,1,1
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0049174,0.2486,0.2264,1,1
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.0049174,0.24796,0.25013,1,1
2,GO L SERINE METABOLIC PROCESS,0.010245,0.24727,0.27613,1,1
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00065623,0.24712,0.21993,1,1
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00038934,0.24674,0.24009,1,1
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00029782,0.24587,0.23021,1,1
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0034322,0.2458,0.24629,1,1
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0027346,0.24537,0.16134,1,1
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.011612,0.24511,0.23128,1,1
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0006154,0.24507,0.18006,1,1
2,GO GLUTATHIONE METABOLIC PROCESS,3.7145e-05,0.24489,0.30063,1,1
2,GO AMINO ACID ACTIVATION,0.00012512,0.2448,0.28844,1,1
2,GO BILE ACID AND BILE SALT TRANSPORT,0.038561,0.24479,0.19904,1,1
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.001191,0.2446,0.23915,1,1
2,GO POSITIVE REGULATION OF TRANSLATION,4.1617e-05,0.24431,0.21518,1,1
2,GO PIGMENT ACCUMULATION,0.0018173,0.24311,0.23967,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.014138,0.24257,0.14992,1,1
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.0020453,0.2422,0.17979,1,1
2,GO ALDITOL METABOLIC PROCESS,0.00042998,0.24196,0.29156,1,1
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0033369,0.24189,0.25778,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.001986,0.24169,0.24642,1,1
2,GO SECRETION BY TISSUE,0.00084609,0.24153,0.26552,1,1
2,GO RESPONSE TO X RAY,0.00021167,0.24149,0.32623,1,1
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.02166,0.24111,0.23275,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0010859,0.24071,0.20213,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0013054,0.24067,0.22835,1,1
2,GO RESPIRATORY BURST,0.0071468,0.24015,0.208,1,1
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00030804,0.2401,0.23034,1,1
2,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.019739,0.23977,0.25071,1,1
2,GO RESPONSE TO SALT STRESS,0.015203,0.23956,0.21946,1,1
2,GO LIPID OXIDATION,0.0021062,0.23939,0.17205,1,1
2,GO BONE GROWTH,0.029068,0.23881,0.1969,1,1
2,GO RESPONSE TO OXYGEN RADICAL,0.0037331,0.23853,0.16552,1,1
2,GO RNA DESTABILIZATION,0.0024367,0.2384,0.17203,1,1
2,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.024846,0.2383,0.23175,1,1
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.025994,0.23823,0.18665,1,1
2,GO MITOCHONDRIAL DNA REPLICATION,0.00065623,0.23789,0.20556,1,1
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0025817,0.23788,0.2218,1,1
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,8.4205e-05,0.2378,0.21736,1,1
2,GO PROTEASOME ASSEMBLY,0.0045306,0.23755,0.17653,1,1
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.00092958,0.23742,0.22919,1,1
2,GO LAMELLIPODIUM ASSEMBLY,0.00072223,0.23741,0.19308,1,1
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0036303,0.23737,0.20855,1,1
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0033369,0.23721,0.1863,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,7.547e-05,0.23686,0.22712,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0013457,0.23666,0.23242,1,1
2,GO PIGMENT METABOLIC PROCESS,0.00079435,0.23664,0.21849,1,1
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00031859,0.23639,0.23097,1,1
2,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.00032948,0.23636,0.18846,1,1
2,GO MITOCHONDRIAL GENE EXPRESSION,0.00069957,0.23604,0.23027,1,1
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.010245,0.23464,0.22901,1,1
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.0069616,0.23437,0.19769,1,1
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.0042883,0.23412,0.21176,1,1
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0069616,0.23371,0.21872,1,1
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.014841,0.23354,0.15149,1,1
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.0057817,0.23337,0.23912,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.010773,0.23317,0.23857,1,1
2,GO PLATELET MORPHOGENESIS,0.00035231,0.23317,0.22927,1,1
2,GO ERYTHROCYTE DEVELOPMENT,0.0045306,0.23289,0.16763,1,1
2,GO APOPTOTIC CELL CLEARANCE,0.0016129,0.23281,0.16276,1,1
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0014738,0.23278,0.1853,1,1
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.017969,0.232,0.23813,1,1
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.00087311,0.23158,0.14143,1,1
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.023205,0.23139,0.1733,1,1
2,GO NIK NF KAPPAB SIGNALING,0.00069957,0.23138,0.18493,1,1
2,GO PEPTIDYL METHIONINE MODIFICATION,0.0021062,0.23137,0.2324,1,1
2,GO BLASTOCYST FORMATION,0.00018427,0.23087,0.21374,1,1
2,GO RESPONSE TO MANGANESE ION,0.0032441,0.23076,0.21233,1,1
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0027346,0.23076,0.21381,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0006154,0.23059,0.22253,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.010245,0.23008,0.16171,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,4.4878e-05,0.22963,0.18907,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.0022332,0.22962,0.29499,1,1
2,GO MALE GENITALIA DEVELOPMENT,0.0021062,0.22959,0.2365,1,1
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00012074,0.22931,0.24113,1,1
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0073363,0.22907,0.20161,1,1
2,GO GOLGI LOCALIZATION,0.013798,0.22894,0.17862,1,1
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0030654,0.22886,0.28273,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.00014418,0.22856,0.19017,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0010528,0.22811,0.15312,1,1
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.029068,0.22789,0.2342,1,1
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,6.7728e-06,0.2271,0.20914,1,1
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.00028792,0.22699,0.22064,1,1
2,GO RESPONSE TO INTERLEUKIN 1,0.00047456,0.22602,0.17607,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.0051916,0.22589,0.25335,1,1
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0028957,0.22506,0.15516,1,1
2,GO CYTOCHROME COMPLEX ASSEMBLY,0.0051916,0.22504,0.19169,1,1
2,GO LIVER REGENERATION,0.009256,0.22487,0.17921,1,1
2,GO MATURATION OF 5 8S RRNA,0.0013872,0.22463,0.26926,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0028141,0.22434,0.18227,1,1
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0059384,0.22408,0.14845,1,1
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.0025817,0.22397,0.23425,1,1
2,GO FATTY ACID BETA OXIDATION,0.0097392,0.22386,0.13625,1,1
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0022992,0.22377,0.25427,1,1
2,GO ARGININE METABOLIC PROCESS,0.042857,0.22346,0.19524,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.001191,0.22342,0.23147,1,1
2,GO TRANSLATIONAL TERMINATION,0.001662,0.22313,0.21854,1,1
2,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00353,0.22311,0.19444,1,1
2,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.047551,0.22297,0.12548,1,1
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.001986,0.22295,0.22217,1,1
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.001228,0.22269,0.1664,1,1
2,GO NUCLEUS LOCALIZATION,0.0022992,0.22255,0.17072,1,1
2,GO INTESTINAL ABSORPTION,0.0087944,0.22167,0.19457,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,3.1888e-05,0.22099,0.21191,1,1
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0021062,0.22023,0.22781,1,1
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,6.7596e-05,0.22022,0.21071,1,1
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.026586,0.21991,0.22807,1,1
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0073363,0.21941,0.17182,1,1
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.0014299,0.21924,0.20608,1,1
2,GO RIBOSOME BIOGENESIS,0.00027832,0.21919,0.25342,1,1
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0013872,0.21916,0.1558,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00034072,0.21914,0.23942,1,1
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0001165,0.21882,0.18182,1,1
2,GO ICOSANOID METABOLIC PROCESS,0.001986,0.21868,0.18629,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,6.2786e-05,0.21847,0.19701,1,1
2,GO T CELL RECEPTOR SIGNALING PATHWAY,7.547e-05,0.21796,0.18325,1,1
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.00057693,0.2177,0.19629,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.017137,0.21665,0.1399,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00054072,0.21655,0.15534,1,1
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0013457,0.21629,0.18669,1,1
2,GO AMINO SUGAR CATABOLIC PROCESS,0.02843,0.21616,0.17568,1,1
2,GO T CELL APOPTOTIC PROCESS,0.00042998,0.21578,0.23293,1,1
2,GO IRON ION HOMEOSTASIS,0.00353,0.21575,0.16266,1,1
2,GO KERATAN SULFATE METABOLIC PROCESS,0.042857,0.21563,0.1387,1,1
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00047456,0.21534,0.22068,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0054795,0.21529,0.23026,1,1
2,GO MAINTENANCE OF CELL NUMBER,0.00028792,0.21523,0.20008,1,1
2,GO REGULATION OF GENE SILENCING,5.0683e-06,0.21484,0.20369,1,1
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0045306,0.21476,0.17825,1,1
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.0020453,0.2146,0.23118,1,1
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0024367,0.21452,0.16188,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.017969,0.21442,0.17791,1,1
2,GO AMYLOID BETA CLEARANCE,0.0053338,0.21354,0.19606,1,1
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00035231,0.2133,0.22123,1,1
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.015953,0.21288,0.16625,1,1
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0087944,0.2128,0.19349,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.010245,0.21234,0.19501,1,1
2,GO LEUKOCYTE APOPTOTIC PROCESS,0.0017641,0.21185,0.19463,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00038934,0.21182,0.21758,1,1
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0062634,0.21164,0.15797,1,1
2,GO B CELL APOPTOTIC PROCESS,0.012203,0.21164,0.14712,1,1
2,GO INTERACTION WITH HOST,0.0015653,0.21138,0.17433,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00059588,0.21126,0.22841,1,1
2,GO MULTI ORGANISM LOCALIZATION,0.00011241,0.21104,0.18282,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0028957,0.21095,0.16386,1,1
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00017186,0.21095,0.22245,1,1
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00035231,0.21028,0.20847,1,1
2,GO RESPONSE TO INTERLEUKIN 7,0.0025817,0.2102,0.1538,1,1
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.035393,0.21012,0.17625,1,1
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0073363,0.20983,0.34947,1,1
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.001986,0.20965,0.18519,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,5.0226e-05,0.2095,0.19498,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,0.00024286,0.20924,0.16592,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.00012074,0.20924,0.19773,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.011047,0.20914,0.15851,1,1
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.00353,0.20899,0.1704,1,1
2,GO REGULATION OF NECROTIC CELL DEATH,0.010773,0.20837,0.21633,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0059384,0.20828,0.15751,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.031059,0.20813,0.13046,1,1
2,GO REGULATION OF B CELL PROLIFERATION,0.0034322,0.20778,0.16856,1,1
2,GO TYPE I INTERFERON PRODUCTION,0.0064317,0.20764,0.17278,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0075304,0.20759,0.20384,1,1
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00013433,0.20735,0.26378,1,1
2,GO RNA POLYADENYLATION,0.00090094,0.20729,0.15255,1,1
2,GO THIOESTER METABOLIC PROCESS,0.0017123,0.20708,0.19953,1,1
2,GO CYTOPLASM ORGANIZATION,0.014138,0.20701,0.22853,1,1
2,GO RNA STABILIZATION,0.0010859,0.20696,0.15655,1,1
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.017549,0.20675,0.17263,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0040578,0.20642,0.15938,1,1
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.00041602,0.20632,0.23578,1,1
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.043763,0.20628,0.15932,1,1
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0050528,0.20625,0.15868,1,1
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.025994,0.20513,0.18979,1,1
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00011241,0.20513,0.18637,1,1
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00098941,0.20481,0.21861,1,1
2,GO NCRNA PROCESSING,0.00041602,0.20423,0.2166,1,1
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.0013872,0.20411,0.18274,1,1
2,GO NCRNA EXPORT FROM NUCLEUS,9.7801e-06,0.20398,0.25326,1,1
2,GO CORNIFICATION,0.0054795,0.20373,0.26068,1,1
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.00063551,0.20371,0.1765,1,1
2,GO LATERAL VENTRICLE DEVELOPMENT,0.00079435,0.2034,0.26889,1,1
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.0030654,0.20338,0.21657,1,1
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.0099891,0.20327,0.15712,1,1
2,GO HISTONE DEUBIQUITINATION,7.547e-05,0.2029,0.18267,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00353,0.20256,0.21796,1,1
2,GO CYTOPLASMIC TRANSLATION,0.027803,0.20244,0.1905,1,1
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0021062,0.20239,0.17034,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00021167,0.20213,0.2128,1,1
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0010859,0.20199,0.18167,1,1
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0006154,0.2018,0.18869,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0099891,0.20159,0.14887,1,1
2,GO COPII COATED VESICLE CARGO LOADING,0.0038387,0.20083,0.15725,1,1
2,GO RESPONSE TO ESTROGEN,0.0087944,0.20081,0.17641,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.031748,0.20068,0.16199,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0051916,0.20066,0.225,1,1
2,GO CELLULAR IRON ION HOMEOSTASIS,0.0028957,0.20054,0.14857,1,1
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0023671,0.20051,0.12722,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.02166,0.20016,0.1438,1,1
2,GO PROTEIN ADP RIBOSYLATION,0.0038387,0.2001,0.20733,1,1
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.025994,0.20005,0.18769,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,9.0551e-05,0.20004,0.17681,1,1
2,GO REGULATION OF CELLULAR RESPIRATION,0.025414,0.19993,0.16782,1,1
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.00029782,0.19988,0.18905,1,1
2,GO INTERACTION WITH SYMBIONT,0.00013917,0.19985,0.21832,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0039469,0.19936,0.23072,1,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.010506,0.19913,0.15499,1,1
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.0015189,0.19911,0.25399,1,1
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,9.0551e-05,0.19886,0.19566,1,1
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.02268,0.19854,0.17481,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00013917,0.19847,0.1919,1,1
2,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.0085714,0.19833,0.20911,1,1
2,GO MICROVILLUS ORGANIZATION,0.018398,0.19815,0.28573,1,1
2,GO RNA METHYLATION,0.00092958,0.19798,0.16294,1,1
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0094949,0.19781,0.19501,1,1
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00017186,0.1976,0.2146,1,1
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.0028957,0.19753,0.16624,1,1
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0014299,0.19602,0.1642,1,1
2,GO POLYOL BIOSYNTHETIC PROCESS,0.0075304,0.19591,0.12552,1,1
2,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.024288,0.19573,0.21444,1,1
2,GO REGULATION OF BONE DEVELOPMENT,0.0047853,0.1957,0.14912,1,1
2,GO LEFT RIGHT PATTERN FORMATION,0.0085714,0.19557,0.23464,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0031536,0.19524,0.19626,1,1
2,GO REGULATION OF T CELL CHEMOTAXIS,0.016339,0.19508,0.18222,1,1
2,GO RRNA METABOLIC PROCESS,0.00055855,0.1949,0.22801,1,1
2,GO PEPTIDYL ARGININE MODIFICATION,5.2139e-05,0.19463,0.21572,1,1
2,GO AEROBIC RESPIRATION,0.00067758,0.19461,0.20015,1,1
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.041967,0.19459,0.11585,1,1
2,GO PRIMARY MIRNA PROCESSING,0.0011549,0.19456,0.20914,1,1
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.011047,0.19441,0.16738,1,1
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.019283,0.19425,0.13959,1,1
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0013054,0.19389,0.16848,1,1
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.017137,0.19358,0.19846,1,1
2,GO INTERLEUKIN 10 PRODUCTION,0.016734,0.19333,0.15527,1,1
2,GO GENITALIA MORPHOGENESIS,0.033894,0.19304,0.18236,1,1
2,GO ORGANIC ACID CATABOLIC PROCESS,0.00081984,0.19263,0.15868,1,1
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0053338,0.1925,0.15136,1,1
2,GO CHYLOMICRON ASSEMBLY,0.010245,0.19239,0.13701,1,1
2,GO DENDRITIC CELL CHEMOTAXIS,0.0054795,0.19231,0.21851,1,1
2,GO AXIS ELONGATION,0.0057817,0.19211,0.29493,1,1
2,GO DIGESTIVE SYSTEM PROCESS,0.0019282,0.19199,0.16639,1,1
2,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.030383,0.19172,0.21302,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00021909,0.19153,0.23874,1,1
2,GO NEGATIVE T CELL SELECTION,0.0097392,0.19146,0.10581,1,1
2,GO TRNA TRANSPORT,1.2962e-05,0.19136,0.24443,1,1
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.0022992,0.19126,0.18958,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00017186,0.19105,0.1935,1,1
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0013872,0.19076,0.15061,1,1
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.02166,0.19062,0.1709,1,1
2,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.0020453,0.19051,0.18013,1,1
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.018836,0.19027,0.12598,1,1
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,1.1964e-05,0.19023,0.1697,1,1
2,GO TRNA METABOLIC PROCESS,0.00024286,0.19017,0.18626,1,1
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0064317,0.19007,0.16536,1,1
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.004408,0.18971,0.13579,1,1
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.013798,0.18928,0.1723,1,1
2,GO ISOPRENOID METABOLIC PROCESS,0.0046564,0.18915,0.16219,1,1
2,GO GLUTAMINE METABOLIC PROCESS,0.00026903,0.18909,0.24946,1,1
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,1.8251e-06,0.18902,0.20438,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00057693,0.18899,0.15748,1,1
2,GO THYMUS DEVELOPMENT,0.0037331,0.18875,0.16836,1,1
2,GO NCRNA METABOLIC PROCESS,0.00055855,0.18855,0.19249,1,1
2,GO TOXIN TRANSPORT,0.0057817,0.1885,0.1456,1,1
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0051916,0.18804,0.21643,1,1
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.0022332,0.18785,0.18755,1,1
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,1.104e-05,0.18701,0.20664,1,1
2,GO TRANSLATIONAL INITIATION,0.030383,0.18694,0.17979,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.0025817,0.18598,0.19064,1,1
2,GO FATTY ACID CATABOLIC PROCESS,0.016734,0.18597,0.12578,1,1
2,GO RNA INTERFERENCE,0.0079323,0.18581,0.17857,1,1
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0012662,0.18571,0.18463,1,1
2,GO PIGMENT GRANULE ORGANIZATION,8.7323e-05,0.18527,0.22708,1,1
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0069616,0.18433,0.11737,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0069616,0.18345,0.13427,1,1
2,GO PINOCYTOSIS,0.014841,0.18316,0.12439,1,1
2,GO RESPONSE TO ANTIBIOTIC,0.0006154,0.18295,0.19425,1,1
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.0022332,0.18237,0.14422,1,1
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00012964,0.18213,0.16658,1,1
2,GO TERPENOID METABOLIC PROCESS,0.014138,0.18173,0.16093,1,1
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0045306,0.18087,0.15133,1,1
2,GO TRICARBOXYLIC ACID CYCLE,0.0022332,0.18054,0.22706,1,1
2,GO RESPONSE TO OSMOTIC STRESS,0.0015653,0.18012,0.16492,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.03245,0.18005,0.25633,1,1
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,7.547e-05,0.17989,0.2359,1,1
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.011047,0.17951,0.15129,1,1
2,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.023741,0.17946,0.15152,1,1
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.001228,0.17842,0.16056,1,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.030383,0.17838,0.13751,1,1
2,GO FATTY ACID TRANSPORT,0.00047456,0.17825,0.15179,1,1
2,GO RNA MODIFICATION,0.00044439,0.17762,0.15747,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0024367,0.17744,0.16598,1,1
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.023205,0.17733,0.16175,1,1
2,GO SYMBIOTIC PROCESS,0.00024286,0.17731,0.1543,1,1
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.041093,0.17726,0.15127,1,1
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00095906,0.17713,0.16939,1,1
2,GO LIPID MODIFICATION,0.0021689,0.17696,0.12455,1,1
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0034322,0.17693,0.1522,1,1
2,GO NATURAL KILLER CELL PROLIFERATION,0.024288,0.17676,0.2034,1,1
2,GO REGULATION OF MRNA CATABOLIC PROCESS,0.00017796,0.17655,0.1617,1,1
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,1.0604e-05,0.17621,0.15951,1,1
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00044439,0.17616,0.15531,1,1
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00026003,0.17577,0.17065,1,1
2,GO TRANSLATIONAL ELONGATION,0.0083534,0.17542,0.1696,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00023468,0.17535,0.20304,1,1
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.0028957,0.17527,0.15919,1,1
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.020205,0.17464,0.13701,1,1
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0057817,0.17464,0.21213,1,1
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0094949,0.17437,0.15959,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0011549,0.17327,0.20141,1,1
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0042883,0.17306,0.17563,1,1
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0021689,0.17303,0.13629,1,1
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.014486,0.17283,0.1539,1,1
2,GO ANIMAL ORGAN REGENERATION,0.027188,0.17246,0.12398,1,1
2,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0037331,0.17227,0.19047,1,1
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.026586,0.17219,0.12706,1,1
2,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.017549,0.17208,0.16465,1,1
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.00050664,0.17196,0.17433,1,1
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.025414,0.17191,0.10941,1,1
2,GO HISTONE H3 K4 TRIMETHYLATION,0.0015653,0.1718,0.17091,1,1
2,GO INTERFERON GAMMA PRODUCTION,0.001662,0.17143,0.14687,1,1
2,GO MYOBLAST DIFFERENTIATION,0.009256,0.17078,0.18835,1,1
2,GO HISTONE H2B UBIQUITINATION,0.007729,0.17077,0.14854,1,1
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.015574,0.17074,0.15454,1,1
2,GO TRNA PROCESSING,0.00049035,0.17067,0.17675,1,1
2,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.046579,0.17014,0.12077,1,1
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00054072,0.17004,0.17289,1,1
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0006154,0.16995,0.19681,1,1
2,GO CELLULAR RESPONSE TO ALCOHOL,0.00042998,0.1698,0.17626,1,1
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0025083,0.16922,0.21776,1,1
2,GO APICAL JUNCTION ASSEMBLY,0.023205,0.16919,0.17737,1,1
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.01282,0.16889,0.11203,1,1
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.0046564,0.16874,0.16218,1,1
2,GO FATTY ACID METABOLIC PROCESS,0.00038934,0.1686,0.16018,1,1
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.0027346,0.16813,0.18006,1,1
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.025414,0.16808,0.2129,1,1
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00074557,0.16787,0.13555,1,1
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.03939,0.16748,0.16595,1,1
2,GO CELL CELL JUNCTION ORGANIZATION,0.041967,0.16729,0.11507,1,1
2,GO B CELL PROLIFERATION,0.0047853,0.16701,0.14361,1,1
2,GO MRNA METHYLATION,0.043763,0.16696,0.13958,1,1
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.001228,0.16684,0.19329,1,1
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.025414,0.16674,0.14619,1,1
2,GO REGULATION OF SYMBIOTIC PROCESS,0.011904,0.1666,0.17072,1,1
2,GO VIRAL LIFE CYCLE,0.0036303,0.16567,0.15337,1,1
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0053338,0.16558,0.16805,1,1
2,GO HISTONE H3 K14 ACETYLATION,0.0001165,0.16544,0.16381,1,1
2,GO SCHWANN CELL DIFFERENTIATION,0.018836,0.16524,0.13202,1,1
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.0022332,0.16519,0.13686,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0057817,0.16474,0.13628,1,1
2,GO LIPID HOMEOSTASIS,0.0066042,0.16454,0.13305,1,1
2,GO FC RECEPTOR SIGNALING PATHWAY,0.0024367,0.1636,0.14178,1,1
2,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0014738,0.16358,0.14047,1,1
2,GO PEPTIDE METABOLIC PROCESS,0.0010528,0.16319,0.1454,1,1
2,GO PHOTOPERIODISM,0.037747,0.163,0.10871,1,1
2,GO RNA CATABOLIC PROCESS,0.00065623,0.16236,0.15626,1,1
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.044685,0.16235,0.15542,1,1
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0036303,0.16221,0.11467,1,1
2,GO MRNA TRANSCRIPTION,0.0054795,0.1621,0.15992,1,1
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0011199,0.16207,0.18441,1,1
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.023205,0.16192,0.14178,1,1
2,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.035393,0.16185,0.15526,1,1
2,GO INTERLEUKIN 17 PRODUCTION,0.0083534,0.16154,0.13889,1,1
2,GO CELLULAR LIPID METABOLIC PROCESS,0.00045924,0.16152,0.1328,1,1
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.017969,0.1614,0.10898,1,1
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0064317,0.16078,0.11643,1,1
2,GO STEROL BIOSYNTHETIC PROCESS,0.013139,0.16041,0.17544,1,1
2,GO ERBB SIGNALING PATHWAY,0.0025083,0.16019,0.13469,1,1
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.023205,0.16015,0.15877,1,1
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00050664,0.15975,0.16706,1,1
2,GO MYELOID LEUKOCYTE ACTIVATION,0.0039469,0.15965,0.13605,1,1
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.001662,0.15962,0.17465,1,1
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.014841,0.1596,0.14453,1,1
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.035393,0.15896,0.12123,1,1
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0020453,0.15803,0.2254,1,1
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0099891,0.15693,0.16133,1,1
2,GO POLYAMINE METABOLIC PROCESS,0.018836,0.15685,0.13907,1,1
2,GO TRANSITION METAL ION HOMEOSTASIS,0.0032441,0.15641,0.15467,1,1
2,GO VIRAL RNA GENOME REPLICATION,0.037747,0.15628,0.13703,1,1
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.0071468,0.15591,0.12945,1,1
2,GO ALPHA AMINO ACID METABOLIC PROCESS,0.00026003,0.15589,0.16989,1,1
2,GO P BODY ASSEMBLY,0.0021062,0.15574,0.13824,1,1
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00092958,0.15548,0.15424,1,1
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.0099891,0.15546,0.11883,1,1
2,GO ALCOHOL METABOLIC PROCESS,0.00016023,0.15532,0.16415,1,1
2,GO NUCLEOBASE METABOLIC PROCESS,0.0010206,0.15521,0.19759,1,1
2,GO REGULATION OF DEFENSE RESPONSE,0.0037331,0.1552,0.11424,1,1
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.0020453,0.1547,0.12485,1,1
2,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0087944,0.15451,0.1445,1,1
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0038387,0.15392,0.11986,1,1
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.018836,0.15387,0.12064,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0007696,0.15353,0.18701,1,1
2,GO ELECTRON TRANSPORT CHAIN,0.0075304,0.15341,0.1267,1,1
2,GO REGULATION OF HAIR CYCLE,0.015203,0.15329,0.21629,1,1
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00016023,0.15322,0.17951,1,1
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.0012662,0.15321,0.26055,1,1
2,GO VESICLE TARGETING,0.0027346,0.15303,0.13314,1,1
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0064317,0.15296,0.14558,1,1
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00055855,0.15295,0.14861,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00019753,0.15285,0.13176,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.014138,0.1527,0.15803,1,1
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00054072,0.15264,0.1465,1,1
2,GO PHAGOCYTOSIS,0.0053338,0.15245,0.14532,1,1
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0023671,0.15244,0.16936,1,1
2,GO DIGESTION,0.010245,0.15226,0.12736,1,1
2,GO CELLULAR RESPONSE TO VIRUS,0.01282,0.15211,0.13598,1,1
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,8.1192e-05,0.15147,0.14497,1,1
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,1.2454e-05,0.15134,0.17892,1,1
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.0099891,0.15133,0.228,1,1
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.00025131,0.15068,0.1261,1,1
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0019282,0.15066,0.16843,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00026903,0.15027,0.16241,1,1
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00029782,0.15017,0.14509,1,1
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0011549,0.14967,0.1426,1,1
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0028957,0.14932,0.15495,1,1
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.029719,0.14929,0.20822,1,1
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0025083,0.1487,0.13906,1,1
2,GO PROGRAMMED NECROTIC CELL DEATH,0.024846,0.14852,0.15197,1,1
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.014138,0.14815,0.12236,1,1
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0069616,0.14791,0.18175,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE,0.00055855,0.14791,0.14492,1,1
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.015203,0.14779,0.12728,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00065623,0.14779,0.13653,1,1
2,GO GOLGI VESICLE BUDDING,0.001191,0.1476,0.12614,1,1
2,GO PROTEIN IMPORT,0.0019282,0.14747,0.13069,1,1
2,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.019283,0.14734,0.19193,1,1
2,GO TRANSEPITHELIAL TRANSPORT,0.0099891,0.14711,0.16459,1,1
2,GO REGULATION OF ACTION POTENTIAL,0.035393,0.14703,0.12533,1,1
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.009256,0.14702,0.13791,1,1
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.030383,0.147,0.13639,1,1
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,4.0073e-05,0.14657,0.1437,1,1
2,GO RECEPTOR CATABOLIC PROCESS,0.023205,0.14637,0.15217,1,1
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0064317,0.14602,0.12032,1,1
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0013872,0.14542,0.16642,1,1
2,GO LIPOPROTEIN LOCALIZATION,0.041967,0.14542,0.10338,1,1
2,GO IMPORT INTO NUCLEUS,0.02166,0.14532,0.11211,1,1
2,GO ACTIN FILAMENT ORGANIZATION,0.013465,0.1451,0.10265,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.0039469,0.1451,0.16692,1,1
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.029068,0.14507,0.1199,1,1
2,GO GMP METABOLIC PROCESS,0.029068,0.14505,0.14564,1,1
2,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.041967,0.14461,0.16146,1,1
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.00045924,0.14451,0.14198,1,1
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0097392,0.14404,0.10802,1,1
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0027346,0.14395,0.22552,1,1
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0053338,0.1438,0.17457,1,1
2,GO RESPONSE TO OXIDATIVE STRESS,0.010506,0.14334,0.10937,1,1
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.013139,0.14308,0.11518,1,1
2,GO SERTOLI CELL DIFFERENTIATION,0.023741,0.14298,0.20433,1,1
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.004408,0.1428,0.16105,1,1
2,GO GOLGI RIBBON FORMATION,0.018398,0.14271,0.13842,1,1
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.01282,0.14237,0.09459,1,1
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.00065623,0.14228,0.12581,1,1
2,GO SIGNAL PEPTIDE PROCESSING,0.024846,0.14192,0.18904,1,1
2,GO OXIDATION REDUCTION PROCESS,0.0017641,0.14183,0.12411,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.016339,0.14159,0.09467,1,1
2,GO HEXOSE CATABOLIC PROCESS,0.0079323,0.1415,0.17319,1,1
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00045924,0.14128,0.12944,1,1
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.012508,0.14123,0.11833,1,1
2,GO RESPONSE TO GAMMA RADIATION,0.001228,0.14088,0.18212,1,1
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.02843,0.14062,0.16459,1,1
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.00034072,0.14024,0.1391,1,1
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.010245,0.14011,0.14857,1,1
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.011047,0.14009,0.1295,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0021062,0.14006,0.1955,1,1
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00045924,0.14001,0.18454,1,1
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.0017641,0.13993,0.1523,1,1
2,GO POLYOL METABOLIC PROCESS,0.00022676,0.13931,0.16091,1,1
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0060989,0.13914,0.11523,1,1
2,GO TISSUE HOMEOSTASIS,0.010506,0.13892,0.095562,1,1
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,7.8282e-05,0.13869,0.13004,1,1
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0024367,0.13867,0.13598,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,5.8301e-05,0.13846,0.13368,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0090226,0.13832,0.11569,1,1
2,GO GLYCEROLIPID METABOLIC PROCESS,3.1888e-05,0.13781,0.14227,1,1
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.0017123,0.13778,0.12931,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,7.8282e-05,0.1376,0.15382,1,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.0034322,0.13759,0.1665,1,1
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.00028792,0.13758,0.17884,1,1
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.018398,0.13753,0.087825,1,1
2,GO ACTIN FILAMENT BASED MOVEMENT,0.013465,0.13733,0.1162,1,1
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0027346,0.13732,0.13605,1,1
2,GO COPII COATED VESICLE BUDDING,0.0010859,0.13715,0.12497,1,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.014486,0.13686,0.14357,1,1
2,GO RESPONSE TO ACTIVITY,0.02843,0.13685,0.096477,1,1
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0059384,0.13645,0.15131,1,1
2,GO LIPID BIOSYNTHETIC PROCESS,0.00025131,0.13617,0.13029,1,1
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.020205,0.13609,0.13976,1,1
2,GO BASE EXCISION REPAIR,0.0038387,0.13528,0.12574,1,1
2,GO NUCLEAR EXPORT,9.7346e-05,0.13523,0.16091,1,1
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.01282,0.13487,0.12132,1,1
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.019283,0.13353,0.10579,1,1
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.00029782,0.13335,0.15018,1,1
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.013798,0.13291,0.12961,1,1
2,GO TELOMERE ORGANIZATION,0.00038934,0.13287,0.13776,1,1
2,GO LIPID METABOLIC PROCESS,0.0011199,0.13283,0.11064,1,1
2,GO PROTEIN AUTOPHOSPHORYLATION,0.0025817,0.13282,0.11717,1,1
2,GO DNA GEOMETRIC CHANGE,0.00014418,0.13213,0.15335,1,1
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00049035,0.13205,0.12337,1,1
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.034637,0.13135,0.13753,1,1
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,7.2754e-05,0.13118,0.13638,1,1
2,GO ORGANIC ACID METABOLIC PROCESS,0.0010859,0.13044,0.11862,1,1
2,GO CELL CELL RECOGNITION,0.016734,0.13043,0.10222,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00052342,0.13042,0.15987,1,1
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.0054795,0.12974,0.12503,1,1
2,GO RESPONSE TO TOXIC SUBSTANCE,0.0036303,0.12951,0.12591,1,1
2,GO STEROID BIOSYNTHETIC PROCESS,0.0053338,0.12924,0.12441,1,1
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0090226,0.12856,0.12848,1,1
2,GO MRNA CLEAVAGE,2.2524e-05,0.12849,0.1658,1,1
2,GO BODY FLUID SECRETION,0.00090094,0.12831,0.15203,1,1
2,GO MRNA 3 END PROCESSING,0.00045924,0.12808,0.14323,1,1
2,GO HISTONE PHOSPHORYLATION,0.0090226,0.12784,0.10778,1,1
2,GO OXIDATIVE DEMETHYLATION,0.020205,0.12765,0.092979,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0090226,0.12752,0.13045,1,1
2,GO GOLGI VESICLE TRANSPORT,0.0015189,0.12696,0.098636,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.0022332,0.12681,0.13721,1,1
2,GO NUCLEOTIDE PHOSPHORYLATION,0.042857,0.1268,0.083463,1,1
2,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.046579,0.12674,0.081802,1,1
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.001872,0.12617,0.12099,1,1
2,GO STEROL IMPORT,0.01282,0.12604,0.17471,1,1
2,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.019283,0.12555,0.088981,1,1
2,GO LIPID CATABOLIC PROCESS,0.011904,0.1254,0.099419,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,9.7346e-05,0.12488,0.11788,1,1
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.019739,0.12444,0.084239,1,1
2,GO HISTONE H3 DEACETYLATION,0.019283,0.12442,0.11692,1,1
2,GO RESPONSE TO IONIZING RADIATION,0.0015189,0.12418,0.16255,1,1
2,GO RNA PROCESSING,0.00016595,0.12406,0.15172,1,1
2,GO GENE SILENCING,1.4609e-05,0.12385,0.13436,1,1
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.041967,0.12359,0.091026,1,1
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.015574,0.1223,0.1206,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0026572,0.12217,0.14542,1,1
2,GO MRNA METABOLIC PROCESS,0.00017796,0.12179,0.13519,1,1
2,GO PROTEIN SUMOYLATION,0.00012074,0.12162,0.12794,1,1
2,GO STRESS GRANULE ASSEMBLY,0.012203,0.12125,0.11656,1,1
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.016339,0.1207,0.11852,1,1
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.0069616,0.1204,0.10391,1,1
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.00021909,0.12029,0.1183,1,1
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0053338,0.12013,0.14305,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.029068,0.11945,0.11822,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0017123,0.11902,0.14885,1,1
2,GO OXIDATIVE PHOSPHORYLATION,0.041967,0.11893,0.11637,1,1
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.027803,0.11866,0.083935,1,1
2,GO REGULATION OF MYELINATION,0.038561,0.11862,0.10344,1,1
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.033166,0.11851,0.10815,1,1
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0028957,0.11847,0.10615,1,1
2,GO PROTEIN NEDDYLATION,0.029719,0.1179,0.10556,1,1
2,GO RESPONSE TO STEROID HORMONE,0.047551,0.11788,0.095905,1,1
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00022676,0.11771,0.13518,1,1
2,GO ACTIN NUCLEATION,0.018836,0.11733,0.11748,1,1
2,GO REGULATION OF ORGAN GROWTH,0.044685,0.11715,0.1211,1,1
2,GO NON RECOMBINATIONAL REPAIR,0.0094949,0.11703,0.1006,1,1
2,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0037331,0.11662,0.091428,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00084609,0.11653,0.15272,1,1
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.0033369,0.11639,0.10396,1,1
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.0032441,0.11633,0.097154,1,1
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0033369,0.1161,0.10579,1,1
2,GO DNA BIOSYNTHETIC PROCESS,0.00035231,0.11606,0.10502,1,1
2,GO RESPONSE TO ALCOHOL,0.030383,0.11596,0.089355,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00042998,0.11559,0.13664,1,1
2,GO PEROXISOMAL TRANSPORT,0.0062634,0.11531,0.13382,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.0022992,0.11526,0.12147,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.02268,0.11509,0.16863,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0083534,0.11383,0.10364,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.033894,0.11371,0.11804,1,1
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.033166,0.11368,0.091151,1,1
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0046564,0.11353,0.16041,1,1
2,GO ACTIVATION OF GTPASE ACTIVITY,0.02268,0.11326,0.098049,1,1
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.017969,0.11311,0.078825,1,1
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.015203,0.11295,0.095117,1,1
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.046579,0.11292,0.15119,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00047456,0.11254,0.13846,1,1
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.033166,0.11249,0.11698,1,1
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.013139,0.11244,0.092192,1,1
2,GO REGULATION OF MRNA 3 END PROCESSING,0.015203,0.11232,0.11,1,1
2,GO NUCLEOSIDE METABOLIC PROCESS,0.0053338,0.11221,0.11821,1,1
2,GO NUCLEAR TRANSPORT,0.0018173,0.11205,0.11881,1,1
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.027803,0.11186,0.085733,1,1
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.033894,0.11167,0.081114,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0018173,0.11141,0.12801,1,1
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.02843,0.11116,0.10349,1,1
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.011047,0.11097,0.083466,1,1
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.031748,0.11092,0.13206,1,1
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0026572,0.11053,0.13885,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.010506,0.11016,0.10935,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0067808,0.11001,0.12022,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.035393,0.10958,0.078272,1,1
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00020448,0.10956,0.14177,1,1
2,GO PEROXISOME ORGANIZATION,0.0079323,0.10944,0.11875,1,1
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0024367,0.1094,0.11329,1,1
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.00084609,0.10883,0.11147,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.0087944,0.10781,0.10084,1,1
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0029794,0.10774,0.082699,1,1
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.013139,0.1067,0.087767,1,1
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.042857,0.10645,0.11624,1,1
2,GO POSITIVE REGULATION OF AUTOPHAGY,0.035393,0.10585,0.09222,1,1
2,GO RESPONSE TO SALT,0.025414,0.10581,0.16652,1,1
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.031748,0.10467,0.10111,1,1
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.036164,0.10462,0.10478,1,1
2,GO MRNA TRANSPORT,0.00098941,0.10385,0.13743,1,1
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.023741,0.1036,0.13061,1,1
2,GO SENSORY PERCEPTION OF TASTE,0.0079323,0.10355,0.24638,1,1
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.004408,0.10246,0.096349,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,6.2786e-05,0.10215,0.13018,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0014738,0.10198,0.11941,1,1
2,GO MRNA PROCESSING,0.00098941,0.10175,0.10927,1,1
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.0022332,0.10162,0.13468,1,1
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.02068,0.1014,0.0759,1,1
2,GO RNA 3 END PROCESSING,0.0057817,0.099327,0.11797,1,1
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00057693,0.099124,0.098164,1,1
2,GO VESICLE BUDDING FROM MEMBRANE,0.023741,0.098839,0.081716,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.036164,0.098715,0.07261,1,1
2,GO RNA LOCALIZATION,0.00018427,0.098195,0.15138,1,1
2,GO MEGAKARYOCYTE DIFFERENTIATION,0.0025817,0.097503,0.12772,1,1
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.045624,0.097182,0.075032,1,1
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.018398,0.096798,0.066552,1,1
2,GO REGULATION OF CATABOLIC PROCESS,0.0045306,0.096121,0.075563,1,1
2,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.0099891,0.09543,0.095039,1,1
2,GO DNA METHYLATION,0.009256,0.09471,0.090647,1,1
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.007729,0.094352,0.098635,1,1
2,GO STEM CELL DIFFERENTIATION,0.010506,0.094058,0.12132,1,1
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.03939,0.093606,0.13947,1,1
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.00026903,0.093346,0.10056,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0059384,0.093334,0.12289,1,1
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0037331,0.092719,0.099204,1,1
2,GO EPIDERMAL CELL DIFFERENTIATION,0.016734,0.090882,0.17315,1,1
2,GO DNA CONFORMATION CHANGE,0.0094949,0.090581,0.083715,1,1
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.033166,0.09009,0.05905,1,1
2,GO RESPONSE TO UV,0.0054795,0.089115,0.12713,1,1
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0017123,0.089078,0.099938,1,1
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.029068,0.088773,0.086824,1,1
2,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.0081404,0.088757,0.10054,1,1
2,GO RNA SPLICING,0.0020453,0.088566,0.107,1,1
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0001165,0.088133,0.11976,1,1
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.00074557,0.0881,0.11853,1,1
2,GO GLUCOSE METABOLIC PROCESS,0.025414,0.087595,0.056385,1,1
2,GO PROTEIN POLYUBIQUITINATION,0.021165,0.087472,0.072275,1,1
2,GO CARBOHYDRATE METABOLIC PROCESS,0.0064317,0.08741,0.077006,1,1
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.001986,0.087387,0.081898,1,1
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.024288,0.087296,0.15212,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.017549,0.08723,0.086512,1,1
2,GO CHROMATIN REMODELING,0.0028141,0.08717,0.097614,1,1
2,GO REGULATION OF HISTONE UBIQUITINATION,0.024288,0.086722,0.099406,1,1
2,GO CELL CYCLE PHASE TRANSITION,0.013465,0.084988,0.07816,1,1
2,GO MACROMOLECULE CATABOLIC PROCESS,0.0051916,0.084422,0.074039,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.043763,0.083876,0.064938,1,1
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.011904,0.083078,0.08958,1,1
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.001872,0.082814,0.090291,1,1
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.031059,0.080511,0.077587,1,1
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.014841,0.080462,0.056878,1,1
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00092958,0.080457,0.097065,1,1
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.015203,0.080293,0.083498,1,1
2,GO HISTONE H3 ACETYLATION,0.0027346,0.079136,0.091673,1,1
2,GO MAINTENANCE OF ORGANELLE LOCATION,0.033166,0.078754,0.15685,1,1
2,GO CELLULAR RESPONSE TO UV,0.0069616,0.078364,0.11375,1,1
2,GO PROTEIN CATABOLIC PROCESS,0.036948,0.077488,0.050192,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.024288,0.077301,0.066165,1,1
2,GO DOUBLE STRAND BREAK REPAIR,0.0094949,0.077022,0.090903,1,1
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.024288,0.07674,0.09339,1,1
2,GO CELLULAR COMPONENT DISASSEMBLY,0.047551,0.075331,0.056464,1,1
2,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.018836,0.073754,0.10395,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.02166,0.073512,0.070546,1,1
2,GO ALCOHOL CATABOLIC PROCESS,0.026586,0.073346,0.13253,1,1
2,GO HISTONE DEACETYLATION,0.0099891,0.073149,0.086896,1,1
2,GO MACROAUTOPHAGY,0.017137,0.0718,0.058488,1,1
2,GO RESPONSE TO RADIATION,0.026586,0.070833,0.063464,1,1
2,GO REGULATION OF DNA METABOLIC PROCESS,0.0051916,0.068134,0.076837,1,1
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.025994,0.067604,0.060824,1,1
2,GO REGULATION OF GTPASE ACTIVITY,0.046579,0.066185,0.065842,1,1
2,GO DNA INTEGRITY CHECKPOINT,0.023741,0.065549,0.083447,1,1
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.02268,0.063877,0.05164,1,1
2,GO DNA METABOLIC PROCESS,0.004408,0.0637,0.06765,1,1
2,GO DNA MODIFICATION,0.015203,0.06315,0.059423,1,1
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.011326,0.06093,0.084026,1,1
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.044685,0.059932,0.075487,1,1
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.044685,0.059404,0.068066,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0056288,0.058792,0.05732,1,1
2,GO DNA REPAIR,0.010506,0.056856,0.066843,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.025414,0.054148,0.046814,1,1
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.017137,0.053453,0.051302,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.04854,0.051571,0.065494,1,1
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.014486,0.048574,0.065694,1,1
2,GO CHROMOSOME ORGANIZATION,0.033894,0.03304,0.055595,1,1
3,GO OXYGEN TRANSPORT,7.547e-05,0.81539,0.747,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.1888e-05,0.78882,0.71035,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.5816e-05,0.72334,0.66453,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.1964e-05,0.71028,0.61784,1,1
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,5.2139e-05,0.64875,0.55119,1,1
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,3.3287e-06,0.63001,0.61814,1,1
3,GO RESPONSE TO HISTAMINE,2.0833e-05,0.61441,0.63341,1,1
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,9.7801e-06,0.60828,0.57979,1,1
3,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,2.9532e-05,0.59411,0.58126,1,1
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,5.2139e-05,0.58202,0.58056,1,1
3,GO GAS TRANSPORT,0.00018427,0.57434,0.54092,1,1
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,5.2139e-05,0.56973,0.46119,1,1
3,GO RESPONSE TO L GLUTAMATE,1.7118e-05,0.5632,0.54731,1,1
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.00079435,0.55166,0.45742,1,1
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00045924,0.54979,0.4128,1,1
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,3.3287e-06,0.53768,0.54006,1,1
3,GO GLYCINE TRANSPORT,0.0013054,0.53755,0.45246,1,1
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,6.7728e-06,0.52581,0.51835,1,1
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,5.8301e-05,0.52235,0.52449,1,1
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,2.9532e-05,0.52075,0.4714,1,1
3,GO RIBOSOME ASSEMBLY,1.2454e-05,0.51965,0.52271,1,1
3,GO RRNA PSEUDOURIDINE SYNTHESIS,0.00057693,0.51373,0.47329,1,1
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00063551,0.51371,0.55799,1,1
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,5.0226e-05,0.51244,0.43381,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,5.2139e-05,0.50845,0.43768,1,1
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,1.5201e-05,0.50695,0.52578,1,1
3,GO UV PROTECTION,9.4334e-07,0.50261,0.49723,1,1
3,GO CYTOPLASMIC TRANSLATION,3.0689e-05,0.50222,0.49325,1,1
3,GO MATURATION OF LSU RRNA,4.1112e-06,0.502,0.52582,1,1
3,GO IMP METABOLIC PROCESS,6.7728e-06,0.49745,0.52991,1,1
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,7.6603e-06,0.49722,0.46517,1,1
3,GO SYNAPTIC VESICLE MATURATION,0.00032948,0.49002,0.46862,1,1
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,4.8612e-06,0.48957,0.52222,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,2.1663e-05,0.48707,0.4741,1,1
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0016129,0.48064,0.3453,1,1
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.00023468,0.4804,0.55075,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,4.3218e-05,0.47808,0.45036,1,1
3,GO PLASMA MEMBRANE REPAIR,1.7118e-05,0.47515,0.43057,1,1
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00022676,0.47195,0.35921,1,1
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,9.7801e-06,0.46923,0.41322,1,1
3,GO AROMATIC AMINO ACID TRANSPORT,0.00055855,0.46866,0.47831,1,1
3,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.0034322,0.46605,0.40317,1,1
3,GO CORPUS CALLOSUM DEVELOPMENT,1.7474e-06,0.46223,0.46803,1,1
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,5.9841e-06,0.4566,0.47396,1,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.0010206,0.45403,0.33701,1,1
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,4.6623e-06,0.45177,0.42629,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00090094,0.44779,0.4969,1,1
3,GO PSEUDOURIDINE SYNTHESIS,0.00090094,0.44589,0.36452,1,1
3,GO MYOBLAST PROLIFERATION,2.2658e-06,0.44337,0.42829,1,1
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,2.8077e-06,0.4422,0.38801,1,1
3,GO GLYCINE METABOLIC PROCESS,0.0028141,0.43581,0.3201,1,1
3,GO REGULATION OF GONAD DEVELOPMENT,0.0040578,0.43436,0.25227,1,1
3,GO PURINE NUCLEOBASE METABOLIC PROCESS,3.7145e-05,0.43423,0.42594,1,1
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,2.8418e-05,0.43092,0.46841,1,1
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,7.9801e-06,0.4301,0.48694,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00010092,0.42967,0.42685,1,1
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,3.3132e-05,0.42733,0.37696,1,1
3,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.030383,0.42493,0.19913,1,1
3,GO RESPONSE TO ELECTRICAL STIMULUS,0.00026003,0.42415,0.32079,1,1
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00055855,0.42385,0.41074,1,1
3,GO TRANSLATIONAL INITIATION,7.547e-05,0.41916,0.42211,1,1
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,3.1888e-05,0.41789,0.46439,1,1
3,GO SUCKLING BEHAVIOR,0.00026903,0.4172,0.33519,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.00035231,0.41604,0.49831,1,1
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,5.0683e-06,0.41334,0.38134,1,1
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,1.9263e-05,0.40305,0.42321,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,2.5308e-05,0.40108,0.41323,1,1
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.010506,0.40104,0.28928,1,1
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.00012074,0.39933,0.39412,1,1
3,GO MATURATION OF SSU RRNA,6.2367e-06,0.39869,0.44019,1,1
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00042998,0.3971,0.41154,1,1
3,GO VIRAL TRANSLATION,7.2754e-05,0.3964,0.39111,1,1
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0001547,0.39577,0.46904,1,1
3,GO MITOCHONDRIAL TRANSCRIPTION,2.7343e-05,0.39541,0.37787,1,1
3,GO SNORNA METABOLIC PROCESS,0.00029782,0.39513,0.40738,1,1
3,GO EXCITATORY SYNAPSE ASSEMBLY,0.00092958,0.39423,0.35709,1,1
3,GO TELOMERASE RNA LOCALIZATION,4.8612e-06,0.39353,0.45365,1,1
3,GO CRISTAE FORMATION,0.00054072,0.39055,0.29118,1,1
3,GO ADULT HEART DEVELOPMENT,0.00037661,0.38782,0.35746,1,1
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.0027346,0.38363,0.34733,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,4.3218e-05,0.38243,0.41963,1,1
3,GO SNORNA 3 END PROCESSING,5.2139e-05,0.38121,0.44397,1,1
3,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.011326,0.38101,0.26645,1,1
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.00050664,0.37775,0.38325,1,1
3,GO SHORT TERM MEMORY,0.00095906,0.37704,0.40963,1,1
3,GO L GLUTAMATE IMPORT,0.00029782,0.37583,0.3149,1,1
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00098941,0.37401,0.34407,1,1
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.00012964,0.3711,0.36059,1,1
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.00050664,0.37102,0.42067,1,1
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00037661,0.36981,0.37519,1,1
3,GO MATURATION OF 5 8S RRNA,3.8583e-05,0.36945,0.37424,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00019753,0.36444,0.35376,1,1
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00054072,0.36443,0.38469,1,1
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,1.5201e-05,0.36311,0.41577,1,1
3,GO ARGININE METABOLIC PROCESS,0.0046564,0.36281,0.30972,1,1
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,4.6597e-05,0.36187,0.34182,1,1
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.00012964,0.36154,0.30061,1,1
3,GO REGULATION OF TRANSLATIONAL TERMINATION,0.00035231,0.36102,0.32193,1,1
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00010462,0.3597,0.34641,1,1
3,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.0010859,0.35691,0.32071,1,1
3,GO INNERVATION,0.0039469,0.35026,0.33228,1,1
3,GO NEUROBLAST DIVISION,0.011612,0.34975,0.28156,1,1
3,GO PEPTIDYL ARGININE N METHYLATION,3.6228e-06,0.34889,0.39181,1,1
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.00042998,0.34806,0.28949,1,1
3,GO PENTOSE METABOLIC PROCESS,0.00014935,0.34481,0.31658,1,1
3,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0069616,0.34396,0.22937,1,1
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.00037661,0.34094,0.27564,1,1
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.0007696,0.3396,0.27294,1,1
3,GO TRNA WOBBLE URIDINE MODIFICATION,3.7145e-05,0.33157,0.30388,1,1
3,GO MITOCHONDRIAL RNA PROCESSING,0.0015653,0.33131,0.30878,1,1
3,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0026572,0.32997,0.31892,1,1
3,GO MITOCHONDRIAL TRNA PROCESSING,0.013465,0.32818,0.24099,1,1
3,GO REGULATION OF MRNA BINDING,1.8521e-05,0.32602,0.39788,1,1
3,GO VIRAL GENE EXPRESSION,0.00084609,0.324,0.33686,1,1
3,GO TRNA MODIFICATION,1.7474e-06,0.32353,0.31884,1,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,9.0551e-05,0.3233,0.37047,1,1
3,GO TRNA WOBBLE BASE MODIFICATION,8.3127e-06,0.32282,0.32446,1,1
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.00059588,0.31962,0.31253,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.00034072,0.31902,0.31313,1,1
3,GO PROTEIN TARGETING TO MEMBRANE,0.00038934,0.31485,0.30664,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00026003,0.31477,0.24803,1,1
3,GO GTP METABOLIC PROCESS,0.00067758,0.31441,0.28031,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.017969,0.31376,0.23899,1,1
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,9.389e-05,0.31309,0.25901,1,1
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.011326,0.31244,0.21095,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00050664,0.31142,0.28401,1,1
3,GO VESICLE FUSION TO PLASMA MEMBRANE,0.00087311,0.30888,0.36835,1,1
3,GO RIBOSOME BIOGENESIS,1.5201e-05,0.30689,0.38255,1,1
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,3.0689e-05,0.30657,0.24294,1,1
3,GO NUCLEOBASE METABOLIC PROCESS,7.2754e-05,0.30498,0.28153,1,1
3,GO RRNA MODIFICATION,0.00019079,0.3047,0.35171,1,1
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,3.1888e-05,0.30322,0.37676,1,1
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.010506,0.30297,0.20661,1,1
3,GO REGULATION OF RIBOSOME BIOGENESIS,0.0020453,0.30247,0.24302,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.018398,0.30166,0.21952,1,1
3,GO PEPTIDYL HISTIDINE MODIFICATION,9.7346e-05,0.30067,0.26078,1,1
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00079435,0.30007,0.18658,1,1
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,6.7596e-05,0.29759,0.34957,1,1
3,GO MRNA MODIFICATION,4.8379e-05,0.29207,0.30818,1,1
3,GO TETRAHYDROFOLATE INTERCONVERSION,0.015574,0.29146,0.20846,1,1
3,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.00052342,0.29102,0.28985,1,1
3,GO TRNA PROCESSING,1.2962e-05,0.29098,0.2654,1,1
3,GO EMBRYONIC BRAIN DEVELOPMENT,8.7323e-05,0.29082,0.30253,1,1
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,8.6584e-06,0.2905,0.29277,1,1
3,GO NAD METABOLIC PROCESS,0.0023671,0.28961,0.22695,1,1
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,6.5149e-05,0.28915,0.28619,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00028792,0.28897,0.30145,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,9.0179e-06,0.28815,0.27527,1,1
3,GO TRANSLATIONAL ELONGATION,1.1964e-05,0.28733,0.32113,1,1
3,GO SYNAPTIC VESICLE PRIMING,0.0028957,0.2873,0.30296,1,1
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.02166,0.28604,0.24007,1,1
3,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.0022992,0.28452,0.2835,1,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.029719,0.28363,0.18988,1,1
3,GO RRNA METABOLIC PROCESS,2.3418e-05,0.28323,0.34974,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,9.3916e-06,0.27902,0.3275,1,1
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.00090094,0.27851,0.25073,1,1
3,GO RRNA METHYLATION,0.00026903,0.27841,0.29014,1,1
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00030804,0.27816,0.28971,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.0016129,0.27614,0.26508,1,1
3,GO REGULATION OF RNA BINDING,1.1964e-05,0.27574,0.32944,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.00074557,0.27567,0.30316,1,1
3,GO HEART VALVE FORMATION,0.0046564,0.27408,0.30475,1,1
3,GO MITOCHONDRIAL TRANSLATION,9.7346e-05,0.27364,0.32059,1,1
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,7.013e-05,0.27345,0.32831,1,1
3,GO TRNA METHYLATION,3.5759e-05,0.27313,0.26945,1,1
3,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00030804,0.27291,0.23048,1,1
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.001662,0.27016,0.21343,1,1
3,GO AMINO ACID IMPORT,0.0012662,0.2701,0.22735,1,1
3,GO AORTA DEVELOPMENT,0.0085714,0.26865,0.15313,1,1
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0015189,0.26804,0.21471,1,1
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.0001165,0.26645,0.3032,1,1
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.0040578,0.26605,0.17922,1,1
3,GO MITOCHONDRIAL GENE EXPRESSION,7.2754e-05,0.26601,0.31884,1,1
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0085714,0.26571,0.18409,1,1
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.031748,0.26536,0.17453,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00072223,0.26487,0.30639,1,1
3,GO FOLIC ACID METABOLIC PROCESS,0.0023671,0.26395,0.24744,1,1
3,GO RNA SURVEILLANCE,0.00047456,0.26387,0.23038,1,1
3,GO HISTONE ARGININE METHYLATION,0.00026003,0.26385,0.24286,1,1
3,GO TRNA METABOLIC PROCESS,7.547e-05,0.2631,0.22931,1,1
3,GO RRNA TRANSCRIPTION,2.1663e-05,0.26243,0.2901,1,1
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0067808,0.26079,0.18637,1,1
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00026903,0.25989,0.18357,1,1
3,GO OXIDATIVE PHOSPHORYLATION,0.00029782,0.25896,0.22688,1,1
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.041093,0.25782,0.22084,1,1
3,GO BONE GROWTH,0.018398,0.25539,0.2292,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,8.4205e-05,0.25489,0.25305,1,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.00067758,0.25404,0.22668,1,1
3,GO HEME METABOLIC PROCESS,0.0087944,0.25225,0.22885,1,1
3,GO PEPTIDYL ARGININE METHYLATION,2.9532e-05,0.25169,0.27082,1,1
3,GO GLUCOSE CATABOLIC PROCESS,0.009256,0.25137,0.19355,1,1
3,GO RNA 5 END PROCESSING,0.0012662,0.25107,0.26658,1,1
3,GO AMINO ACID ACTIVATION,0.0038387,0.25083,0.24203,1,1
3,GO MITOCHONDRION DISTRIBUTION,0.0041716,0.25013,0.19736,1,1
3,GO NCRNA PROCESSING,2.4346e-05,0.25012,0.28976,1,1
3,GO REGULATION OF LYASE ACTIVITY,0.00012512,0.25006,0.21597,1,1
3,GO LATERAL VENTRICLE DEVELOPMENT,0.0040578,0.2496,0.26919,1,1
3,GO MRNA METHYLATION,0.00047456,0.24908,0.26081,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,5.2139e-05,0.24816,0.30018,1,1
3,GO TRANSLATIONAL TERMINATION,9.389e-05,0.24753,0.30948,1,1
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.0001165,0.24642,0.25393,1,1
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.001986,0.24464,0.23949,1,1
3,GO REPRODUCTIVE BEHAVIOR,0.013139,0.24426,0.19899,1,1
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,2.0033e-05,0.24352,0.25784,1,1
3,GO L SERINE METABOLIC PROCESS,0.029068,0.2424,0.26917,1,1
3,GO AEROBIC RESPIRATION,0.00022676,0.24054,0.21892,1,1
3,GO STRESS GRANULE ASSEMBLY,8.7323e-05,0.24006,0.20617,1,1
3,GO HISTONE SERINE PHOSPHORYLATION,0.0029794,0.23994,0.18481,1,1
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0013054,0.23922,0.18418,1,1
3,GO NEURON REMODELING,0.0028957,0.23903,0.2714,1,1
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00026003,0.23721,0.21392,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0030654,0.23662,0.19149,1,1
3,GO INHIBITORY SYNAPSE ASSEMBLY,0.0066042,0.23485,0.36675,1,1
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0024367,0.23401,0.19118,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0087944,0.23216,0.185,1,1
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,2.0833e-05,0.23187,0.24768,1,1
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.00047456,0.23181,0.26376,1,1
3,GO CELLULAR RESPONSE TO PH,5.4121e-05,0.23124,0.2288,1,1
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.0033369,0.2308,0.20321,1,1
3,GO NCRNA METABOLIC PROCESS,6.0504e-05,0.23025,0.2474,1,1
3,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.044685,0.22964,0.15744,1,1
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.00042998,0.22875,0.20767,1,1
3,GO FIBROBLAST APOPTOTIC PROCESS,0.011326,0.22693,0.18548,1,1
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,1.7806e-05,0.22669,0.26374,1,1
3,GO AMP METABOLIC PROCESS,0.029719,0.2251,0.16922,1,1
3,GO NADH METABOLIC PROCESS,0.0007696,0.22498,0.22987,1,1
3,GO POSITIVE REGULATION OF TRANSLATION,0.00084609,0.2226,0.17045,1,1
3,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00040247,0.22204,0.26714,1,1
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.001986,0.22115,0.21126,1,1
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.0018173,0.22081,0.17842,1,1
3,GO RESPONSE TO INTERLEUKIN 7,0.00012512,0.22077,0.19732,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00084609,0.21987,0.18513,1,1
3,GO URONIC ACID METABOLIC PROCESS,0.001986,0.21957,0.161,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.020205,0.21892,0.15312,1,1
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.00025131,0.21733,0.17642,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.019283,0.21696,0.14742,1,1
3,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0031536,0.21505,0.20453,1,1
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.00042998,0.21449,0.21563,1,1
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.030383,0.21117,0.15313,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.00012512,0.21083,0.22161,1,1
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,2.7343e-05,0.21048,0.31127,1,1
3,GO POSITIVE REGULATION OF MRNA PROCESSING,2.7343e-05,0.20975,0.1878,1,1
3,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0014738,0.20959,0.21568,1,1
3,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.0021689,0.20851,0.35715,1,1
3,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.027188,0.20638,0.16504,1,1
3,GO RNA METHYLATION,9.7346e-05,0.20608,0.21429,1,1
3,GO CELLULAR RESPIRATION,0.00055855,0.20466,0.20082,1,1
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0054795,0.2013,0.16895,1,1
3,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00084609,0.20001,0.17039,1,1
3,GO CARDIOLIPIN METABOLIC PROCESS,0.011612,0.19883,0.16015,1,1
3,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0079323,0.19813,0.17612,1,1
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.042857,0.19738,0.2132,1,1
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.047551,0.19694,0.1282,1,1
3,GO TRNA TRANSPORT,0.00074557,0.19685,0.19311,1,1
3,GO TELOMERIC LOOP DISASSEMBLY,0.0014299,0.1967,0.19765,1,1
3,GO RNA POLYADENYLATION,8.7323e-05,0.19661,0.16335,1,1
3,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.01282,0.19605,0.1674,1,1
3,GO RNA MODIFICATION,9.0551e-05,0.19588,0.20752,1,1
3,GO AMIDE BIOSYNTHETIC PROCESS,0.00055855,0.19512,0.18251,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.00034072,0.19488,0.16853,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.00063551,0.1948,0.18255,1,1
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.045624,0.19459,0.10704,1,1
3,GO TRICARBOXYLIC ACID CYCLE,0.00079435,0.19226,0.19157,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,7.013e-05,0.191,0.17125,1,1
3,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.00050664,0.19092,0.22242,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.029719,0.1902,0.10359,1,1
3,GO GLUTAMINE METABOLIC PROCESS,0.00024286,0.18877,0.24166,1,1
3,GO PIGMENT BIOSYNTHETIC PROCESS,0.00098941,0.18773,0.21328,1,1
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.025414,0.18693,0.14308,1,1
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.00013917,0.18592,0.21921,1,1
3,GO CELLULAR RESPONSE TO HEAT,0.00023468,0.18574,0.14786,1,1
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00016023,0.18542,0.16356,1,1
3,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.0037331,0.18531,0.30413,1,1
3,GO ALDITOL METABOLIC PROCESS,0.0029794,0.18512,0.20195,1,1
3,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.0013872,0.1845,0.18435,1,1
3,GO NCRNA EXPORT FROM NUCLEUS,0.001986,0.18321,0.18447,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.001191,0.18259,0.16225,1,1
3,GO L AMINO ACID TRANSPORT,6.7596e-05,0.18257,0.25269,1,1
3,GO HISTONE MRNA METABOLIC PROCESS,8.1192e-05,0.18232,0.1896,1,1
3,GO NUCLEAR PORE ORGANIZATION,0.0034322,0.18041,0.18694,1,1
3,GO DNA REPLICATION INITIATION,0.00044439,0.1803,0.17175,1,1
3,GO NCRNA 3 END PROCESSING,0.0015653,0.1799,0.16386,1,1
3,GO REGULATION OF TRANSLATIONAL INITIATION,9.7346e-05,0.17928,0.14631,1,1
3,GO PYRUVATE METABOLIC PROCESS,0.0028141,0.17695,0.12956,1,1
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.016734,0.17618,0.12509,1,1
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00067758,0.17613,0.17633,1,1
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.019739,0.17482,0.15559,1,1
3,GO FEAR RESPONSE,0.040234,0.17401,0.14304,1,1
3,GO PEPTIDE METABOLIC PROCESS,0.0020453,0.17382,0.15312,1,1
3,GO RNA CATABOLIC PROCESS,0.0010528,0.17373,0.18606,1,1
3,GO PROTEIN TARGETING,0.0014299,0.17188,0.15307,1,1
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0050528,0.1712,0.15105,1,1
3,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0066042,0.17104,0.11742,1,1
3,GO RRNA 3 END PROCESSING,0.034637,0.17099,0.16181,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.00055855,0.16987,0.16561,1,1
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.03939,0.16857,0.12819,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.009256,0.16719,0.14266,1,1
3,GO REGULATION OF TELOMERE MAINTENANCE,0.00010845,0.16676,0.16848,1,1
3,GO HISTONE H3 K9 DEMETHYLATION,0.02068,0.16455,0.17417,1,1
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0027346,0.16445,0.13019,1,1
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.0056288,0.16343,0.16223,1,1
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0011199,0.16322,0.15465,1,1
3,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.033166,0.16174,0.13603,1,1
3,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.036948,0.16164,0.054186,1,1
3,GO PIGMENT METABOLIC PROCESS,0.0049174,0.15784,0.18293,1,1
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0015189,0.15639,0.18525,1,1
3,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.0087944,0.15523,0.11227,1,1
3,GO BASE EXCISION REPAIR,0.0025083,0.15485,0.1283,1,1
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0059384,0.15353,0.16122,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0049174,0.15252,0.19714,1,1
3,GO REGULATION OF SPINDLE CHECKPOINT,0.0029794,0.15153,0.13355,1,1
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.019283,0.15054,0.12565,1,1
3,GO PROTEIN DENEDDYLATION,0.033166,0.1458,0.13333,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0015653,0.14574,0.12856,1,1
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.0057817,0.14571,0.22388,1,1
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0066042,0.1451,0.16892,1,1
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.011047,0.14122,0.12256,1,1
3,GO REGULATION OF CELL CYCLE ARREST,0.0069616,0.14045,0.09516,1,1
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00092958,0.14039,0.15646,1,1
3,GO PEPTIDYL METHIONINE MODIFICATION,0.013798,0.14015,0.12367,1,1
3,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0050528,0.13944,0.15305,1,1
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.027188,0.1394,0.10495,1,1
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0062634,0.13934,0.14105,1,1
3,GO ATP METABOLIC PROCESS,0.00036427,0.13891,0.13733,1,1
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0015653,0.13878,0.12525,1,1
3,GO MODULATION BY HOST OF VIRAL PROCESS,0.0032441,0.13858,0.15865,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.013139,0.13854,0.13794,1,1
3,GO PROTEIN HETEROOLIGOMERIZATION,0.0039469,0.1377,0.15345,1,1
3,GO REGULATION OF MRNA POLYADENYLATION,0.0017123,0.13645,0.12495,1,1
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.00021167,0.13509,0.13119,1,1
3,GO MRNA METABOLIC PROCESS,0.00010845,0.13445,0.15089,1,1
3,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.024846,0.13404,0.14161,1,1
3,GO TRNA 5 END PROCESSING,0.0067808,0.13388,0.21578,1,1
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.02268,0.13344,0.14731,1,1
3,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.01282,0.13252,0.1515,1,1
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0054795,0.13233,0.10657,1,1
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.0075304,0.12987,0.12196,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0040578,0.12982,0.098093,1,1
3,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.02166,0.12856,0.14164,1,1
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0073363,0.12815,0.10145,1,1
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.029068,0.12728,0.13142,1,1
3,GO RNA 3 END PROCESSING,0.00044439,0.1272,0.12357,1,1
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.0050528,0.12566,0.083652,1,1
3,GO REGULATION OF MRNA PROCESSING,0.0032441,0.12523,0.093725,1,1
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.0023671,0.12477,0.14432,1,1
3,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.0056288,0.1247,0.13827,1,1
3,GO MRNA 3 END PROCESSING,0.0015189,0.12438,0.10174,1,1
3,GO NUCLEOTIDE PHOSPHORYLATION,0.0047853,0.12371,0.11945,1,1
3,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.015574,0.12358,0.11078,1,1
3,GO RNA CAPPING,0.0051916,0.12224,0.11244,1,1
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00023468,0.12069,0.12789,1,1
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.0059384,0.12048,0.1204,1,1
3,GO CELLULAR RESPONSE TO DRUG,0.0046564,0.11946,0.12898,1,1
3,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.027803,0.11878,0.18356,1,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.010245,0.11848,0.15949,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.014841,0.11796,0.095721,1,1
3,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0037331,0.11663,0.14972,1,1
3,GO APOPTOTIC DNA FRAGMENTATION,0.047551,0.11629,0.068816,1,1
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.00010462,0.11569,0.17534,1,1
3,GO NCRNA TRANSCRIPTION,0.00021909,0.11512,0.1263,1,1
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.02068,0.1146,0.10974,1,1
3,GO MITOTIC DNA REPLICATION CHECKPOINT,0.027188,0.11392,0.13377,1,1
3,GO PROTEIN TETRAMERIZATION,0.0011199,0.11376,0.12733,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.0034322,0.11335,0.11355,1,1
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.011904,0.11264,0.084577,1,1
3,GO BLASTOCYST FORMATION,0.047551,0.11239,0.08888,1,1
3,GO REPLICATION FORK PROCESSING,0.013798,0.11194,0.11154,1,1
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.042857,0.11171,0.088376,1,1
3,GO RNA PROCESSING,1.8521e-05,0.11065,0.16722,1,1
3,GO TELOMERE ORGANIZATION,0.00032948,0.1101,0.13039,1,1
3,GO PROTEIN HETEROTETRAMERIZATION,0.00353,0.10828,0.13485,1,1
3,GO DNA REPLICATION CHECKPOINT,0.027803,0.10672,0.1064,1,1
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0010206,0.10638,0.11963,1,1
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.011326,0.10624,0.099335,1,1
3,GO RNA LOCALIZATION,0.00055855,0.1058,0.14285,1,1
3,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.023205,0.10424,0.082899,1,1
3,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.046579,0.10341,0.079547,1,1
3,GO ERROR FREE TRANSLESION SYNTHESIS,0.019283,0.10313,0.10302,1,1
3,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0094949,0.1026,0.079982,1,1
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.013139,0.10156,0.097536,1,1
3,GO PROTEIN NEDDYLATION,0.02166,0.10136,0.1262,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.0075304,0.10107,0.10394,1,1
3,GO NUCLEAR EXPORT,0.0014299,0.099419,0.10354,1,1
3,GO DNA DEPENDENT DNA REPLICATION,0.02166,0.099319,0.083646,1,1
3,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.011612,0.098656,0.094442,1,1
3,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.0064317,0.098564,0.11973,1,1
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.025414,0.098278,0.1227,1,1
3,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.017969,0.098273,0.16477,1,1
3,GO MRNA EXPORT FROM NUCLEUS,0.0097392,0.096912,0.10888,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.001191,0.095508,0.096131,1,1
3,GO METHYLATION,0.0019282,0.094303,0.087309,1,1
3,GO NUCLEOTIDE EXCISION REPAIR,0.013139,0.094189,0.076672,1,1
3,GO NUCLEAR TRANSPORT,0.0056288,0.093246,0.073385,1,1
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.009256,0.091452,0.093086,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.013139,0.090542,0.091484,1,1
3,GO CELLULAR RESPONSE TO UV,0.023741,0.089531,0.083355,1,1
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.00079435,0.08906,0.11576,1,1
3,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.014486,0.088299,0.062428,1,1
3,GO MRNA PROCESSING,0.00054072,0.084613,0.10714,1,1
3,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.017549,0.083357,0.069036,1,1
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0042883,0.081822,0.091204,1,1
3,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.040234,0.079823,0.052653,1,1
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.02268,0.077697,0.075358,1,1
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.004408,0.07556,0.082134,1,1
3,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.026586,0.075138,0.04598,1,1
3,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.043763,0.07361,0.049126,1,1
3,GO RNA SPLICING,0.001986,0.072933,0.09655,1,1
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.010773,0.066106,0.069703,1,1
3,GO INTERSTRAND CROSS LINK REPAIR,0.0090226,0.063217,0.080227,1,1
3,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.013465,0.06315,0.08346,1,1
3,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.0059384,0.055239,0.086292,1,1
3,GO PROTEIN LOCALIZATION TO ORGANELLE,0.033894,0.052704,0.046358,1,1
3,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.043763,0.051406,0.065806,1,1
3,GO MITOCHONDRION ORGANIZATION,0.046579,0.049212,0.052838,1,1
3,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.036948,0.043057,0.0782,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0040578,1.0353,0.91381,1,1
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.014138,0.99549,0.61131,1,1
4,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,4.4712e-06,0.97462,1.0214,1,1
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,2.5308e-05,0.88751,0.61766,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.0049174,0.88692,0.72637,1,1
4,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00041602,0.8722,0.64801,1,1
4,GO GLYCOSIDE METABOLIC PROCESS,0.0013872,0.86553,0.8549,1,1
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,5.508e-06,0.84862,0.75607,1,1
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.00010462,0.84853,0.58017,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,3.9926e-07,0.77046,0.73808,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,2.0833e-05,0.76592,0.78822,1,1
4,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00010092,0.74598,0.69495,1,1
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00010092,0.73643,0.62128,1,1
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0037331,0.72815,0.55926,1,1
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,5.6174e-05,0.71562,0.6318,1,1
4,GO HISTAMINE SECRETION,6.2985e-07,0.70834,0.69611,1,1
4,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.0029794,0.69319,0.44862,1,1
4,GO PROGESTERONE METABOLIC PROCESS,7.2754e-05,0.68692,0.92235,1,1
4,GO TOLERANCE INDUCTION,0.0064317,0.68437,0.44712,1,1
4,GO DOPAMINE BIOSYNTHETIC PROCESS,1.2454e-05,0.67914,0.70678,1,1
4,GO GERMINAL CENTER FORMATION,0.00010092,0.67825,0.52145,1,1
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,1.4674e-06,0.67711,0.63039,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,5.8301e-05,0.67693,0.61165,1,1
4,GO MUCUS SECRETION,0.00026003,0.67366,0.61397,1,1
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0046564,0.66712,0.47712,1,1
4,GO QUINONE METABOLIC PROCESS,6.0504e-05,0.65692,0.66878,1,1
4,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.00041602,0.65675,0.47396,1,1
4,GO RENAL ABSORPTION,2.1663e-05,0.65415,0.66074,1,1
4,GO LIPID DROPLET FORMATION,3.0576e-06,0.65137,0.68134,1,1
4,GO ACTIN FILAMENT NETWORK FORMATION,0.011904,0.641,0.32846,1,1
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.00021909,0.63787,0.55033,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00028792,0.63568,0.46561,1,1
4,GO CYTIDINE TO URIDINE EDITING,0.00036427,0.63072,0.61837,1,1
4,GO ACTIN FILAMENT SEVERING,0.00010462,0.62813,0.50593,1,1
4,GO HISTAMINE TRANSPORT,6.0198e-07,0.62544,0.66413,1,1
4,GO RESPONSE TO INTERFERON BETA,0.00072223,0.62376,0.45758,1,1
4,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.0015653,0.6148,0.42716,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00016023,0.61244,0.49726,1,1
4,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,4.0073e-05,0.60248,0.52633,1,1
4,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.038561,0.60079,0.40259,1,1
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,9.4334e-07,0.5899,0.60056,1,1
4,GO RESPONSE TO TYPE I INTERFERON,6.2786e-05,0.58953,0.5358,1,1
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,1.7118e-05,0.58705,0.64636,1,1
4,GO INTESTINAL LIPID ABSORPTION,4.4712e-06,0.58025,0.68765,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,3.3132e-05,0.56344,0.52731,1,1
4,GO NEGATIVE REGULATION OF BONE REMODELING,4.6623e-06,0.5582,0.56422,1,1
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,8.4205e-05,0.55632,0.56875,1,1
4,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.00052342,0.55423,0.38314,1,1
4,GO TOXIN METABOLIC PROCESS,1.1267e-06,0.55021,0.5504,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0064317,0.54712,0.5329,1,1
4,GO FRUCTOSE METABOLIC PROCESS,0.00019079,0.54565,0.57128,1,1
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,1.0184e-05,0.54156,0.49972,1,1
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.007729,0.54023,0.65633,1,1
4,GO KETONE CATABOLIC PROCESS,0.00098941,0.53833,0.43593,1,1
4,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00020448,0.53559,0.39458,1,1
4,GO REGULATION OF PLASMINOGEN ACTIVATION,0.013465,0.53226,0.36365,1,1
4,GO POSITIVE REGULATION OF CELL MATURATION,7.8282e-05,0.52905,0.50147,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00032948,0.52569,0.4757,1,1
4,GO ADHESION OF SYMBIONT TO HOST,0.009256,0.52551,0.33775,1,1
4,GO RETINAL METABOLIC PROCESS,0.0013457,0.5247,0.59356,1,1
4,GO GLYCOLIPID CATABOLIC PROCESS,6.2786e-05,0.52462,0.53033,1,1
4,GO RESPONSE TO NITROSATIVE STRESS,0.00074557,0.52216,0.4344,1,1
4,GO T CELL MEDIATED CYTOTOXICITY,0.0050528,0.52032,0.34569,1,1
4,GO CYSTEINE METABOLIC PROCESS,0.010773,0.5188,0.42217,1,1
4,GO LIPID DIGESTION,2.3418e-05,0.51795,0.60338,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00016023,0.51655,0.46322,1,1
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,4.6597e-05,0.51514,0.47593,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00018427,0.51385,0.48642,1,1
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,1.349e-05,0.51337,0.48787,1,1
4,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.00090094,0.51266,0.46089,1,1
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,7.547e-05,0.51147,0.52983,1,1
4,GO RESPONSE TO INTERLEUKIN 18,0.0075304,0.51096,0.44183,1,1
4,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00030804,0.50852,0.5515,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.1112e-06,0.50785,0.51709,1,1
4,GO SUPEROXIDE ANION GENERATION,3.0689e-05,0.50745,0.48849,1,1
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,6.5149e-05,0.50529,0.47929,1,1
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00049035,0.50496,0.40235,1,1
4,GO CYCLOOXYGENASE PATHWAY,0.00098941,0.50453,0.52269,1,1
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,9.0221e-07,0.50437,0.51308,1,1
4,GO REGULATION OF HORMONE METABOLIC PROCESS,0.00024286,0.49977,0.38759,1,1
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,3.0576e-06,0.49824,0.4741,1,1
4,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.0050528,0.49719,0.31099,1,1
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0087944,0.49686,0.34768,1,1
4,GO RESPONSE TO PAIN,2.0784e-06,0.49302,0.47618,1,1
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00079435,0.49156,0.43467,1,1
4,GO NEGATIVE REGULATION OF ANOIKIS,0.00012964,0.49059,0.47958,1,1
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,3.4421e-05,0.4905,0.58024,1,1
4,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.0017123,0.48935,0.3626,1,1
4,GO DENDRITIC CELL DIFFERENTIATION,0.0066042,0.48928,0.3381,1,1
4,GO RESPONSE TO EPINEPHRINE,0.0094949,0.48914,0.32043,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0073363,0.48906,0.38471,1,1
4,GO SPHINGOMYELIN METABOLIC PROCESS,2.3418e-05,0.4886,0.41949,1,1
4,GO GALACTOSE METABOLIC PROCESS,2.2524e-05,0.48813,0.59255,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00019753,0.48564,0.59695,1,1
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00059588,0.48518,0.38915,1,1
4,GO PHAGOLYSOSOME ASSEMBLY,9.3916e-06,0.48403,0.47416,1,1
4,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.020205,0.48376,0.43335,1,1
4,GO REGULATION OF WATER LOSS VIA SKIN,0.0010859,0.48138,0.40154,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,3.3132e-05,0.47648,0.43503,1,1
4,GO METHIONINE BIOSYNTHETIC PROCESS,1.2454e-05,0.47569,0.45209,1,1
4,GO RESPONSE TO COLD,4.5813e-07,0.47522,0.4508,1,1
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.2658e-06,0.47377,0.40744,1,1
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,2.6307e-05,0.47307,0.40702,1,1
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00047456,0.4726,0.37064,1,1
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0040578,0.4723,0.4397,1,1
4,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.00012074,0.47027,0.61289,1,1
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00016023,0.46977,0.41024,1,1
4,GO SECONDARY METABOLIC PROCESS,0.00019753,0.46942,0.42694,1,1
4,GO RESPONSE TO INTERFERON ALPHA,0.0042883,0.46663,0.30748,1,1
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,2.8418e-05,0.46623,0.47836,1,1
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.00016023,0.46621,0.39127,1,1
4,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.0031536,0.46513,0.45567,1,1
4,GO T CELL EXTRAVASATION,0.0014738,0.46452,0.49626,1,1
4,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.0062634,0.46377,0.31255,1,1
4,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,2.6307e-05,0.46365,0.38713,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,8.6584e-06,0.46333,0.45527,1,1
4,GO O GLYCAN PROCESSING,0.00016023,0.4633,0.39627,1,1
4,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0099891,0.46201,0.3576,1,1
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00012964,0.45912,0.48722,1,1
4,GO SIGNAL PEPTIDE PROCESSING,3.1904e-06,0.45727,0.47064,1,1
4,GO NADP METABOLIC PROCESS,0.00038934,0.45707,0.33894,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0019282,0.45608,0.31798,1,1
4,GO DETECTION OF OTHER ORGANISM,0.00044439,0.45538,0.43354,1,1
4,GO REGULATION OF FIBRINOLYSIS,0.00012512,0.45504,0.4655,1,1
4,GO VASCULAR TRANSPORT,0.0012662,0.45375,0.37519,1,1
4,GO RESPONSE TO DIETARY EXCESS,2.6307e-05,0.44852,0.44942,1,1
4,GO PROSTANOID METABOLIC PROCESS,0.0015653,0.44824,0.39708,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,3.1888e-05,0.4482,0.46602,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00030804,0.44752,0.43711,1,1
4,GO REGULATION OF NEURON MATURATION,0.00025131,0.44583,0.35655,1,1
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,5.0226e-05,0.44543,0.37517,1,1
4,GO LEYDIG CELL DIFFERENTIATION,0.00022676,0.44515,0.51508,1,1
4,GO MATURE B CELL DIFFERENTIATION,9.389e-05,0.44493,0.40029,1,1
4,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00037661,0.44437,0.36479,1,1
4,GO PROTEIN DEGLYCOSYLATION,1.1964e-05,0.44129,0.4349,1,1
4,GO REGULATION OF ANOIKIS,0.00010845,0.44121,0.41415,1,1
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.00042998,0.44011,0.33216,1,1
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.00030804,0.4388,0.36405,1,1
4,GO CELL ADHESION MEDIATED BY INTEGRIN,5.4121e-05,0.43705,0.40823,1,1
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,2.5308e-05,0.43678,0.47565,1,1
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.00019079,0.43647,0.40515,1,1
4,GO ZYMOGEN ACTIVATION,0.00025131,0.43405,0.3917,1,1
4,GO CERAMIDE CATABOLIC PROCESS,0.00031859,0.43274,0.43139,1,1
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,4.6597e-05,0.43137,0.54721,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00032948,0.4312,0.37754,1,1
4,GO STEROID ESTERIFICATION,0.00010092,0.43018,0.55875,1,1
4,GO INTESTINAL ABSORPTION,6.4994e-06,0.42998,0.58626,1,1
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.00095906,0.42834,0.4157,1,1
4,GO NEGATIVE REGULATION OF COAGULATION,0.0017123,0.42833,0.35596,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0047853,0.42818,0.35424,1,1
4,GO BASIC AMINO ACID TRANSPORT,0.0045306,0.42711,0.41423,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0027346,0.42564,0.33063,1,1
4,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.031059,0.42401,0.33055,1,1
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,6.5149e-05,0.42246,0.47442,1,1
4,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.00037661,0.42119,0.39408,1,1
4,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.00020448,0.4207,0.34112,1,1
4,GO REGULATION OF INTEGRIN ACTIVATION,9.4334e-07,0.42049,0.49854,1,1
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00065623,0.42022,0.38488,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00054072,0.41991,0.40644,1,1
4,GO BONE RESORPTION,1.9904e-06,0.41918,0.42817,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,6.2367e-06,0.41896,0.43528,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00014418,0.41893,0.36257,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0037331,0.4177,0.29901,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00052342,0.41676,0.3428,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0018173,0.41639,0.38568,1,1
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,5.6174e-05,0.41635,0.51497,1,1
4,GO CELLULAR DEFENSE RESPONSE,4.2876e-06,0.41362,0.42398,1,1
4,GO LYSINE METABOLIC PROCESS,0.012508,0.41285,0.2663,1,1
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.1617e-05,0.41091,0.44459,1,1
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,1.5201e-05,0.41077,0.32851,1,1
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.00010462,0.41015,0.42927,1,1
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,2.5308e-05,0.4099,0.35232,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0016129,0.4093,0.36227,1,1
4,GO VACUOLAR ACIDIFICATION,1.2366e-07,0.40868,0.44048,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.00029782,0.40855,0.36355,1,1
4,GO KETONE BODY METABOLIC PROCESS,0.0025817,0.40625,0.33581,1,1
4,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00095906,0.40538,0.36851,1,1
4,GO EOSINOPHIL MIGRATION,0.001228,0.40498,0.3562,1,1
4,GO REGULATION OF BONE REMODELING,3.4728e-06,0.40409,0.43719,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00037661,0.40398,0.38875,1,1
4,GO VASODILATION,8.1192e-05,0.40384,0.53819,1,1
4,GO NADPH REGENERATION,0.024846,0.40375,0.21958,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00026903,0.40318,0.37035,1,1
4,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0016129,0.40163,0.34332,1,1
4,GO KETONE BIOSYNTHETIC PROCESS,0.00024286,0.4011,0.34529,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,4.2876e-06,0.40096,0.41284,1,1
4,GO RESPONSE TO ACIDIC PH,0.0014738,0.40059,0.30607,1,1
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,3.1888e-05,0.40016,0.38135,1,1
4,GO AMMONIUM ION METABOLIC PROCESS,5.4121e-05,0.40001,0.45979,1,1
4,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.0022992,0.39982,0.31147,1,1
4,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.0054795,0.39827,0.36145,1,1
4,GO REGULATION OF PLATELET AGGREGATION,0.0071468,0.39786,0.29363,1,1
4,GO PHAGOSOME ACIDIFICATION,7.2756e-08,0.3964,0.43599,1,1
4,GO REGULATION OF PLATELET ACTIVATION,0.00079435,0.39636,0.3168,1,1
4,GO BARBED END ACTIN FILAMENT CAPPING,0.0090226,0.39532,0.35072,1,1
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.001662,0.39479,0.34277,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0030654,0.39441,0.42783,1,1
4,GO B CELL APOPTOTIC PROCESS,1.2962e-05,0.39426,0.35922,1,1
4,GO INSEMINATION,0.00025131,0.39426,0.35747,1,1
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,5.2139e-05,0.39393,0.30083,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0019282,0.39378,0.41772,1,1
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.0016129,0.39251,0.29674,1,1
4,GO MITOCHONDRIAL DEPOLARIZATION,3.0689e-05,0.39175,0.35454,1,1
4,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0062634,0.39113,0.42086,1,1
4,GO GAP JUNCTION ASSEMBLY,0.0099891,0.39086,0.28064,1,1
4,GO NUCLEOTIDE SALVAGE,0.00081984,0.39062,0.34564,1,1
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.0033e-05,0.3906,0.47339,1,1
4,GO HEPARIN METABOLIC PROCESS,0.033166,0.39058,0.21187,1,1
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.00012964,0.38975,0.3766,1,1
4,GO BILE ACID AND BILE SALT TRANSPORT,0.00026903,0.38923,0.58641,1,1
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00026903,0.38859,0.38606,1,1
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,4.3218e-05,0.38755,0.41942,1,1
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,2.6307e-05,0.38602,0.3251,1,1
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00021909,0.38503,0.38008,1,1
4,GO AMINE BIOSYNTHETIC PROCESS,1.3441e-06,0.38413,0.39382,1,1
4,GO L PHENYLALANINE METABOLIC PROCESS,0.00090094,0.3815,0.56335,1,1
4,GO EOSINOPHIL CHEMOTAXIS,0.0014299,0.3814,0.36408,1,1
4,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0094949,0.38071,0.3641,1,1
4,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.024846,0.38022,0.31924,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,4.4878e-05,0.38019,0.3188,1,1
4,GO REGULATION OF NEUTROPHIL MIGRATION,1.2862e-06,0.37986,0.38623,1,1
4,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.00036427,0.37976,0.32912,1,1
4,GO UBIQUINONE METABOLIC PROCESS,3.1904e-06,0.37784,0.35618,1,1
4,GO N GLYCAN PROCESSING,0.0026572,0.37707,0.28663,1,1
4,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.0025083,0.37665,0.24707,1,1
4,GO REGULATORY T CELL DIFFERENTIATION,0.00038934,0.37664,0.30893,1,1
4,GO PROTEIN DEMANNOSYLATION,3.4421e-05,0.37576,0.416,1,1
4,GO ACUTE PHASE RESPONSE,0.00019079,0.37529,0.3115,1,1
4,GO PLASMINOGEN ACTIVATION,0.0021062,0.37529,0.42612,1,1
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.00084609,0.37525,0.30076,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.012203,0.37433,0.25468,1,1
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.018836,0.37357,0.28158,1,1
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00023468,0.37284,0.31712,1,1
4,GO CORTICOSTEROID HORMONE SECRETION,0.0033369,0.37233,0.31446,1,1
4,GO PEPTIDYL PROLINE HYDROXYLATION,0.00030804,0.37168,0.41095,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00012964,0.37151,0.3719,1,1
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00026903,0.37136,0.30858,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.012203,0.37056,0.22504,1,1
4,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.001662,0.37005,0.34702,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00044439,0.36978,0.4612,1,1
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,8.6584e-06,0.36967,0.34412,1,1
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0017641,0.3669,0.29132,1,1
4,GO TYPE B PANCREATIC CELL PROLIFERATION,0.0087944,0.36682,0.30049,1,1
4,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0042883,0.36642,0.31232,1,1
4,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.035393,0.36631,0.24165,1,1
4,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.00044439,0.36618,0.31856,1,1
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.00028792,0.3661,0.39917,1,1
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00017186,0.36492,0.41003,1,1
4,GO SMOOTH MUSCLE CELL MIGRATION,0.0022332,0.3649,0.28471,1,1
4,GO RESPONSE TO LITHIUM ION,3.3132e-05,0.36354,0.45494,1,1
4,GO REGULATION OF COAGULATION,0.00037661,0.36349,0.30854,1,1
4,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.0027346,0.36335,0.39405,1,1
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00026003,0.36269,0.34791,1,1
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0018173,0.36231,0.26531,1,1
4,GO METHIONINE METABOLIC PROCESS,2.0833e-05,0.36227,0.34216,1,1
4,GO REGULATION OF TISSUE REMODELING,7.9801e-06,0.36148,0.37487,1,1
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0012662,0.36107,0.37549,1,1
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0025083,0.36107,0.3036,1,1
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.0020453,0.36097,0.30627,1,1
4,GO THYMOCYTE APOPTOTIC PROCESS,0.0037331,0.36051,0.2652,1,1
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,2.2658e-06,0.35872,0.35666,1,1
4,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00038934,0.35821,0.33077,1,1
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.01282,0.35819,0.28876,1,1
4,GO REGULATION OF MYOBLAST FUSION,0.00016595,0.35753,0.33134,1,1
4,GO INTEGRIN ACTIVATION,5.508e-06,0.35733,0.37059,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS,0.00014418,0.35593,0.32879,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0025817,0.35569,0.36671,1,1
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,2.0833e-05,0.3553,0.36421,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00059588,0.35485,0.37066,1,1
4,GO REGULATION OF ICOSANOID SECRETION,0.0001547,0.35459,0.32159,1,1
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,3.8583e-05,0.35208,0.30766,1,1
4,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,8.1192e-05,0.35193,0.31122,1,1
4,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.001662,0.35188,0.30994,1,1
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00026003,0.35187,0.35299,1,1
4,GO REGULATION OF VIRAL GENOME REPLICATION,0.0013872,0.35001,0.23511,1,1
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00055855,0.34992,0.36339,1,1
4,GO REGULATION OF STEROID METABOLIC PROCESS,6.0504e-05,0.34972,0.29205,1,1
4,GO ETHER METABOLIC PROCESS,0.0023671,0.34896,0.23392,1,1
4,GO AMINO ACID BETAINE METABOLIC PROCESS,3.8583e-05,0.34885,0.39422,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00019753,0.34882,0.35256,1,1
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.0050528,0.34798,0.36587,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,6.2786e-05,0.34783,0.28906,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0006154,0.34714,0.31126,1,1
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00030804,0.34698,0.36363,1,1
4,GO SNARE COMPLEX ASSEMBLY,0.00019753,0.34616,0.28327,1,1
4,GO POSITIVE REGULATION OF CELL KILLING,0.0006154,0.34594,0.26512,1,1
4,GO LYTIC VACUOLE ORGANIZATION,6.5896e-07,0.3459,0.34854,1,1
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0013457,0.34493,0.29459,1,1
4,GO RESPONSE TO DEXAMETHASONE,0.0017123,0.34466,0.2709,1,1
4,GO PROTEIN AUTOPROCESSING,2.1663e-05,0.34438,0.38428,1,1
4,GO ANOIKIS,4.4878e-05,0.34435,0.29752,1,1
4,GO BILE ACID METABOLIC PROCESS,4.0073e-05,0.34373,0.36134,1,1
4,GO STEROID HORMONE SECRETION,0.0011199,0.34338,0.29335,1,1
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00079435,0.34301,0.34668,1,1
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.00041602,0.34296,0.27672,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00047456,0.34212,0.33239,1,1
4,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.0010528,0.34086,0.26307,1,1
4,GO ICOSANOID METABOLIC PROCESS,5.0226e-05,0.34061,0.3399,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,7.013e-05,0.34043,0.31022,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.019739,0.33975,0.31849,1,1
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.004408,0.33961,0.45905,1,1
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,8.1192e-05,0.33943,0.28575,1,1
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0015653,0.33916,0.3064,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.9263e-05,0.33902,0.35413,1,1
4,GO TISSUE REMODELING,5.4121e-05,0.33875,0.29149,1,1
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0038387,0.33761,0.32151,1,1
4,GO POSITIVE REGULATION OF CELL SIZE,2.6307e-05,0.33732,0.36143,1,1
4,GO MITOCHONDRIAL RNA PROCESSING,0.0024367,0.33718,0.26332,1,1
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0041716,0.33715,0.27789,1,1
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00019753,0.33635,0.30504,1,1
4,GO CELLULAR RESPONSE TO FATTY ACID,8.4205e-05,0.33626,0.34154,1,1
4,GO RESPONSE TO THYROID HORMONE,0.001662,0.33591,0.26629,1,1
4,GO IMMUNOGLOBULIN SECRETION,0.00087311,0.33585,0.25448,1,1
4,GO LEUKOTRIENE METABOLIC PROCESS,0.00029782,0.33577,0.30249,1,1
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,9.0551e-05,0.33538,0.32819,1,1
4,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00029782,0.33538,0.28571,1,1
4,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.013798,0.33533,0.26968,1,1
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00030804,0.33528,0.25469,1,1
4,GO SULFUR AMINO ACID METABOLIC PROCESS,0.00049035,0.33522,0.276,1,1
4,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0016129,0.33413,0.33969,1,1
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.019739,0.33412,0.3841,1,1
4,GO LIPOPROTEIN CATABOLIC PROCESS,0.00016023,0.33408,0.29169,1,1
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0010528,0.33386,0.28915,1,1
4,GO TRICARBOXYLIC ACID CYCLE,0.0037331,0.33322,0.25574,1,1
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.00065623,0.33312,0.25212,1,1
4,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.0083534,0.333,0.31622,1,1
4,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.0037331,0.33297,0.26077,1,1
4,GO POSITIVE REGULATION OF WOUND HEALING,0.00040247,0.33275,0.31992,1,1
4,GO LIVER MORPHOGENESIS,0.0013054,0.33211,0.28853,1,1
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0024367,0.33191,0.35379,1,1
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,8.6584e-06,0.33164,0.31315,1,1
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.4346e-05,0.33039,0.2797,1,1
4,GO CARNITINE METABOLIC PROCESS,0.0012662,0.33037,0.28276,1,1
4,GO KERATAN SULFATE CATABOLIC PROCESS,0.00035231,0.33032,0.34232,1,1
4,GO RESPONSE TO PEPTIDOGLYCAN,0.00057693,0.32883,0.25565,1,1
4,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.00049035,0.32861,0.25744,1,1
4,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.021165,0.32834,0.31057,1,1
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.00054072,0.32801,0.3787,1,1
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0045306,0.328,0.26689,1,1
4,GO DORSAL AORTA DEVELOPMENT,0.0094949,0.3276,0.22094,1,1
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.00012074,0.32664,0.30501,1,1
4,GO ACUTE INFLAMMATORY RESPONSE,7.013e-05,0.32563,0.32903,1,1
4,GO DENDRITIC CELL APOPTOTIC PROCESS,0.016339,0.3256,0.26958,1,1
4,GO FATTY ACID CATABOLIC PROCESS,1.2862e-06,0.32552,0.3251,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.104e-05,0.32489,0.30706,1,1
4,GO REGULATION OF LIGASE ACTIVITY,0.00098941,0.32473,0.24243,1,1
4,GO BLOOD VESSEL REMODELING,0.00044439,0.32471,0.29259,1,1
4,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.022165,0.32469,0.18226,1,1
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.0018173,0.32446,0.29134,1,1
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.018398,0.32368,0.26222,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,1.9263e-05,0.32365,0.28001,1,1
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.033894,0.32353,0.28879,1,1
4,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.0015189,0.3234,0.34022,1,1
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0099891,0.32331,0.215,1,1
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00010845,0.32319,0.35819,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.001191,0.32297,0.26934,1,1
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,4.1617e-05,0.32252,0.26871,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00025131,0.32219,0.28893,1,1
4,GO INTRACELLULAR STEROL TRANSPORT,0.0006154,0.32206,0.30877,1,1
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.0021062,0.32144,0.25569,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.0081404,0.32107,0.18329,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0013054,0.32062,0.28659,1,1
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0015189,0.32023,0.34478,1,1
4,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.0022332,0.32007,0.29684,1,1
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,7.013e-05,0.32004,0.38951,1,1
4,GO MACROMOLECULE DEPALMITOYLATION,1.2962e-05,0.32001,0.32374,1,1
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00092958,0.31981,0.22971,1,1
4,GO BONE REMODELING,2.5308e-05,0.31964,0.34277,1,1
4,GO EPITHELIAL CELL CELL ADHESION,0.011047,0.31961,0.34722,1,1
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0026572,0.3196,0.19337,1,1
4,GO PLATELET DEGRANULATION,0.00072223,0.31951,0.2569,1,1
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.00019753,0.31933,0.27788,1,1
4,GO STEROID METABOLIC PROCESS,1.349e-05,0.31933,0.29674,1,1
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.001872,0.31874,0.26659,1,1
4,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.001872,0.3186,0.21269,1,1
4,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.5201e-05,0.31807,0.29468,1,1
4,GO STEROID BIOSYNTHETIC PROCESS,1.349e-05,0.31782,0.27591,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,4.3218e-05,0.3178,0.33123,1,1
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.5816e-05,0.31768,0.33622,1,1
4,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.0019282,0.31693,0.1978,1,1
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0001547,0.31686,0.2781,1,1
4,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00038934,0.31667,0.22806,1,1
4,GO DIGESTION,0.00010462,0.31611,0.29321,1,1
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.00029782,0.31542,0.28057,1,1
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0013457,0.31504,0.29487,1,1
4,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0038387,0.3139,0.24463,1,1
4,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.0049174,0.31386,0.26686,1,1
4,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00055855,0.31343,0.29455,1,1
4,GO REGULATION OF CHLORIDE TRANSPORT,0.0023671,0.31314,0.35411,1,1
4,GO DEFENSE RESPONSE TO VIRUS,0.00057693,0.31303,0.22803,1,1
4,GO REGULATION OF CELL PROJECTION SIZE,0.013465,0.31296,0.26879,1,1
4,GO REGULATION OF RENAL SYSTEM PROCESS,0.0046564,0.31288,0.22853,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.025994,0.31249,0.25174,1,1
4,GO FOAM CELL DIFFERENTIATION,0.00016023,0.31222,0.27021,1,1
4,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00057693,0.31219,0.33255,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.014841,0.31145,0.21875,1,1
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.4421e-05,0.31107,0.2639,1,1
4,GO RESPONSE TO CORTICOSTERONE,0.0081404,0.3108,0.20861,1,1
4,GO PH REDUCTION,1.5331e-06,0.3106,0.29002,1,1
4,GO RESPONSE TO GROWTH HORMONE,3.3132e-05,0.31005,0.35136,1,1
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.014138,0.30989,0.23071,1,1
4,GO ALPHA BETA T CELL PROLIFERATION,0.00065623,0.3096,0.28001,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.00035231,0.30927,0.26918,1,1
4,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0067808,0.30921,0.1998,1,1
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0057817,0.30891,0.39838,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.036164,0.30821,0.20022,1,1
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,6.2786e-05,0.30665,0.23431,1,1
4,GO INOSITOL METABOLIC PROCESS,1.0184e-05,0.30602,0.33113,1,1
4,GO B CELL MEDIATED IMMUNITY,0.00044439,0.30538,0.23407,1,1
4,GO PROTEIN O LINKED GLYCOSYLATION,0.00010092,0.30517,0.28338,1,1
4,GO REGULATION OF B CELL DIFFERENTIATION,0.0001547,0.30513,0.28843,1,1
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,1.8251e-06,0.3051,0.30096,1,1
4,GO PHAGOSOME MATURATION,2.9301e-06,0.30491,0.3315,1,1
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0010528,0.30445,0.24222,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,7.6603e-06,0.3044,0.34405,1,1
4,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00059588,0.30402,0.28883,1,1
4,GO IMMUNE EFFECTOR PROCESS,9.389e-05,0.30383,0.22774,1,1
4,GO RESPONSE TO INTERFERON GAMMA,0.00090094,0.30338,0.26169,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.001872,0.30313,0.19516,1,1
4,GO NUCLEOSIDE CATABOLIC PROCESS,0.0014738,0.303,0.21449,1,1
4,GO RESPONSE TO STEROL DEPLETION,0.00065623,0.30284,0.39355,1,1
4,GO MICROVILLUS ORGANIZATION,0.0085714,0.30268,0.28782,1,1
4,GO RESPONSE TO MINERALOCORTICOID,0.00054072,0.30248,0.26654,1,1
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0025083,0.30213,0.25921,1,1
4,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.041967,0.30209,0.18826,1,1
4,GO PHOSPHOLIPID EFFLUX,0.00098941,0.30176,0.35159,1,1
4,GO GLUTATHIONE METABOLIC PROCESS,0.0053338,0.30164,0.30259,1,1
4,GO REGULATION OF TOLERANCE INDUCTION,0.031059,0.30051,0.33504,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0021062,0.30041,0.30005,1,1
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,5.7413e-06,0.29988,0.31504,1,1
4,GO TRANSCYTOSIS,6.7596e-05,0.29937,0.30395,1,1
4,GO KERATAN SULFATE METABOLIC PROCESS,0.00067758,0.29919,0.24604,1,1
4,GO PROTEIN HYDROXYLATION,0.0026572,0.29878,0.27369,1,1
4,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00074557,0.29875,0.19627,1,1
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.001662,0.2987,0.25804,1,1
4,GO RESPIRATORY BURST,0.00016595,0.29868,0.28292,1,1
4,GO ENTRY INTO HOST,0.0020453,0.29841,0.22126,1,1
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00037661,0.2984,0.27915,1,1
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.6174e-05,0.29828,0.24937,1,1
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.015953,0.2982,0.24607,1,1
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.023741,0.29815,0.22379,1,1
4,GO RESPONSE TO INTERLEUKIN 6,0.00047456,0.29805,0.28472,1,1
4,GO REGULATION OF B CELL PROLIFERATION,1.4609e-05,0.2979,0.28028,1,1
4,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.031748,0.29781,0.20368,1,1
4,GO MAST CELL ACTIVATION,2.3418e-05,0.29759,0.29178,1,1
4,GO ARACHIDONIC ACID SECRETION,0.00012512,0.29699,0.26294,1,1
4,GO OSTEOBLAST PROLIFERATION,0.0013457,0.29693,0.27359,1,1
4,GO LEUKOCYTE MEDIATED IMMUNITY,5.4121e-05,0.2965,0.24976,1,1
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,4.2876e-06,0.29637,0.27738,1,1
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,7.8282e-05,0.29619,0.29395,1,1
4,GO ZYMOGEN INHIBITION,0.0053338,0.29614,0.22553,1,1
4,GO DIGESTIVE SYSTEM PROCESS,0.00035231,0.29564,0.25741,1,1
4,GO IMMUNOLOGICAL MEMORY PROCESS,0.0028957,0.29513,0.2685,1,1
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,7.013e-05,0.29489,0.23424,1,1
4,GO VITAMIN D METABOLIC PROCESS,0.0047853,0.2948,0.26811,1,1
4,GO GOLGI TO ENDOSOME TRANSPORT,0.00087311,0.29471,0.27414,1,1
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00027832,0.29466,0.22049,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0053338,0.29452,0.19646,1,1
4,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0050528,0.29435,0.2032,1,1
4,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0021689,0.29401,0.21758,1,1
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0046564,0.29371,0.19663,1,1
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,3.0689e-05,0.29335,0.26052,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.00031859,0.29309,0.2609,1,1
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.00072223,0.29281,0.22028,1,1
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00010462,0.29239,0.2742,1,1
4,GO VIRAL GENOME REPLICATION,0.0020453,0.29216,0.1903,1,1
4,GO RESPONSE TO INTERLEUKIN 2,0.0015653,0.29214,0.23346,1,1
4,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0067808,0.29142,0.26493,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00010462,0.29116,0.2592,1,1
4,GO REGULATION OF WOUND HEALING,0.00040247,0.29114,0.26565,1,1
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,2.9301e-06,0.29102,0.25158,1,1
4,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00049035,0.29073,0.37375,1,1
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00017186,0.29067,0.36045,1,1
4,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.00040247,0.2903,0.24676,1,1
4,GO REGULATION OF RESPIRATORY BURST,0.00019079,0.29029,0.32414,1,1
4,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.0041716,0.29028,0.2495,1,1
4,GO RADIAL GLIAL CELL DIFFERENTIATION,0.0099891,0.29013,0.29447,1,1
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.00054072,0.28993,0.19837,1,1
4,GO CELL REDOX HOMEOSTASIS,0.00012964,0.28984,0.30175,1,1
4,GO HYPOTHALAMUS DEVELOPMENT,0.00042998,0.28963,0.27052,1,1
4,GO REGULATION OF VIRAL LIFE CYCLE,0.0010206,0.28939,0.2304,1,1
4,GO ENDOCRINE PROCESS,0.00023468,0.28882,0.2591,1,1
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,5.6174e-05,0.28871,0.29471,1,1
4,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0032441,0.28867,0.3307,1,1
4,GO T CELL MEDIATED IMMUNITY,0.0090226,0.28867,0.21263,1,1
4,GO PROTEIN CONTAINING COMPLEX REMODELING,0.0041716,0.28842,0.2333,1,1
4,GO POLYOL TRANSPORT,0.0025083,0.28821,0.30054,1,1
4,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.0073363,0.28756,0.30903,1,1
4,GO REGULATION OF AMYLOID BETA CLEARANCE,0.017137,0.28706,0.21499,1,1
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0028957,0.2869,0.22682,1,1
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0012662,0.28681,0.26146,1,1
4,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.004408,0.28654,0.27969,1,1
4,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.00044439,0.28649,0.28826,1,1
4,GO FATTY ACID DERIVATIVE TRANSPORT,0.00041602,0.28593,0.26172,1,1
4,GO STEROL METABOLIC PROCESS,0.00026903,0.28578,0.24154,1,1
4,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0015653,0.28568,0.24734,1,1
4,GO CORNIFICATION,0.00057693,0.28567,0.27446,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.001191,0.28533,0.25014,1,1
4,GO HYALURONAN CATABOLIC PROCESS,0.010506,0.28521,0.16458,1,1
4,GO OPTIC NERVE DEVELOPMENT,0.00047456,0.28499,0.40531,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00065623,0.28467,0.22666,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00013433,0.28451,0.23234,1,1
4,GO PROSTANOID BIOSYNTHETIC PROCESS,0.001986,0.28429,0.28818,1,1
4,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0020453,0.28428,0.28801,1,1
4,GO AMYLOID BETA CLEARANCE,0.0028141,0.2837,0.1999,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0014299,0.28358,0.24018,1,1
4,GO PURINE NUCLEOTIDE TRANSPORT,2.6307e-05,0.28357,0.25133,1,1
4,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.010773,0.28297,0.21418,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00052342,0.28253,0.20437,1,1
4,GO MAST CELL MEDIATED IMMUNITY,6.7596e-05,0.28247,0.27768,1,1
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00037661,0.28236,0.3119,1,1
4,GO OLIGOPEPTIDE TRANSPORT,0.001662,0.28233,0.3482,1,1
4,GO NEUTROPHIL MIGRATION,4.8612e-06,0.28216,0.23798,1,1
4,GO ETHANOL METABOLIC PROCESS,0.0041716,0.28205,0.25936,1,1
4,GO AMINO ACID ACTIVATION,0.00353,0.28188,0.22072,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.010506,0.28187,0.22493,1,1
4,GO AMINE METABOLIC PROCESS,7.5427e-07,0.28177,0.3026,1,1
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0006154,0.2817,0.23192,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0021689,0.28169,0.21058,1,1
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,2.5308e-05,0.28169,0.28188,1,1
4,GO INDOLALKYLAMINE METABOLIC PROCESS,0.00042998,0.2813,0.31481,1,1
4,GO ANIMAL ORGAN REGENERATION,0.0023671,0.28121,0.17819,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0014738,0.28099,0.27803,1,1
4,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0014299,0.28072,0.26053,1,1
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,4.1617e-05,0.28051,0.28431,1,1
4,GO LUNG ALVEOLUS DEVELOPMENT,0.00041602,0.28032,0.25307,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0060989,0.28032,0.22501,1,1
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,3.7145e-05,0.27947,0.25379,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00081984,0.27944,0.20541,1,1
4,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00026003,0.27911,0.19306,1,1
4,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.0057817,0.27901,0.30777,1,1
4,GO STEROL TRANSPORT,0.00021167,0.27898,0.25706,1,1
4,GO INNATE IMMUNE RESPONSE,9.0551e-05,0.27862,0.22074,1,1
4,GO CELL KILLING,3.8583e-05,0.27857,0.2356,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0037331,0.2785,0.23681,1,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00031859,0.27827,0.33483,1,1
4,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.041093,0.27823,0.1609,1,1
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,2.0033e-05,0.27789,0.27504,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0025083,0.27776,0.28332,1,1
4,GO RESPONSE TO CORTICOSTEROID,0.001662,0.27733,0.2038,1,1
4,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00059588,0.27722,0.25368,1,1
4,GO LIPID DROPLET ORGANIZATION,2.7343e-05,0.27719,0.30015,1,1
4,GO AEROBIC RESPIRATION,0.00055855,0.27698,0.25023,1,1
4,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.03939,0.27664,0.21907,1,1
4,GO PHOSPHOLIPID TRANSPORT,9.7801e-06,0.27628,0.24174,1,1
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.0015653,0.27626,0.28617,1,1
4,GO APICAL JUNCTION ASSEMBLY,0.001228,0.27577,0.28827,1,1
4,GO RESPONSE TO ANGIOTENSIN,0.0042883,0.27571,0.24978,1,1
4,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.036948,0.2757,0.2567,1,1
4,GO REGULATION OF CELL KILLING,0.00044439,0.27566,0.24209,1,1
4,GO OXALATE TRANSPORT,0.00040247,0.27491,0.23902,1,1
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,6.5149e-05,0.27488,0.27618,1,1
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,7.013e-05,0.27453,0.21558,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00065623,0.27445,0.2084,1,1
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.0081404,0.27439,0.17913,1,1
4,GO MYELOID LEUKOCYTE ACTIVATION,4.8379e-05,0.27432,0.24552,1,1
4,GO INTERLEUKIN 8 PRODUCTION,0.00019753,0.27402,0.25058,1,1
4,GO RESPONSE TO COPPER ION,0.013465,0.27347,0.29142,1,1
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.00081984,0.27346,0.23646,1,1
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.00090094,0.27317,0.23202,1,1
4,GO INTERLEUKIN 10 PRODUCTION,0.00020448,0.27291,0.21802,1,1
4,GO POSITIVE REGULATION OF TISSUE REMODELING,0.00087311,0.27238,0.29621,1,1
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,1.7806e-05,0.27234,0.3085,1,1
4,GO HORMONE METABOLIC PROCESS,0.0001165,0.2723,0.29058,1,1
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.0027346,0.27228,0.29999,1,1
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0062634,0.27199,0.25058,1,1
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0025083,0.2714,0.18538,1,1
4,GO IMMUNE RESPONSE TO TUMOR CELL,0.010773,0.27138,0.28879,1,1
4,GO RESPONSE TO PROTOZOAN,0.00057693,0.2711,0.22455,1,1
4,GO SUPEROXIDE METABOLIC PROCESS,0.00024286,0.27103,0.24156,1,1
4,GO ARACHIDONIC ACID METABOLIC PROCESS,7.8282e-05,0.27096,0.30718,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.022165,0.27089,0.22116,1,1
4,GO FUCOSE METABOLIC PROCESS,0.034637,0.27019,0.26171,1,1
4,GO BEHAVIORAL RESPONSE TO PAIN,0.027803,0.27011,0.20874,1,1
4,GO DEFENSE RESPONSE TO BACTERIUM,5.7413e-06,0.27007,0.24588,1,1
4,GO PROTEIN O LINKED MANNOSYLATION,0.0012662,0.27002,0.24522,1,1
4,GO LABYRINTHINE LAYER DEVELOPMENT,0.012203,0.26985,0.20846,1,1
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.0018173,0.26971,0.31229,1,1
4,GO BILE ACID BIOSYNTHETIC PROCESS,0.00050664,0.26941,0.28358,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0051916,0.26939,0.1964,1,1
4,GO RESPONSE TO FATTY ACID,0.00072223,0.26937,0.2193,1,1
4,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.010245,0.26926,0.38654,1,1
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.00029782,0.26925,0.30853,1,1
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.00063551,0.26917,0.33439,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,1.9263e-05,0.26905,0.3006,1,1
4,GO NEGATIVE REGULATION OF WOUND HEALING,0.0015653,0.26902,0.27915,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00353,0.26897,0.21287,1,1
4,GO CHYLOMICRON ASSEMBLY,0.02166,0.26892,0.27631,1,1
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.0040578,0.26864,0.21881,1,1
4,GO RETINOL METABOLIC PROCESS,0.00084609,0.26806,0.3805,1,1
4,GO GRANULOCYTE MIGRATION,3.0689e-05,0.26786,0.22874,1,1
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0010528,0.2677,0.18434,1,1
4,GO ANTIMICROBIAL HUMORAL RESPONSE,2.7343e-05,0.26765,0.23115,1,1
4,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00019079,0.26714,0.28598,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00010845,0.26705,0.27127,1,1
4,GO CYTOKINE METABOLIC PROCESS,0.00045924,0.26685,0.19168,1,1
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.0028141,0.26654,0.20086,1,1
4,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.021165,0.26636,0.23572,1,1
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.017969,0.26627,0.20244,1,1
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,2.0033e-05,0.26598,0.23643,1,1
4,GO DOPAMINE TRANSPORT,0.0021689,0.26585,0.31654,1,1
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,8.4205e-05,0.26582,0.21381,1,1
4,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.004408,0.26568,0.28836,1,1
4,GO RESPONSE TO PH,0.0010528,0.26537,0.20872,1,1
4,GO MAGNESIUM ION TRANSPORT,0.00072223,0.26502,0.2565,1,1
4,GO DEFENSE RESPONSE,6.5149e-05,0.26488,0.20549,1,1
4,GO STEROL HOMEOSTASIS,0.0019282,0.26476,0.2628,1,1
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.029068,0.26472,0.17337,1,1
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.0039469,0.26425,0.20492,1,1
4,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.001986,0.26381,0.1756,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00052342,0.26366,0.21405,1,1
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.00029782,0.2627,0.31385,1,1
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0014738,0.26226,0.25638,1,1
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00095906,0.26205,0.17464,1,1
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00031859,0.26175,0.26951,1,1
4,GO REGULATION OF FATTY ACID BETA OXIDATION,0.00042998,0.26156,0.25088,1,1
4,GO LIPID LOCALIZATION,5.0683e-06,0.26155,0.27163,1,1
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0001165,0.26145,0.23193,1,1
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.0001547,0.26104,0.26902,1,1
4,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.022165,0.26098,0.24675,1,1
4,GO POSITIVE REGULATION OF ANION TRANSPORT,9.7346e-05,0.26097,0.321,1,1
4,GO ADAPTIVE IMMUNE RESPONSE,0.00065623,0.26028,0.21422,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0027346,0.26013,0.26404,1,1
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.001228,0.26011,0.23393,1,1
4,GO CELLULAR RESPONSE TO ALCOHOL,0.0056288,0.26006,0.1645,1,1
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0015189,0.25981,0.23382,1,1
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.0604e-05,0.25938,0.29973,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0066042,0.25911,0.18074,1,1
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0013054,0.25891,0.2309,1,1
4,GO LYMPHOCYTE MIGRATION,0.00052342,0.25889,0.18917,1,1
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0001165,0.25847,0.23556,1,1
4,GO SEQUESTERING OF TRIGLYCERIDE,0.010773,0.25844,0.22888,1,1
4,GO HOMOTYPIC CELL CELL ADHESION,0.00069957,0.25843,0.24572,1,1
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.00021909,0.25791,0.24692,1,1
4,GO KERATINIZATION,0.00055855,0.25781,0.23318,1,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.001872,0.25764,0.20518,1,1
4,GO TRANSFERRIN TRANSPORT,1.7474e-06,0.25715,0.33978,1,1
4,GO FLUID TRANSPORT,6.0504e-05,0.25713,0.23442,1,1
4,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.017549,0.25707,0.14529,1,1
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00023468,0.25693,0.2784,1,1
4,GO SECRETION BY TISSUE,0.0014299,0.25686,0.22494,1,1
4,GO REGULATION OF B CELL ACTIVATION,2.8418e-05,0.25677,0.23076,1,1
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00069957,0.25645,0.26309,1,1
4,GO RESPONSE TO GONADOTROPIN,0.00074557,0.25639,0.25171,1,1
4,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0059384,0.25628,0.36157,1,1
4,GO WATER HOMEOSTASIS,0.00079435,0.25618,0.24022,1,1
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0067808,0.25605,0.18214,1,1
4,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0069616,0.25603,0.17705,1,1
4,GO LIPID TRANSLOCATION,0.00081984,0.25567,0.23754,1,1
4,GO ELECTRON TRANSPORT CHAIN,0.00017186,0.2555,0.25103,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.02268,0.25546,0.24661,1,1
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,2.9532e-05,0.25525,0.23874,1,1
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.0030654,0.25494,0.24869,1,1
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,4.0073e-05,0.25483,0.24051,1,1
4,GO CELLULAR KETONE METABOLIC PROCESS,0.0001547,0.25428,0.23799,1,1
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.0046564,0.25418,0.17087,1,1
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,3.4421e-05,0.25353,0.30858,1,1
4,GO EMBRYONIC PLACENTA DEVELOPMENT,0.036948,0.25345,0.15403,1,1
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00020448,0.25304,0.23602,1,1
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.001872,0.25292,0.20818,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00052342,0.25277,0.20396,1,1
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00027832,0.25211,0.20216,1,1
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,3.7145e-05,0.25207,0.23506,1,1
4,GO B CELL PROLIFERATION,2.8418e-05,0.252,0.23122,1,1
4,GO REGULATION OF LYSOSOMAL LUMEN PH,9.389e-05,0.25184,0.33202,1,1
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00072223,0.25172,0.18883,1,1
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0018173,0.25169,0.24072,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.023741,0.25112,0.19119,1,1
4,GO MOVEMENT IN HOST ENVIRONMENT,0.0022992,0.25103,0.19977,1,1
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.0014738,0.25085,0.28917,1,1
4,GO ER OVERLOAD RESPONSE,0.0025817,0.25063,0.26579,1,1
4,GO CERAMIDE TRANSPORT,0.0073363,0.25052,0.33431,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0047853,0.25041,0.18647,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00059588,0.25033,0.24166,1,1
4,GO GLYCOSYLATION,9.0551e-05,0.25032,0.25008,1,1
4,GO CD40 SIGNALING PATHWAY,0.0026572,0.25,0.17739,1,1
4,GO DOPAMINE METABOLIC PROCESS,0.00087311,0.24991,0.29757,1,1
4,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0081404,0.24988,0.2432,1,1
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.00010092,0.24974,0.30764,1,1
4,GO REGULATION OF CELLULAR PH,2.9301e-06,0.24968,0.23482,1,1
4,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,8.4205e-05,0.24935,0.23111,1,1
4,GO MACROPHAGE PROLIFERATION,0.035393,0.2488,0.2184,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0014299,0.24879,0.22877,1,1
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00028792,0.24878,0.27819,1,1
4,GO HEXOSE CATABOLIC PROCESS,0.00095906,0.24876,0.24996,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00050664,0.24866,0.16568,1,1
4,GO PEROXISOMAL TRANSPORT,4.0073e-05,0.24843,0.25232,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.018398,0.24835,0.19669,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION,0.0013872,0.24828,0.21602,1,1
4,GO RESPONSE TO INSECTICIDE,0.0073363,0.24828,0.33947,1,1
4,GO DETECTION OF BIOTIC STIMULUS,0.0017641,0.24806,0.26518,1,1
4,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.041967,0.24802,0.18254,1,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.041093,0.24781,0.23366,1,1
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.00055855,0.24766,0.26701,1,1
4,GO ORGANELLE MEMBRANE FUSION,0.0001547,0.24735,0.21782,1,1
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00010845,0.2468,0.21649,1,1
4,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00095906,0.24659,0.30988,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.035393,0.24658,0.13137,1,1
4,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.025994,0.24649,0.16743,1,1
4,GO RESPONSE TO BIOTIC STIMULUS,0.00019753,0.24617,0.18194,1,1
4,GO GOLGI VESICLE BUDDING,0.00010092,0.24615,0.22903,1,1
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,8.1192e-05,0.24597,0.20758,1,1
4,GO REGULATION OF CELLULAR EXTRAVASATION,0.03245,0.24579,0.17917,1,1
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,2.9532e-05,0.24575,0.22189,1,1
4,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0022992,0.24565,0.20964,1,1
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00023468,0.24553,0.24372,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00055855,0.24548,0.1931,1,1
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.021165,0.24484,0.13256,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0031536,0.24436,0.20457,1,1
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0026572,0.24427,0.23003,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.013465,0.24415,0.18541,1,1
4,GO COPII COATED VESICLE BUDDING,0.00019079,0.24364,0.22064,1,1
4,GO LIPID OXIDATION,6.0504e-05,0.24357,0.23518,1,1
4,GO XENOBIOTIC TRANSPORT,0.00024286,0.24348,0.33093,1,1
4,GO RESPONSE TO VIRUS,0.00052342,0.24335,0.19836,1,1
4,GO REGULATION OF CELLULAR RESPIRATION,0.013465,0.24316,0.22742,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.015203,0.24306,0.1861,1,1
4,GO RESPONSE TO PROGESTERONE,0.0049174,0.24299,0.19624,1,1
4,GO INTRACELLULAR LIPID TRANSPORT,0.00052342,0.2429,0.23655,1,1
4,GO VESICLE BUDDING FROM MEMBRANE,0.0031536,0.24287,0.18866,1,1
4,GO POSITIVE REGULATION OF LIPID STORAGE,0.0022992,0.24232,0.22834,1,1
4,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0087944,0.24221,0.22148,1,1
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00013917,0.24216,0.24635,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.024288,0.24203,0.17843,1,1
4,GO MONOSACCHARIDE CATABOLIC PROCESS,0.00084609,0.24172,0.23067,1,1
4,GO REGULATION OF ACTIN NUCLEATION,0.00054072,0.24146,0.28043,1,1
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0041716,0.24131,0.2197,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.015574,0.24119,0.20429,1,1
4,GO MYELOID LEUKOCYTE MIGRATION,5.6174e-05,0.24103,0.21258,1,1
4,GO IRON SULFUR CLUSTER ASSEMBLY,0.0062634,0.24052,0.23202,1,1
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,9.389e-05,0.24035,0.21959,1,1
4,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.015953,0.24022,0.16349,1,1
4,GO AMELOGENESIS,0.011047,0.24017,0.21911,1,1
4,GO REVERSE CHOLESTEROL TRANSPORT,0.010506,0.24016,0.34637,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.00047456,0.23999,0.2445,1,1
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0013872,0.23932,0.18294,1,1
4,GO NUCLEOTIDE TRANSPORT,5.6174e-05,0.23923,0.23261,1,1
4,GO STEROL BIOSYNTHETIC PROCESS,0.00090094,0.23895,0.22704,1,1
4,GO REGULATION OF PH,4.8612e-06,0.23879,0.22887,1,1
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.001872,0.23875,0.23861,1,1
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.031748,0.23861,0.20801,1,1
4,GO PROGRAMMED NECROTIC CELL DEATH,0.0006154,0.23844,0.23949,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.001872,0.2382,0.17995,1,1
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.0012662,0.23809,0.27036,1,1
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00013917,0.23803,0.22611,1,1
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0033369,0.23798,0.17715,1,1
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00041602,0.23791,0.26104,1,1
4,GO HYALURONAN METABOLIC PROCESS,0.0010859,0.23783,0.17362,1,1
4,GO RESPONSE TO CYTOKINE,0.00019079,0.23767,0.18563,1,1
4,GO TYPE I INTERFERON PRODUCTION,0.00035231,0.23766,0.21007,1,1
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.020205,0.23756,0.17872,1,1
4,GO DIOL METABOLIC PROCESS,0.0053338,0.23728,0.27482,1,1
4,GO CHEMOKINE PRODUCTION,0.0042883,0.23715,0.16688,1,1
4,GO RESPONSE TO NUTRIENT,0.0050528,0.23701,0.16223,1,1
4,GO MITOCHONDRIAL TRNA PROCESSING,0.004408,0.23697,0.24434,1,1
4,GO MUSCLE HYPERTROPHY,0.00098941,0.23691,0.18313,1,1
4,GO ANDROGEN METABOLIC PROCESS,0.00019079,0.23656,0.36961,1,1
4,GO POLYSACCHARIDE METABOLIC PROCESS,0.00028792,0.23647,0.19557,1,1
4,GO ALANINE TRANSPORT,0.0045306,0.2364,0.29334,1,1
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.011612,0.23635,0.17006,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0025817,0.23583,0.19735,1,1
4,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.011326,0.23575,0.17144,1,1
4,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0073363,0.23574,0.23717,1,1
4,GO INTERLEUKIN 12 PRODUCTION,6.5149e-05,0.23558,0.24324,1,1
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,1.2962e-05,0.23556,0.20561,1,1
4,GO GOLGI TO VACUOLE TRANSPORT,0.0057817,0.23542,0.17951,1,1
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.00098941,0.2354,0.28024,1,1
4,GO FATTY ACID BETA OXIDATION,2.9532e-05,0.23518,0.2745,1,1
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,8.1192e-05,0.23508,0.24717,1,1
4,GO CELL CHEMOTAXIS,0.00010092,0.23498,0.20016,1,1
4,GO LIPID EXPORT FROM CELL,0.0016129,0.23484,0.26248,1,1
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0026572,0.23461,0.19324,1,1
4,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0013457,0.23445,0.21676,1,1
4,GO CELLULAR LIPID CATABOLIC PROCESS,1.0604e-05,0.23406,0.27192,1,1
4,GO MEMBRANE FUSION,0.0001547,0.23406,0.19994,1,1
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.014486,0.23388,0.17986,1,1
4,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0015653,0.23365,0.26651,1,1
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.0059384,0.23362,0.24358,1,1
4,GO SPERM CAPACITATION,0.0017123,0.2336,0.22643,1,1
4,GO LEUKOCYTE MIGRATION,0.00036427,0.23358,0.18929,1,1
4,GO AMINOGLYCAN CATABOLIC PROCESS,0.020205,0.23356,0.16415,1,1
4,GO REGULATION OF INNATE IMMUNE RESPONSE,5.4121e-05,0.2335,0.22203,1,1
4,GO RESPONSE TO ACTIVITY,0.0013457,0.23348,0.20778,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00047456,0.23342,0.22432,1,1
4,GO RESPONSE TO BACTERIUM,0.00034072,0.23322,0.18272,1,1
4,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00034072,0.23319,0.16312,1,1
4,GO REGULATION OF FATTY ACID TRANSPORT,0.00020448,0.23301,0.30784,1,1
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.023205,0.23295,0.15666,1,1
4,GO AUTOPHAGY OF NUCLEUS,0.038561,0.23293,0.17141,1,1
4,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.012508,0.23249,0.25227,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.0017123,0.23244,0.25325,1,1
4,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.00072223,0.23202,0.23534,1,1
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.035393,0.23188,0.26982,1,1
4,GO RESPONSE TO CADMIUM ION,0.024846,0.23163,0.16648,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.010245,0.23134,0.17836,1,1
4,GO INFLAMMATORY RESPONSE,0.00010845,0.23132,0.19562,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0062634,0.23131,0.28925,1,1
4,GO VESICLE TARGETING,0.0018173,0.23129,0.20744,1,1
4,GO RENAL SYSTEM PROCESS,0.00052342,0.23124,0.20105,1,1
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,3.6228e-06,0.23109,0.31383,1,1
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00069957,0.23098,0.21189,1,1
4,GO EXOCYTOSIS,5.8301e-05,0.23088,0.1968,1,1
4,GO MEMBRANE PROTEIN PROTEOLYSIS,0.0097392,0.23085,0.14933,1,1
4,GO REGULATION OF FERTILIZATION,0.0023671,0.23082,0.28278,1,1
4,GO REGULATION OF PROSTAGLANDIN SECRETION,0.0030654,0.23051,0.2611,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0037331,0.23041,0.26753,1,1
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,8.7323e-05,0.23039,0.19628,1,1
4,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.036164,0.23034,0.18815,1,1
4,GO MONOCARBOXYLIC ACID TRANSPORT,3.7145e-05,0.22999,0.23653,1,1
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.020205,0.22994,0.14847,1,1
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0049174,0.22985,0.21574,1,1
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0071468,0.22985,0.17109,1,1
4,GO ALCOHOL METABOLIC PROCESS,7.547e-05,0.22977,0.23213,1,1
4,GO CYTOKINE PRODUCTION,0.00028792,0.22913,0.18827,1,1
4,GO MANNOSYLATION,1.6455e-05,0.22889,0.26715,1,1
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.044685,0.22872,0.17805,1,1
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.023205,0.22866,0.23154,1,1
4,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.0033369,0.22864,0.18467,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,3.1888e-05,0.22861,0.22606,1,1
4,GO PEPTIDYL ASPARAGINE MODIFICATION,0.00095906,0.22858,0.23896,1,1
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.0001165,0.22852,0.22887,1,1
4,GO RESPONSE TO ISCHEMIA,0.00059588,0.2282,0.22884,1,1
4,GO CELLULAR RESPONSE TO KETONE,0.0031536,0.22814,0.21145,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0013457,0.22777,0.19761,1,1
4,GO NEUTRAL AMINO ACID TRANSPORT,0.0057817,0.22774,0.25232,1,1
4,GO PROTEIN ACTIVATION CASCADE,0.033894,0.22731,0.24267,1,1
4,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0050528,0.22705,0.16234,1,1
4,GO FIBROBLAST PROLIFERATION,0.029068,0.22702,0.13047,1,1
4,GO REGULATION OF TRANSLATIONAL FIDELITY,0.036164,0.22696,0.1544,1,1
4,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00019753,0.22656,0.28994,1,1
4,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0019282,0.22655,0.17621,1,1
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0066042,0.2265,0.16417,1,1
4,GO REGULATION OF POSITIVE CHEMOTAXIS,0.0099891,0.22649,0.17387,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0018173,0.22636,0.18278,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00074557,0.22607,0.17848,1,1
4,GO DENDRITIC CELL MIGRATION,0.011612,0.22602,0.15037,1,1
4,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0034322,0.22583,0.2678,1,1
4,GO COMPLEMENT ACTIVATION,0.0083534,0.2255,0.17941,1,1
4,GO LIPID STORAGE,0.0013457,0.22532,0.2231,1,1
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0049174,0.22509,0.16809,1,1
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00019753,0.22496,0.24208,1,1
4,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.0079323,0.2249,0.20385,1,1
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0032441,0.2247,0.22143,1,1
4,GO CELLULAR RESPONSE TO STEROL,0.0039469,0.22464,0.22356,1,1
4,GO SELECTIVE AUTOPHAGY,6.5149e-05,0.2246,0.23616,1,1
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00038934,0.22446,0.19789,1,1
4,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00022676,0.22423,0.1949,1,1
4,GO REGULATION OF PROTON TRANSPORT,0.025994,0.22394,0.17826,1,1
4,GO FUCOSYLATION,0.021165,0.22367,0.23115,1,1
4,GO INCLUSION BODY ASSEMBLY,0.0079323,0.22292,0.26184,1,1
4,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.012508,0.2227,0.29603,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.7806e-05,0.2227,0.24703,1,1
4,GO ESTROGEN BIOSYNTHETIC PROCESS,0.0049174,0.22267,0.27458,1,1
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.0027346,0.22266,0.1658,1,1
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,7.547e-05,0.22246,0.18961,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.0024367,0.22244,0.16681,1,1
4,GO MUSCLE CELL MIGRATION,0.013465,0.22236,0.17715,1,1
4,GO REGULATION OF FATTY ACID OXIDATION,0.0023671,0.22235,0.21763,1,1
4,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.016734,0.22219,0.17892,1,1
4,GO CELLULAR RESPONSE TO STARVATION,1.2962e-05,0.22215,0.2354,1,1
4,GO MITOPHAGY,0.0040578,0.22204,0.18015,1,1
4,GO SEQUESTERING OF CALCIUM ION,0.00069957,0.22199,0.17233,1,1
4,GO PROTEIN N LINKED GLYCOSYLATION,5.4121e-05,0.22162,0.2519,1,1
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.00017796,0.22157,0.20458,1,1
4,GO REGULATION OF BODY FLUID LEVELS,0.0010206,0.22099,0.16046,1,1
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0025817,0.22098,0.14459,1,1
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.0029794,0.22082,0.17069,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00045924,0.22066,0.19625,1,1
4,GO LOCOMOTOR RHYTHM,0.025994,0.22063,0.17758,1,1
4,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0007696,0.2204,0.27475,1,1
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.013798,0.22035,0.17597,1,1
4,GO REGULATION OF ACTION POTENTIAL,0.043763,0.22002,0.14596,1,1
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,1.4039e-05,0.21996,0.22833,1,1
4,GO COAGULATION,0.0021062,0.21938,0.15592,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0021689,0.21929,0.20037,1,1
4,GO CYTOCHROME COMPLEX ASSEMBLY,0.00079435,0.21919,0.25092,1,1
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.014841,0.21914,0.19687,1,1
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00032948,0.21876,0.19758,1,1
4,GO PHOSPHOLIPID CATABOLIC PROCESS,0.00067758,0.21862,0.29631,1,1
4,GO VITAMIN TRANSPORT,0.0094949,0.21861,0.20829,1,1
4,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00067758,0.21856,0.22575,1,1
4,GO HAIR CELL DIFFERENTIATION,0.0038387,0.21801,0.19346,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0051916,0.21752,0.19038,1,1
4,GO POSITIVE REGULATION OF FERTILIZATION,0.035393,0.21748,0.20428,1,1
4,GO REGULATION OF ORGANIC ACID TRANSPORT,0.00038934,0.21737,0.25113,1,1
4,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0090226,0.2172,0.24103,1,1
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,5.9841e-06,0.21719,0.23337,1,1
4,GO LIPOSACCHARIDE METABOLIC PROCESS,0.0010206,0.21714,0.22402,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.015953,0.21712,0.1458,1,1
4,GO INTERFERON ALPHA PRODUCTION,0.0022992,0.21708,0.19732,1,1
4,GO PROTON TRANSMEMBRANE TRANSPORT,1.7474e-06,0.21669,0.24724,1,1
4,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0094949,0.21655,0.1929,1,1
4,GO LONG CHAIN FATTY ACID TRANSPORT,4.1112e-06,0.21645,0.24424,1,1
4,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.044685,0.21638,0.13822,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0014738,0.21637,0.18582,1,1
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0028957,0.2163,0.19628,1,1
4,GO MYOBLAST FUSION,0.0041716,0.21617,0.19473,1,1
4,GO DIOL BIOSYNTHETIC PROCESS,0.0029794,0.21614,0.31512,1,1
4,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0064317,0.21612,0.19739,1,1
4,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.011326,0.21603,0.15387,1,1
4,GO MANGANESE ION TRANSPORT,0.00054072,0.21582,0.22949,1,1
4,GO REGULATION OF MAST CELL ACTIVATION,0.0025083,0.21576,0.19596,1,1
4,GO CELLULAR GLUCAN METABOLIC PROCESS,0.00072223,0.21569,0.17913,1,1
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0037331,0.21562,0.19046,1,1
4,GO T CELL MIGRATION,0.0094949,0.21524,0.16416,1,1
4,GO ORGANELLE FUSION,0.00014418,0.21503,0.18682,1,1
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.001662,0.21473,0.19498,1,1
4,GO SPLEEN DEVELOPMENT,0.004408,0.21429,0.16453,1,1
4,GO PROTEIN TARGETING TO LYSOSOME,0.030383,0.21416,0.19885,1,1
4,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00067758,0.21412,0.24338,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0021062,0.21394,0.2215,1,1
4,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.017969,0.21373,0.13387,1,1
4,GO VIRION ASSEMBLY,0.00052342,0.21309,0.16293,1,1
4,GO CARNITINE SHUTTLE,0.0016129,0.21282,0.24374,1,1
4,GO LEUKOCYTE PROLIFERATION,0.00067758,0.21209,0.17376,1,1
4,GO REGULATION OF RESPONSE TO WOUNDING,0.0025083,0.21198,0.19367,1,1
4,GO WOUND HEALING,0.0083534,0.21192,0.13773,1,1
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00026003,0.21174,0.20035,1,1
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0036303,0.21173,0.17634,1,1
4,GO POSITIVE CHEMOTAXIS,0.0079323,0.21169,0.14815,1,1
4,GO HORMONE CATABOLIC PROCESS,0.0073363,0.21165,0.33642,1,1
4,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.0025083,0.21164,0.22083,1,1
4,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.038561,0.21161,0.12389,1,1
4,GO ORGANIC ACID CATABOLIC PROCESS,5.0226e-05,0.21133,0.23665,1,1
4,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0075304,0.21131,0.17605,1,1
4,GO REGULATION OF ENDOCRINE PROCESS,0.00040247,0.21118,0.22084,1,1
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.015953,0.21087,0.22501,1,1
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.0006154,0.21085,0.21555,1,1
4,GO ENERGY HOMEOSTASIS,0.011047,0.21066,0.18048,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0027346,0.21064,0.1526,1,1
4,GO LIPOPROTEIN METABOLIC PROCESS,0.00013433,0.21057,0.19578,1,1
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.03245,0.21051,0.17169,1,1
4,GO CATECHOLAMINE METABOLIC PROCESS,0.0021062,0.21044,0.25793,1,1
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00028792,0.21041,0.18142,1,1
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0042883,0.21034,0.14936,1,1
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.044685,0.20986,0.22441,1,1
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0022992,0.20985,0.20366,1,1
4,GO GRANULOCYTE CHEMOTAXIS,0.00020448,0.20972,0.17497,1,1
4,GO EPIDERMAL CELL DIFFERENTIATION,0.0014299,0.20961,0.19237,1,1
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.014138,0.20953,0.24386,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0053338,0.20935,0.1654,1,1
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0019282,0.20918,0.15868,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.013798,0.20913,0.14195,1,1
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.00014418,0.2089,0.20083,1,1
4,GO MITOCHONDRIAL GENE EXPRESSION,0.012508,0.20886,0.15792,1,1
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0038387,0.20884,0.2059,1,1
4,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.010506,0.20858,0.13503,1,1
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0085714,0.20819,0.23013,1,1
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,5.4121e-05,0.20807,0.24091,1,1
4,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.0022992,0.20804,0.2149,1,1
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0032441,0.20803,0.15394,1,1
4,GO MITOCHONDRIAL TRANSCRIPTION,0.02268,0.20771,0.18171,1,1
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.00017796,0.20761,0.20726,1,1
4,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.0081404,0.20754,0.18261,1,1
4,GO INTERLEUKIN 1 PRODUCTION,0.0042883,0.2075,0.17377,1,1
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00026003,0.20739,0.20036,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,3.8583e-05,0.20719,0.20009,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.024288,0.20712,0.2118,1,1
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00010845,0.20707,0.2242,1,1
4,GO KERATINOCYTE DIFFERENTIATION,0.001872,0.20706,0.1935,1,1
4,GO PIGMENTATION,0.00069957,0.20703,0.16037,1,1
4,GO CELLULAR RESPIRATION,0.00059588,0.207,0.21313,1,1
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.02068,0.20699,0.12412,1,1
4,GO AUTOPHAGOSOME MATURATION,0.00090094,0.20697,0.21502,1,1
4,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.0028141,0.20672,0.17776,1,1
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0017123,0.20649,0.16093,1,1
4,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0013872,0.20561,0.1966,1,1
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.010506,0.20551,0.14161,1,1
4,GO LYMPHOCYTE HOMEOSTASIS,0.00040247,0.20514,0.17826,1,1
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,8.1192e-05,0.20509,0.27998,1,1
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.00032948,0.20506,0.22226,1,1
4,GO REGULATION OF PEPTIDASE ACTIVITY,0.00034072,0.20502,0.19557,1,1
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00063551,0.20489,0.1808,1,1
4,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.043763,0.20448,0.14172,1,1
4,GO RESPONSE TO CHEMOKINE,7.013e-05,0.20447,0.20566,1,1
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00084609,0.2044,0.1725,1,1
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,5.0226e-05,0.20427,0.19779,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0040578,0.20416,0.24293,1,1
4,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.0022332,0.20385,0.24418,1,1
4,GO DEVELOPMENTAL PIGMENTATION,0.0051916,0.20347,0.14337,1,1
4,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.046579,0.20341,0.11939,1,1
4,GO LYMPHOCYTE COSTIMULATION,0.009256,0.20325,0.14019,1,1
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.01282,0.20324,0.17004,1,1
4,GO RESPONSE TO KETONE,0.0017641,0.20303,0.16838,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0045306,0.20301,0.15407,1,1
4,GO LEUKOCYTE CHEMOTAXIS,0.00010092,0.20292,0.19668,1,1
4,GO MONOCYTE CHEMOTAXIS,0.018398,0.20285,0.15107,1,1
4,GO INTERLEUKIN 1 BETA PRODUCTION,0.0020453,0.20276,0.18831,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0036303,0.20257,0.20195,1,1
4,GO MEMBRANE LIPID METABOLIC PROCESS,0.00021167,0.20252,0.21979,1,1
4,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.024846,0.20252,0.1907,1,1
4,GO PEROXISOME ORGANIZATION,4.4878e-05,0.20251,0.2357,1,1
4,GO OXIDATION REDUCTION PROCESS,3.1888e-05,0.20227,0.2178,1,1
4,GO RESPONSE TO INTERLEUKIN 1,0.00026903,0.20216,0.17528,1,1
4,GO AMYLOID BETA METABOLIC PROCESS,0.0041716,0.20202,0.18989,1,1
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.0007696,0.20149,0.22395,1,1
4,GO CELL ACTIVATION,0.00034072,0.20107,0.17115,1,1
4,GO REGULATION OF ISOTYPE SWITCHING,0.011326,0.20079,0.11269,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0032441,0.20068,0.13701,1,1
4,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.015953,0.20056,0.19489,1,1
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,6.5149e-05,0.20052,0.22282,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.004408,0.2005,0.17177,1,1
4,GO PLATELET MORPHOGENESIS,0.0036303,0.2003,0.2127,1,1
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0041716,0.20006,0.1938,1,1
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00010462,0.19996,0.19731,1,1
4,GO DNA DEAMINATION,0.041967,0.19978,0.20084,1,1
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.010506,0.19948,0.25198,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0042883,0.19947,0.17895,1,1
4,GO TRNA 5 LEADER REMOVAL,0.0097392,0.19922,0.16857,1,1
4,GO CELL CELL JUNCTION ASSEMBLY,0.0039469,0.19921,0.18778,1,1
4,GO RESPONSE TO TESTOSTERONE,0.015574,0.19909,0.14832,1,1
4,GO HEPATOCYTE DIFFERENTIATION,0.030383,0.19903,0.19504,1,1
4,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0079323,0.19876,0.15383,1,1
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.018398,0.19871,0.26355,1,1
4,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.018398,0.19857,0.32755,1,1
4,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0033369,0.19856,0.18845,1,1
4,GO TYPE 2 IMMUNE RESPONSE,0.020205,0.19832,0.15501,1,1
4,GO CELLULAR RESPONSE TO VIRUS,0.0017123,0.19821,0.18327,1,1
4,GO REGULATION OF DEFENSE RESPONSE,0.00012964,0.19813,0.18201,1,1
4,GO INSULIN SECRETION,0.00095906,0.1981,0.17045,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0059384,0.19802,0.21125,1,1
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.024288,0.19778,0.13284,1,1
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0037331,0.19774,0.16313,1,1
4,GO SYNCYTIUM FORMATION,0.0073363,0.1977,0.1468,1,1
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.00081984,0.19769,0.19282,1,1
4,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.026586,0.19768,0.14888,1,1
4,GO AMINO SUGAR CATABOLIC PROCESS,0.00045924,0.19765,0.31263,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00055855,0.19756,0.15384,1,1
4,GO ENDOCYTIC RECYCLING,0.0021062,0.19748,0.14226,1,1
4,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.036164,0.19747,0.18911,1,1
4,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0013872,0.19723,0.28419,1,1
4,GO NECROTIC CELL DEATH,0.0011549,0.19723,0.2131,1,1
4,GO MITOCHONDRIAL TRANSLATION,0.029719,0.19721,0.14608,1,1
4,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0050528,0.19701,0.17076,1,1
4,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.017969,0.19654,0.28828,1,1
4,GO CARDIOLIPIN METABOLIC PROCESS,0.042857,0.19647,0.10062,1,1
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.0094949,0.19623,0.12704,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0059384,0.19616,0.19081,1,1
4,GO NIK NF KAPPAB SIGNALING,0.0006154,0.19602,0.15977,1,1
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.029719,0.19602,0.12797,1,1
4,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.03245,0.19584,0.10355,1,1
4,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.013139,0.19577,0.15287,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0028141,0.19575,0.12491,1,1
4,GO REGULATION OF PEPTIDE SECRETION,6.2786e-05,0.19557,0.17208,1,1
4,GO T CELL DIFFERENTIATION,0.00087311,0.19552,0.13457,1,1
4,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.0016129,0.19541,0.19491,1,1
4,GO FATTY ACID METABOLIC PROCESS,0.00012074,0.19533,0.2241,1,1
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00040247,0.1953,0.17683,1,1
4,GO POLYOL BIOSYNTHETIC PROCESS,0.00028792,0.19521,0.22318,1,1
4,GO ALPHA BETA T CELL ACTIVATION,0.00054072,0.1952,0.17765,1,1
4,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.035393,0.19508,0.15551,1,1
4,GO SMALL MOLECULE CATABOLIC PROCESS,3.4421e-05,0.19491,0.22353,1,1
4,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.011326,0.19483,0.18413,1,1
4,GO CELLULAR RESPONSE TO ALKALOID,0.00042998,0.1948,0.20106,1,1
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.011612,0.1948,0.17704,1,1
4,GO RESPONSE TO INTERLEUKIN 15,0.017549,0.19468,0.21209,1,1
4,GO DETERMINATION OF ADULT LIFESPAN,0.0025083,0.19449,0.24628,1,1
4,GO RESPONSE TO OSMOTIC STRESS,0.015203,0.19429,0.16398,1,1
4,GO DRUG METABOLIC PROCESS,0.0010528,0.19428,0.28771,1,1
4,GO COPULATION,0.0040578,0.19418,0.20722,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE,0.00029782,0.19414,0.16942,1,1
4,GO PEPTIDE CATABOLIC PROCESS,0.0034322,0.19406,0.23257,1,1
4,GO REGULATION OF TUBE SIZE,0.00074557,0.19401,0.20137,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0097392,0.19382,0.15665,1,1
4,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.00054072,0.19378,0.20961,1,1
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,5.6174e-05,0.19374,0.22499,1,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.014138,0.19339,0.13171,1,1
4,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.027188,0.19319,0.12149,1,1
4,GO SULFUR COMPOUND METABOLIC PROCESS,0.00084609,0.1931,0.18406,1,1
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0017123,0.1929,0.15627,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00098941,0.19278,0.1535,1,1
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.001191,0.19269,0.14977,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0059384,0.19265,0.13427,1,1
4,GO REGULATION OF MITOPHAGY,0.0067808,0.19251,0.17008,1,1
4,GO DRINKING BEHAVIOR,0.019739,0.1925,0.1779,1,1
4,GO RESPONSE TO ALCOHOL,0.00067758,0.19249,0.15335,1,1
4,GO B CELL ACTIVATION,9.0551e-05,0.19246,0.18247,1,1
4,GO REGULATION OF RESPONSE TO TUMOR CELL,0.03245,0.19228,0.16368,1,1
4,GO B CELL DIFFERENTIATION,6.2786e-05,0.19222,0.19968,1,1
4,GO PEPTIDE SECRETION,4.3218e-05,0.19183,0.18087,1,1
4,GO NATURAL KILLER CELL ACTIVATION,0.0011199,0.1917,0.16471,1,1
4,GO RESPONSE TO HYDROGEN PEROXIDE,0.0013457,0.19156,0.16058,1,1
4,GO SODIUM ION HOMEOSTASIS,0.010506,0.19146,0.15226,1,1
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0097392,0.19134,0.21569,1,1
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.00029782,0.19114,0.21706,1,1
4,GO REGULATION OF GLUCONEOGENESIS,0.00047456,0.19094,0.23652,1,1
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.00013433,0.19091,0.19925,1,1
4,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.027803,0.19076,0.17028,1,1
4,GO REGULATION OF HORMONE LEVELS,2.9532e-05,0.19042,0.21113,1,1
4,GO FATTY ACID TRANSPORT,5.0226e-05,0.19038,0.22765,1,1
4,GO ERAD PATHWAY,0.0099891,0.19036,0.13697,1,1
4,GO T HELPER CELL LINEAGE COMMITMENT,0.011326,0.19028,0.15563,1,1
4,GO LYMPHOCYTE CHEMOTAXIS,0.042857,0.19021,0.090816,1,1
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0036303,0.19021,0.20947,1,1
4,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0032441,0.1902,0.17907,1,1
4,GO RESPONSE TO INTERLEUKIN 4,0.0011549,0.1902,0.17153,1,1
4,GO ADAPTIVE THERMOGENESIS,0.0001547,0.19012,0.17076,1,1
4,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0012662,0.18991,0.20591,1,1
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.00055855,0.18954,0.19729,1,1
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.00018427,0.1895,0.17626,1,1
4,GO PROSTAGLANDIN TRANSPORT,0.0028957,0.18943,0.28349,1,1
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.001662,0.1894,0.13775,1,1
4,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0028141,0.18933,0.20608,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0022992,0.18925,0.18595,1,1
4,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00038934,0.18917,0.17097,1,1
4,GO NEGATIVE REGULATION OF LIPID STORAGE,0.015203,0.18909,0.15851,1,1
4,GO SENSORY PERCEPTION OF SMELL,3.3132e-05,0.18898,0.19759,1,1
4,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.026586,0.18886,0.10772,1,1
4,GO PROTEIN KINASE B SIGNALING,0.0097392,0.18885,0.12508,1,1
4,GO TETRAPYRROLE METABOLIC PROCESS,0.0024367,0.18881,0.24974,1,1
4,GO VIRAL LIFE CYCLE,0.001191,0.1887,0.15114,1,1
4,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.018398,0.18865,0.12961,1,1
4,GO CELL CELL JUNCTION ORGANIZATION,0.0090226,0.18854,0.17215,1,1
4,GO IRON ION TRANSPORT,0.00012512,0.18842,0.23147,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00095906,0.1884,0.18232,1,1
4,GO REGULATION OF BLOOD PRESSURE,4.8379e-05,0.18834,0.20297,1,1
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.001662,0.18826,0.1541,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.015953,0.18825,0.15731,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.010506,0.18787,0.18974,1,1
4,GO HUMORAL IMMUNE RESPONSE,6.0504e-05,0.18786,0.18729,1,1
4,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0099891,0.18773,0.11729,1,1
4,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.025414,0.18769,0.14941,1,1
4,GO CELLULAR RESPONSE TO DSRNA,0.016734,0.18731,0.14657,1,1
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.001872,0.18692,0.15478,1,1
4,GO NEUTROPHIL CHEMOTAXIS,6.7596e-05,0.18691,0.16992,1,1
4,GO SPHINGOLIPID METABOLIC PROCESS,0.00018427,0.1868,0.22079,1,1
4,GO TISSUE HOMEOSTASIS,0.0021689,0.18675,0.16703,1,1
4,GO REGULATION OF ANION TRANSPORT,0.00045924,0.1867,0.21777,1,1
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0037331,0.18664,0.16204,1,1
4,GO THIOESTER BIOSYNTHETIC PROCESS,0.001986,0.18663,0.19281,1,1
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.00016595,0.18656,0.17006,1,1
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0011199,0.18632,0.15645,1,1
4,GO PROTEIN REFOLDING,0.011047,0.18603,0.19993,1,1
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0053338,0.18603,0.17029,1,1
4,GO REGULATION OF IMMUNE RESPONSE,0.00081984,0.18602,0.15199,1,1
4,GO LIPID BIOSYNTHETIC PROCESS,0.00024286,0.18595,0.17243,1,1
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.013465,0.1859,0.14009,1,1
4,GO PEPTIDYL PROLINE MODIFICATION,0.012203,0.18586,0.15905,1,1
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0042883,0.18584,0.18249,1,1
4,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.0069616,0.1858,0.27073,1,1
4,GO ESTROGEN METABOLIC PROCESS,0.0083534,0.1857,0.18513,1,1
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,5.2139e-05,0.18537,0.21367,1,1
4,GO POSITIVE REGULATION OF COAGULATION,0.0071468,0.18513,0.18686,1,1
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.0039469,0.18504,0.11753,1,1
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0059384,0.18475,0.12769,1,1
4,GO RIG I SIGNALING PATHWAY,0.031059,0.18463,0.11216,1,1
4,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.017969,0.18438,0.14129,1,1
4,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0064317,0.18426,0.27498,1,1
4,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00044439,0.18409,0.2345,1,1
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.040234,0.18408,0.12617,1,1
4,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.0034322,0.18395,0.22786,1,1
4,GO AMINOGLYCAN METABOLIC PROCESS,0.0071468,0.18393,0.15203,1,1
4,GO B CELL RECEPTOR SIGNALING PATHWAY,0.0041716,0.18358,0.19478,1,1
4,GO ALCOHOL BIOSYNTHETIC PROCESS,0.00045924,0.1831,0.20008,1,1
4,GO REGULATION OF LIPID CATABOLIC PROCESS,0.00036427,0.18307,0.17094,1,1
4,GO RESPONSE TO INORGANIC SUBSTANCE,0.00031859,0.18299,0.14774,1,1
4,GO IRON ION TRANSMEMBRANE TRANSPORT,0.021165,0.18298,0.20377,1,1
4,GO PLATELET ACTIVATION,0.0081404,0.18276,0.1367,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION,0.0024367,0.18274,0.15834,1,1
4,GO ACETYL COA METABOLIC PROCESS,0.010245,0.1827,0.17055,1,1
4,GO RESPONSE TO WOUNDING,0.014841,0.1826,0.11376,1,1
4,GO REGULATION OF NECROTIC CELL DEATH,0.017969,0.18257,0.17099,1,1
4,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.001872,0.18246,0.19803,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00079435,0.18227,0.18133,1,1
4,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.02068,0.18221,0.17811,1,1
4,GO GLYCOPROTEIN METABOLIC PROCESS,0.00069957,0.1821,0.18544,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.03939,0.18163,0.13369,1,1
4,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0032441,0.1814,0.18545,1,1
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0024367,0.18135,0.1267,1,1
4,GO ACTIVATION OF IMMUNE RESPONSE,0.0012662,0.1813,0.14986,1,1
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0042883,0.18106,0.1443,1,1
4,GO REGULATION OF CELL ACTIVATION,0.0028141,0.18101,0.12857,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0025817,0.18097,0.20918,1,1
4,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0006154,0.18058,0.17999,1,1
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0006154,0.1805,0.15208,1,1
4,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.013465,0.18019,0.12883,1,1
4,GO ATP BIOSYNTHETIC PROCESS,0.031059,0.18013,0.1591,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0025817,0.18,0.16941,1,1
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00034072,0.17994,0.15359,1,1
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00042998,0.17986,0.2155,1,1
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,5.8301e-05,0.17983,0.22781,1,1
4,GO LIPID CATABOLIC PROCESS,1.2962e-05,0.17976,0.23466,1,1
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00057693,0.17973,0.17876,1,1
4,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.023741,0.17971,0.25058,1,1
4,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.029068,0.17969,0.1429,1,1
4,GO SULFUR COMPOUND CATABOLIC PROCESS,0.014486,0.17965,0.14538,1,1
4,GO MUSCLE CELL APOPTOTIC PROCESS,0.00074557,0.1796,0.18012,1,1
4,GO CELLULAR LIPID METABOLIC PROCESS,0.0001547,0.17957,0.18251,1,1
4,GO LYMPHOCYTE DIFFERENTIATION,0.001191,0.17936,0.1191,1,1
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0041716,0.17932,0.172,1,1
4,GO SKIN DEVELOPMENT,0.0056288,0.17906,0.1406,1,1
4,GO EPIDERMIS DEVELOPMENT,0.0049174,0.17902,0.14574,1,1
4,GO ACTIN FILAMENT DEPOLYMERIZATION,0.0010528,0.17881,0.1741,1,1
4,GO VACUOLE ORGANIZATION,1.4609e-05,0.17877,0.22033,1,1
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0013872,0.17877,0.12618,1,1
4,GO APOPTOTIC SIGNALING PATHWAY,0.00055855,0.17874,0.15082,1,1
4,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.029068,0.17868,0.16976,1,1
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,4.6597e-05,0.17864,0.23951,1,1
4,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.015574,0.17856,0.16192,1,1
4,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0016129,0.1785,0.17688,1,1
4,GO MUSCLE ADAPTATION,0.004408,0.17813,0.14432,1,1
4,GO REGULATION OF CELL CELL ADHESION,0.0051916,0.17805,0.14147,1,1
4,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0045306,0.17802,0.16116,1,1
4,GO HORMONE TRANSPORT,0.00027832,0.17802,0.17371,1,1
4,GO REGULATION OF SYMBIOTIC PROCESS,0.0025083,0.17784,0.15931,1,1
4,GO BROWN FAT CELL DIFFERENTIATION,0.0097392,0.17769,0.14713,1,1
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.00074557,0.17766,0.18382,1,1
4,GO LIPID METABOLIC PROCESS,0.00017186,0.17747,0.17916,1,1
4,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.001872,0.17743,0.31558,1,1
4,GO RESPONSE TO OXIDATIVE STRESS,0.00057693,0.17742,0.15311,1,1
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00040247,0.17733,0.18634,1,1
4,GO MONOSACCHARIDE METABOLIC PROCESS,1.7118e-05,0.17709,0.24367,1,1
4,GO RESPONSE TO METAL ION,0.00050664,0.1769,0.17773,1,1
4,GO T CELL ACTIVATION,0.0023671,0.1769,0.13641,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0031536,0.17689,0.13291,1,1
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00055855,0.17684,0.16071,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.030383,0.17675,0.13997,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00029782,0.17673,0.16293,1,1
4,GO MULTIVESICULAR BODY ORGANIZATION,0.0029794,0.17666,0.13634,1,1
4,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.007729,0.17661,0.18183,1,1
4,GO CARBOHYDRATE TRANSPORT,0.00012964,0.1766,0.21459,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0050528,0.17651,0.15419,1,1
4,GO ORGANIC ANION TRANSPORT,1.9263e-05,0.17644,0.20698,1,1
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00079435,0.17636,0.17856,1,1
4,GO PROTEASOME ASSEMBLY,0.0040578,0.1763,0.18408,1,1
4,GO SMOOTH MUSCLE CELL PROLIFERATION,0.021165,0.1763,0.14024,1,1
4,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.0069616,0.17626,0.17856,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00074557,0.1762,0.20442,1,1
4,GO POSITIVE REGULATION OF HEART RATE,0.037747,0.17611,0.1708,1,1
4,GO DENDRITIC CELL CHEMOTAXIS,0.017137,0.17611,0.1446,1,1
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.014486,0.17598,0.17139,1,1
4,GO REGULATION OF NUCLEASE ACTIVITY,0.0025083,0.17595,0.17944,1,1
4,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.036948,0.17591,0.12398,1,1
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.0027346,0.1759,0.14965,1,1
4,GO REGULATION OF LIPID METABOLIC PROCESS,0.0022332,0.17574,0.14006,1,1
4,GO LYMPHOCYTE ACTIVATION,0.0023671,0.17564,0.12002,1,1
4,GO VIRAL BUDDING,0.0012662,0.17564,0.16236,1,1
4,GO GLUCOSE METABOLIC PROCESS,3.9418e-06,0.1756,0.23073,1,1
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.00019079,0.17553,0.20603,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.014841,0.17546,0.13424,1,1
4,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0034322,0.17509,0.11887,1,1
4,GO PEPTIDE HORMONE SECRETION,0.00067758,0.17505,0.16331,1,1
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0011549,0.17468,0.14984,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.001872,0.1745,0.15636,1,1
4,GO LIPID HOMEOSTASIS,0.0028141,0.17434,0.19529,1,1
4,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.025994,0.17433,0.19922,1,1
4,GO T CELL HOMEOSTASIS,0.0049174,0.17393,0.13601,1,1
4,GO TRIGLYCERIDE METABOLIC PROCESS,0.0071468,0.17385,0.14469,1,1
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0023671,0.1738,0.12809,1,1
4,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.0039469,0.17361,0.1648,1,1
4,GO REGULATION OF MUSCLE ADAPTATION,0.01282,0.17348,0.13132,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00012512,0.17293,0.15908,1,1
4,GO INTERACTION WITH HOST,0.0037331,0.17293,0.15654,1,1
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00032948,0.17291,0.14935,1,1
4,GO AMYLOID BETA FORMATION,0.040234,0.17283,0.14051,1,1
4,GO METAL ION HOMEOSTASIS,0.0015653,0.17282,0.12348,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.0073e-05,0.17264,0.17917,1,1
4,GO POSITIVE REGULATION OF CELL AGING,0.04854,0.1725,0.16158,1,1
4,GO ALPHA BETA T CELL DIFFERENTIATION,0.001872,0.17248,0.15505,1,1
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00013917,0.17224,0.21032,1,1
4,GO ISOPRENOID METABOLIC PROCESS,0.015203,0.17218,0.17673,1,1
4,GO REGULATION OF MUSCLE HYPERTROPHY,0.016734,0.17187,0.14286,1,1
4,GO GLUTAMATE METABOLIC PROCESS,0.011904,0.17184,0.15691,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0034322,0.17181,0.18219,1,1
4,GO IMMUNOGLOBULIN PRODUCTION,0.00027832,0.17159,0.15421,1,1
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0006154,0.17154,0.18564,1,1
4,GO ACTIN NUCLEATION,0.0022332,0.17152,0.15951,1,1
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00031859,0.17136,0.15944,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.029719,0.17127,0.17319,1,1
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.00021909,0.17099,0.17684,1,1
4,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.01282,0.17075,0.15922,1,1
4,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.010773,0.17073,0.13082,1,1
4,GO OLIGODENDROCYTE DEVELOPMENT,0.016339,0.17064,0.15933,1,1
4,GO REGULATION OF HORMONE SECRETION,0.00049035,0.17049,0.16262,1,1
4,GO LIPID IMPORT INTO CELL,0.02843,0.17042,0.17874,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.009256,0.17031,0.13331,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0047853,0.17018,0.13187,1,1
4,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00074557,0.17,0.21464,1,1
4,GO ALPHA AMINO ACID METABOLIC PROCESS,0.00353,0.16999,0.19473,1,1
4,GO POSITIVE REGULATION OF MITOPHAGY,0.013139,0.16994,0.18437,1,1
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.00027832,0.16955,0.18675,1,1
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0045306,0.16955,0.12676,1,1
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.023205,0.1692,0.15039,1,1
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0024367,0.16919,0.17659,1,1
4,GO REGULATION OF VASCULAR PERMEABILITY,0.012508,0.16913,0.16126,1,1
4,GO PROTEIN MATURATION,4.1617e-05,0.16908,0.21151,1,1
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0012662,0.16903,0.12957,1,1
4,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.01282,0.16891,0.22771,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0030654,0.16865,0.16254,1,1
4,GO REGULATION OF T CELL DIFFERENTIATION,0.0036303,0.16842,0.12095,1,1
4,GO MULTI ORGANISM CELLULAR PROCESS,0.025414,0.16841,0.13129,1,1
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0040578,0.16837,0.11211,1,1
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0013054,0.16823,0.219,1,1
4,GO PROTEIN PROCESSING,1.7806e-05,0.16812,0.2562,1,1
4,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.020205,0.16802,0.16776,1,1
4,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.010506,0.16797,0.21194,1,1
4,GO AMINE CATABOLIC PROCESS,0.004408,0.16778,0.28897,1,1
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.018836,0.16771,0.15062,1,1
4,GO HORMONE BIOSYNTHETIC PROCESS,0.025414,0.16766,0.1717,1,1
4,GO P38MAPK CASCADE,0.015953,0.1675,0.15148,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.010506,0.16734,0.14771,1,1
4,GO CELLULAR RESPONSE TO CALCIUM ION,0.0051916,0.16695,0.18575,1,1
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.011326,0.16681,0.12922,1,1
4,GO RESPONSE TO ETHER,0.0085714,0.1668,0.16669,1,1
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00038934,0.16678,0.14893,1,1
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0028141,0.16677,0.20929,1,1
4,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0053338,0.16661,0.15358,1,1
4,GO REGULATION OF LIPID STORAGE,0.004408,0.1666,0.16978,1,1
4,GO LEUKOCYTE APOPTOTIC PROCESS,0.0059384,0.16658,0.14604,1,1
4,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0090226,0.16638,0.16682,1,1
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,8.7323e-05,0.16633,0.19611,1,1
4,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00042998,0.16622,0.22379,1,1
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,2.5308e-05,0.16598,0.21192,1,1
4,GO ERK1 AND ERK2 CASCADE,0.024288,0.16591,0.11348,1,1
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.02843,0.1658,0.15352,1,1
4,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.026586,0.16579,0.12672,1,1
4,GO ACID SECRETION,0.0057817,0.1657,0.16505,1,1
4,GO REGULATION OF LEUKOCYTE MIGRATION,0.010773,0.16559,0.11183,1,1
4,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.0056288,0.16557,0.16031,1,1
4,GO INTERMEDIATE FILAMENT BASED PROCESS,0.019739,0.16521,0.14251,1,1
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.0001547,0.16443,0.16169,1,1
4,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0034322,0.16428,0.17753,1,1
4,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.014841,0.16418,0.23668,1,1
4,GO COPPER ION TRANSPORT,0.018836,0.16378,0.16006,1,1
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0013457,0.16322,0.13454,1,1
4,GO RESPONSE TO FUNGUS,0.0025083,0.16283,0.13253,1,1
4,GO CHOLESTEROL STORAGE,0.045624,0.16267,0.13266,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.0099891,0.16264,0.25414,1,1
4,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0067808,0.16248,0.15414,1,1
4,GO RENAL SODIUM EXCRETION,0.0079323,0.16237,0.18203,1,1
4,GO REGULATION OF ERBB SIGNALING PATHWAY,0.014841,0.16236,0.14719,1,1
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.0010859,0.16236,0.15642,1,1
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0025083,0.16235,0.18359,1,1
4,GO RESPONSE TO STEROL,0.011047,0.16225,0.17476,1,1
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.0010206,0.16206,0.16371,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00065623,0.16193,0.17729,1,1
4,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.016734,0.16187,0.16041,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.015203,0.16178,0.12826,1,1
4,GO OXIDATIVE PHOSPHORYLATION,0.0021689,0.16174,0.1972,1,1
4,GO CYTOKINE SECRETION,0.0020453,0.16171,0.16887,1,1
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0020453,0.16111,0.1465,1,1
4,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.0028141,0.1611,0.2019,1,1
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00090094,0.16093,0.15273,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00019079,0.16089,0.15032,1,1
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.021165,0.16088,0.10725,1,1
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00035231,0.16086,0.13028,1,1
4,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.018836,0.16045,0.18363,1,1
4,GO RESPONSE TO DSRNA,0.0017641,0.16043,0.1506,1,1
4,GO ATP TRANSPORT,0.029068,0.16036,0.10802,1,1
4,GO SULFUR COMPOUND TRANSPORT,0.00027832,0.16032,0.19641,1,1
4,GO ION HOMEOSTASIS,0.0011199,0.1603,0.13058,1,1
4,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.026586,0.15985,0.13951,1,1
4,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0026572,0.15981,0.12728,1,1
4,GO PEROXISOMAL MEMBRANE TRANSPORT,0.0012662,0.15967,0.18455,1,1
4,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.011047,0.15963,0.1681,1,1
4,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0069616,0.1596,0.10407,1,1
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0040578,0.15933,0.14125,1,1
4,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.02068,0.15929,0.19796,1,1
4,GO TEMPERATURE HOMEOSTASIS,0.00087311,0.15927,0.14444,1,1
4,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0081404,0.1591,0.11526,1,1
4,GO CERAMIDE BIOSYNTHETIC PROCESS,0.00098941,0.15887,0.18091,1,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0017641,0.15841,0.12715,1,1
4,GO ENDOTHELIAL CELL MIGRATION,0.0073363,0.15829,0.14977,1,1
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00028792,0.15824,0.16221,1,1
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0017641,0.15822,0.12947,1,1
4,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.0066042,0.15818,0.37617,1,1
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.0014299,0.15808,0.17852,1,1
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.0038387,0.15804,0.12652,1,1
4,GO SECRETION,0.00013433,0.1571,0.1632,1,1
4,GO REGULATION OF PROTEIN FOLDING,0.03939,0.15709,0.11005,1,1
4,GO PROTEIN FOLDING,0.0069616,0.15708,0.13895,1,1
4,GO CERAMIDE METABOLIC PROCESS,0.00052342,0.15681,0.20662,1,1
4,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0045306,0.15678,0.16707,1,1
4,GO PHOSPHOLIPID METABOLIC PROCESS,0.00012964,0.15629,0.1563,1,1
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.027188,0.15626,0.11018,1,1
4,GO PROTEIN MANNOSYLATION,0.0025817,0.15617,0.18299,1,1
4,GO REGULATION OF LIPID LOCALIZATION,0.00090094,0.15607,0.19593,1,1
4,GO ENGULFMENT OF APOPTOTIC CELL,0.02843,0.1558,0.12989,1,1
4,GO REGULATION OF CELL ADHESION,0.0085714,0.15577,0.12348,1,1
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,5.0226e-05,0.15567,0.22735,1,1
4,GO CELLULAR ION HOMEOSTASIS,0.001872,0.15544,0.1228,1,1
4,GO LEUKOCYTE DIFFERENTIATION,0.0013872,0.15537,0.12658,1,1
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0054795,0.15532,0.14529,1,1
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0060989,0.15506,0.1173,1,1
4,GO REGULATION OF MACROPHAGE ACTIVATION,0.030383,0.15484,0.12811,1,1
4,GO RESPONSE TO MECHANICAL STIMULUS,0.00049035,0.15481,0.16048,1,1
4,GO REGULATION OF PROTEOLYSIS,0.00081984,0.15467,0.14182,1,1
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0026572,0.15465,0.12218,1,1
4,GO CARBOHYDRATE HOMEOSTASIS,6.5149e-05,0.15457,0.18883,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.010773,0.15457,0.11886,1,1
4,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.021165,0.15426,0.1745,1,1
4,GO ADIPOSE TISSUE DEVELOPMENT,0.0071468,0.15376,0.1519,1,1
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.00021909,0.15371,0.16137,1,1
4,GO REGULATION OF HEMOPOIESIS,0.001986,0.15367,0.11822,1,1
4,GO RESPONSE TO LIPID,0.0037331,0.15363,0.1208,1,1
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00081984,0.15361,0.1693,1,1
4,GO LEUKOCYTE CELL CELL ADHESION,0.0021062,0.15356,0.14848,1,1
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0050528,0.15329,0.14649,1,1
4,GO RESPONSE TO ACID CHEMICAL,0.0030654,0.15309,0.13452,1,1
4,GO REGULATION OF AMYLOID BETA FORMATION,0.041967,0.15277,0.15946,1,1
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0021062,0.15272,0.13354,1,1
4,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00050664,0.15264,0.21527,1,1
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00017796,0.15252,0.1814,1,1
4,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.010506,0.15235,0.13424,1,1
4,GO CHLORIDE TRANSPORT,0.0007696,0.15233,0.14687,1,1
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0025083,0.15227,0.1637,1,1
4,GO NEUTRAL LIPID METABOLIC PROCESS,0.0057817,0.15223,0.15316,1,1
4,GO DE NOVO PROTEIN FOLDING,0.0047853,0.15189,0.16212,1,1
4,GO ORGANIC ACID METABOLIC PROCESS,0.00029782,0.15184,0.18229,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.027803,0.15163,0.15643,1,1
4,GO PROTEIN TARGETING TO VACUOLE,0.0099891,0.15153,0.15154,1,1
4,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.0021689,0.15122,0.2064,1,1
4,GO T CELL APOPTOTIC PROCESS,0.033166,0.15121,0.12173,1,1
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00034072,0.15116,0.16111,1,1
4,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.041093,0.15106,0.12861,1,1
4,GO INTERFERON BETA PRODUCTION,0.019739,0.15105,0.12656,1,1
4,GO AGING,0.00041602,0.15105,0.14103,1,1
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.0017641,0.15096,0.23355,1,1
4,GO GOLGI ORGANIZATION,4.6597e-05,0.15093,0.18392,1,1
4,GO DEFENSE RESPONSE TO FUNGUS,0.0099891,0.15092,0.12099,1,1
4,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0017641,0.1508,0.25877,1,1
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0051916,0.15079,0.13987,1,1
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.0021689,0.15075,0.14956,1,1
4,GO ALCOHOL CATABOLIC PROCESS,0.00074557,0.15052,0.19257,1,1
4,GO T CELL LINEAGE COMMITMENT,0.0017123,0.15045,0.17614,1,1
4,GO MACROPHAGE ACTIVATION,0.00084609,0.15041,0.15659,1,1
4,GO ANION TRANSPORT,4.3218e-05,0.1504,0.18272,1,1
4,GO LEUKOCYTE HOMEOSTASIS,0.0085714,0.15037,0.12744,1,1
4,GO SYMBIOTIC PROCESS,0.0033369,0.15024,0.108,1,1
4,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0056288,0.15001,0.14716,1,1
4,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.016734,0.14986,0.14372,1,1
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.042857,0.14965,0.10055,1,1
4,GO MITOCHONDRIAL FISSION,0.047551,0.14954,0.16036,1,1
4,GO TERPENOID METABOLIC PROCESS,0.038561,0.14937,0.14916,1,1
4,GO BICARBONATE TRANSPORT,0.007729,0.14928,0.17012,1,1
4,GO EPITHELIAL CELL DIFFERENTIATION,0.0057817,0.14874,0.13304,1,1
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0022992,0.14868,0.13188,1,1
4,GO CHEMICAL HOMEOSTASIS,0.00032948,0.14847,0.14551,1,1
4,GO CALCIUM ION IMPORT,0.043763,0.14838,0.082155,1,1
4,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.042857,0.14822,0.099986,1,1
4,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0064317,0.14822,0.1929,1,1
4,GO RESPONSE TO ANTIBIOTIC,0.023741,0.14808,0.11195,1,1
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00035231,0.14799,0.16302,1,1
4,GO CARBOHYDRATE METABOLIC PROCESS,0.00013917,0.14785,0.18924,1,1
4,GO RESPONSE TO DRUG,0.0039469,0.14765,0.13856,1,1
4,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0079323,0.14756,0.14925,1,1
4,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.0025817,0.14753,0.21628,1,1
4,GO HEME METABOLIC PROCESS,0.013798,0.1475,0.26665,1,1
4,GO MACROPHAGE DIFFERENTIATION,0.029719,0.14745,0.15906,1,1
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.001986,0.14738,0.15985,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.040234,0.14728,0.15251,1,1
4,GO NCRNA CATABOLIC PROCESS,0.02068,0.14723,0.11529,1,1
4,GO TRANSITION METAL ION HOMEOSTASIS,0.031059,0.14701,0.11934,1,1
4,GO RESPONSE TO CALCIUM ION,0.0029794,0.14691,0.16965,1,1
4,GO TOXIN TRANSPORT,0.0056288,0.1469,0.18428,1,1
4,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.00021909,0.14676,0.16834,1,1
4,GO RESPONSE TO MISFOLDED PROTEIN,0.001872,0.14665,0.19484,1,1
4,GO ORGANELLE DISASSEMBLY,0.00038934,0.14649,0.16208,1,1
4,GO REGULATION OF LIPID TRANSPORT,0.0013054,0.14636,0.20425,1,1
4,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00098941,0.14623,0.18186,1,1
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0032441,0.14618,0.17622,1,1
4,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.023741,0.14599,0.17053,1,1
4,GO POSITIVE REGULATION OF SECRETION,0.0001547,0.14576,0.16116,1,1
4,GO OOCYTE DIFFERENTIATION,0.0059384,0.14568,0.12418,1,1
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.009256,0.14545,0.1467,1,1
4,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0013457,0.14535,0.18502,1,1
4,GO MYOTUBE DIFFERENTIATION,0.0015653,0.14469,0.14846,1,1
4,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00049035,0.14459,0.16464,1,1
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.00016023,0.14454,0.16532,1,1
4,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.026586,0.1444,0.12645,1,1
4,GO LYSOSOME LOCALIZATION,0.00079435,0.14364,0.15591,1,1
4,GO POLYAMINE METABOLIC PROCESS,0.020205,0.14352,0.15984,1,1
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.027803,0.14343,0.13728,1,1
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00010845,0.143,0.16742,1,1
4,GO ORGANIC ACID TRANSPORT,7.013e-05,0.14295,0.2025,1,1
4,GO GPI ANCHOR METABOLIC PROCESS,0.0053338,0.1424,0.19539,1,1
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.01282,0.14237,0.11131,1,1
4,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.034637,0.14236,0.12826,1,1
4,GO RESPONSE TO TOXIC SUBSTANCE,0.010773,0.14219,0.16315,1,1
4,GO REGULATION OF INSULIN SECRETION,0.0025817,0.1419,0.14783,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.025994,0.14187,0.19797,1,1
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.0097392,0.14182,0.18437,1,1
4,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.036164,0.14182,0.12359,1,1
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0036303,0.1417,0.13748,1,1
4,GO CELL CELL ADHESION,0.02268,0.14152,0.10283,1,1
4,GO REGULATION OF STEROL TRANSPORT,0.018398,0.14094,0.1435,1,1
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.01282,0.14094,0.14384,1,1
4,GO REGULATION OF MULTI ORGANISM PROCESS,0.02843,0.14094,0.1415,1,1
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.038561,0.14072,0.12399,1,1
4,GO T CELL PROLIFERATION,0.0050528,0.14065,0.14366,1,1
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0010206,0.14048,0.15944,1,1
4,GO MYELOID CELL DIFFERENTIATION,0.0039469,0.14042,0.10779,1,1
4,GO RESPONSE TO STEROID HORMONE,0.0025817,0.14029,0.14619,1,1
4,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0047853,0.14028,0.16596,1,1
4,GO RESPONSE TO HORMONE,0.001662,0.13995,0.13151,1,1
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.0017641,0.13984,0.12997,1,1
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0041716,0.13977,0.14971,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00034072,0.13959,0.15145,1,1
4,GO PLASMA MEMBRANE ORGANIZATION,0.013139,0.13929,0.13657,1,1
4,GO NEGATIVE REGULATION OF OSSIFICATION,0.031748,0.13928,0.12326,1,1
4,GO PROSTAGLANDIN SECRETION,0.02268,0.13926,0.1849,1,1
4,GO RESPONSE TO GAMMA RADIATION,0.020205,0.13926,0.10551,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.043763,0.13921,0.13966,1,1
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00092958,0.13905,0.12761,1,1
4,GO VITAMIN METABOLIC PROCESS,0.013139,0.1389,0.17894,1,1
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.011047,0.13865,0.13676,1,1
4,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.013465,0.13863,0.14723,1,1
4,GO GOLGI RIBBON FORMATION,0.02068,0.13862,0.15664,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0067808,0.13818,0.14965,1,1
4,GO PIGMENT CELL DIFFERENTIATION,0.042857,0.13805,0.10042,1,1
4,GO REGULATION OF PROTEIN BINDING,0.0071468,0.13785,0.1196,1,1
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00021167,0.13769,0.17541,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00079435,0.13752,0.12713,1,1
4,GO RESPONSE TO ETHANOL,0.016734,0.13718,0.10983,1,1
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0011549,0.13715,0.16005,1,1
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0056288,0.13667,0.14148,1,1
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00019753,0.13643,0.15463,1,1
4,GO EPITHELIUM DEVELOPMENT,0.0062634,0.13634,0.10237,1,1
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.0028141,0.13632,0.17884,1,1
4,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.015574,0.13632,0.12462,1,1
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00098941,0.1363,0.14747,1,1
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.0066042,0.13625,0.11745,1,1
4,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.026586,0.13613,0.11282,1,1
4,GO VESICLE ORGANIZATION,0.00087311,0.13599,0.1594,1,1
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00023468,0.13584,0.15261,1,1
4,GO EXCRETION,0.0028957,0.13548,0.16041,1,1
4,GO CHOLESTEROL EFFLUX,0.026586,0.13527,0.15417,1,1
4,GO POSITIVE REGULATION OF CHEMOTAXIS,0.02068,0.13518,0.10505,1,1
4,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.026586,0.13472,0.10209,1,1
4,GO IMMUNE SYSTEM DEVELOPMENT,0.0025817,0.13442,0.098261,1,1
4,GO KILLING OF CELLS OF OTHER ORGANISM,0.00014935,0.13396,0.16649,1,1
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.04854,0.13386,0.11518,1,1
4,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.011326,0.13377,0.12745,1,1
4,GO LIPID MODIFICATION,0.00049035,0.13355,0.16341,1,1
4,GO CARBOHYDRATE CATABOLIC PROCESS,0.00095906,0.13325,0.17678,1,1
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.014486,0.13292,0.13048,1,1
4,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.034637,0.13291,0.088714,1,1
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.0010528,0.13281,0.14114,1,1
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0010206,0.13273,0.13552,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.043763,0.13271,0.069605,1,1
4,GO CELL MATURATION,0.0051916,0.13174,0.10393,1,1
4,GO REGULATION OF T CELL ACTIVATION,0.0064317,0.1315,0.12182,1,1
4,GO GLYCEROLIPID CATABOLIC PROCESS,0.0020453,0.13128,0.20347,1,1
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0013872,0.13123,0.12359,1,1
4,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.001228,0.13104,0.10521,1,1
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.012508,0.13057,0.16165,1,1
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.043763,0.13032,0.10606,1,1
4,GO DETECTION OF STIMULUS,0.00021909,0.12943,0.11678,1,1
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.036164,0.12939,0.12178,1,1
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.001191,0.12912,0.11961,1,1
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.0026572,0.12893,0.137,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0046564,0.1282,0.10991,1,1
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.040234,0.12809,0.09661,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.009256,0.12791,0.12843,1,1
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.0047853,0.1279,0.19785,1,1
4,GO REGULATION OF VASOCONSTRICTION,0.0021062,0.12766,0.19281,1,1
4,GO PIGMENT METABOLIC PROCESS,0.019283,0.1275,0.16416,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.024846,0.12748,0.12098,1,1
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.016734,0.12741,0.096293,1,1
4,GO TISSUE MIGRATION,0.014841,0.12718,0.12442,1,1
4,GO INORGANIC ANION TRANSPORT,0.00045924,0.12715,0.13928,1,1
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.011047,0.12695,0.096411,1,1
4,GO BODY FLUID SECRETION,0.029068,0.12667,0.090429,1,1
4,GO ENDOCRINE HORMONE SECRETION,0.015203,0.12666,0.1184,1,1
4,GO PROTEIN K63 LINKED UBIQUITINATION,0.0020453,0.12656,0.12759,1,1
4,GO RESPONSE TO IRON ION,0.019283,0.1265,0.16932,1,1
4,GO EXECUTION PHASE OF APOPTOSIS,0.00017796,0.12632,0.1637,1,1
4,GO TRANSITION METAL ION TRANSPORT,0.00026003,0.12551,0.20883,1,1
4,GO PROTEIN AUTOUBIQUITINATION,0.0022332,0.12517,0.10747,1,1
4,GO AUTOPHAGY OF MITOCHONDRION,0.0039469,0.12516,0.15477,1,1
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.025414,0.12481,0.14123,1,1
4,GO REGULATION OF CHEMOTAXIS,0.01282,0.12479,0.09712,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.014486,0.12454,0.11905,1,1
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0045306,0.12427,0.15278,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.01282,0.12427,0.11042,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY,0.0013872,0.12425,0.15477,1,1
4,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.027188,0.12386,0.10273,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.03245,0.12375,0.10088,1,1
4,GO T CELL SELECTION,0.010245,0.12372,0.1029,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.036164,0.12369,0.1024,1,1
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.011904,0.12341,0.13153,1,1
4,GO PROTEOLYSIS,0.00026003,0.1234,0.13389,1,1
4,GO REGULATION OF PEPTIDE TRANSPORT,0.00027832,0.12338,0.12219,1,1
4,GO GLYCEROLIPID METABOLIC PROCESS,0.00022676,0.12326,0.15117,1,1
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00011241,0.12308,0.17837,1,1
4,GO REGULATION OF VACUOLE ORGANIZATION,0.0066042,0.12306,0.15714,1,1
4,GO CELLULAR RESPONSE TO LIPID,0.012508,0.12302,0.10697,1,1
4,GO RESPONSE TO ORGANOPHOSPHORUS,0.0051916,0.123,0.14246,1,1
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0022332,0.12298,0.10638,1,1
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00026003,0.12289,0.15361,1,1
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.0056288,0.12209,0.1505,1,1
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.00055855,0.12185,0.12917,1,1
4,GO GLUCOSE IMPORT,0.042857,0.12153,0.11971,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.02068,0.12123,0.093596,1,1
4,GO MAINTENANCE OF LOCATION IN CELL,0.0050528,0.12119,0.11067,1,1
4,GO REGULATION OF CELL DEATH,0.0057817,0.12113,0.090647,1,1
4,GO REGULATION OF ION TRANSPORT,0.042857,0.12111,0.081788,1,1
4,GO STEROL IMPORT,0.02068,0.1209,0.22252,1,1
4,GO ACTIVATION OF MAPK ACTIVITY,0.001662,0.12078,0.12139,1,1
4,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.027188,0.12008,0.11366,1,1
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0029794,0.11971,0.11006,1,1
4,GO BIOLOGICAL ADHESION,0.041093,0.11952,0.08425,1,1
4,GO NEGATIVE REGULATION OF MAPK CASCADE,0.023205,0.11937,0.11486,1,1
4,GO MAINTENANCE OF LOCATION,0.0081404,0.11925,0.10818,1,1
4,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0073363,0.11924,0.15949,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0059384,0.11906,0.098645,1,1
4,GO HOMEOSTATIC PROCESS,0.00029782,0.11897,0.12188,1,1
4,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.026586,0.11895,0.074004,1,1
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0034322,0.11851,0.11703,1,1
4,GO SINGLE FERTILIZATION,0.025414,0.11834,0.082837,1,1
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.0022992,0.11824,0.12165,1,1
4,GO REGULATION OF SECRETION,0.00098941,0.1176,0.13141,1,1
4,GO RESPONSE TO INSULIN,0.0013457,0.11747,0.13992,1,1
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.012508,0.11744,0.13336,1,1
4,GO RESPONSE TO OXYGEN LEVELS,0.0081404,0.11738,0.10854,1,1
4,GO REGULATION OF GLUCOSE IMPORT,0.025994,0.11728,0.12409,1,1
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.00079435,0.11709,0.12074,1,1
4,GO ANION TRANSMEMBRANE TRANSPORT,0.00057693,0.11668,0.15236,1,1
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.04854,0.11624,0.15401,1,1
4,GO CELL CELL RECOGNITION,0.03939,0.11621,0.12383,1,1
4,GO MITOCHONDRIAL TRANSPORT,0.0013872,0.11615,0.10367,1,1
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.010245,0.11614,0.11358,1,1
4,GO REGULATION OF RESPONSE TO STRESS,0.001872,0.11608,0.11356,1,1
4,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.046579,0.11599,0.12358,1,1
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.019283,0.11595,0.077585,1,1
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.00010845,0.11574,0.1635,1,1
4,GO GLAND DEVELOPMENT,0.024288,0.11572,0.080118,1,1
4,GO CIRCULATORY SYSTEM PROCESS,0.0034322,0.11543,0.12009,1,1
4,GO TOR SIGNALING,0.0010528,0.11533,0.092004,1,1
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.027803,0.11504,0.09338,1,1
4,GO PYRUVATE METABOLIC PROCESS,0.033166,0.11464,0.10642,1,1
4,GO SENSORY PERCEPTION OF BITTER TASTE,0.013798,0.11454,0.09667,1,1
4,GO THIOESTER METABOLIC PROCESS,0.0032441,0.11412,0.16932,1,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.041093,0.11409,0.080127,1,1
4,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.009256,0.11405,0.21688,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.011326,0.11389,0.1103,1,1
4,GO APOPTOTIC PROCESS,0.0053338,0.11327,0.091091,1,1
4,GO CATECHOLAMINE SECRETION,0.041093,0.11319,0.23199,1,1
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0017641,0.11315,0.12337,1,1
4,GO ATP METABOLIC PROCESS,0.0032441,0.11301,0.13594,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.013465,0.11278,0.12469,1,1
4,GO REGULATION OF MAP KINASE ACTIVITY,0.0050528,0.11238,0.12307,1,1
4,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.0090226,0.11217,0.13115,1,1
4,GO SOMITOGENESIS,0.0073363,0.11188,0.11761,1,1
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.027188,0.11186,0.086644,1,1
4,GO REGULATION OF TOR SIGNALING,0.004408,0.1118,0.099662,1,1
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0097392,0.11179,0.10756,1,1
4,GO RESPONSE TO PEPTIDE HORMONE,0.0028957,0.1111,0.11411,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION,0.0075304,0.11066,0.081661,1,1
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0075304,0.11049,0.11861,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.0066042,0.11019,0.11142,1,1
4,GO EXOCYTIC PROCESS,0.014841,0.10988,0.16802,1,1
4,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.0014299,0.10976,0.1215,1,1
4,GO WATER TRANSPORT,0.042857,0.10952,0.085683,1,1
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.012203,0.10952,0.14833,1,1
4,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.012508,0.10948,0.11121,1,1
4,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.0050528,0.10929,0.14418,1,1
4,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.01282,0.10927,0.10193,1,1
4,GO ERYTHROCYTE HOMEOSTASIS,0.0051916,0.10849,0.11488,1,1
4,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.035393,0.10835,0.16892,1,1
4,GO INTERFERON GAMMA PRODUCTION,0.02268,0.10812,0.10643,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0022992,0.10805,0.1339,1,1
4,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0037331,0.10803,0.15645,1,1
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.013139,0.10775,0.12367,1,1
4,GO SECOND MESSENGER MEDIATED SIGNALING,0.0085714,0.1063,0.094009,1,1
4,GO RESPONSE TO TEMPERATURE STIMULUS,0.0012662,0.10612,0.12962,1,1
4,GO RESPONSE TO PEPTIDE,0.0054795,0.10601,0.09639,1,1
4,GO TRANSMEMBRANE TRANSPORT,0.00054072,0.10589,0.1366,1,1
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.012203,0.10567,0.099175,1,1
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.014138,0.10562,0.080227,1,1
4,GO FEEDING BEHAVIOR,0.041093,0.1054,0.11211,1,1
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0067808,0.10525,0.10809,1,1
4,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.045624,0.10503,0.18161,1,1
4,GO REGULATION OF BLOOD CIRCULATION,0.03939,0.10495,0.097418,1,1
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0014738,0.10445,0.11539,1,1
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0069616,0.10435,0.10492,1,1
4,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.019739,0.10371,0.08958,1,1
4,GO T CELL RECEPTOR SIGNALING PATHWAY,0.0079323,0.10321,0.11238,1,1
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0013872,0.10317,0.12602,1,1
4,GO POSITIVE REGULATION OF SIGNALING,0.0027346,0.1031,0.096319,1,1
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0025083,0.10287,0.1084,1,1
4,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.041967,0.10263,0.11864,1,1
4,GO STEROID CATABOLIC PROCESS,0.041967,0.10249,0.21942,1,1
4,GO MAMMARY GLAND DEVELOPMENT,0.041093,0.10216,0.090254,1,1
4,GO CELLULAR HOMEOSTASIS,0.0022992,0.10195,0.11459,1,1
4,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0085714,0.10182,0.094039,1,1
4,GO RESPONSE TO CAMP,0.040234,0.1017,0.12506,1,1
4,GO CELLULAR AMIDE METABOLIC PROCESS,0.012203,0.10164,0.10659,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.022165,0.10158,0.074507,1,1
4,GO REGULATION OF MAPK CASCADE,0.013798,0.1014,0.10035,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE,0.0079323,0.10106,0.09814,1,1
4,GO ACTIVATION OF GTPASE ACTIVITY,0.03939,0.10089,0.071636,1,1
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.017549,0.10079,0.10395,1,1
4,GO BIOMINERALIZATION,0.041093,0.10063,0.094104,1,1
4,GO SPERM EGG RECOGNITION,0.015203,0.10027,0.116,1,1
4,GO REGULATION OF ATP METABOLIC PROCESS,0.015953,0.10006,0.10359,1,1
4,GO IRON ION HOMEOSTASIS,0.030383,0.099012,0.13166,1,1
4,GO NEGATIVE REGULATION OF CELL DEATH,0.011904,0.09875,0.087896,1,1
4,GO RESPONSE TO ABIOTIC STIMULUS,0.0085714,0.098437,0.083532,1,1
4,GO RESPONSE TO NITROGEN COMPOUND,0.0029794,0.09811,0.099993,1,1
4,GO REGULATION OF CELL POPULATION PROLIFERATION,0.019739,0.098044,0.081646,1,1
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0081404,0.097842,0.089367,1,1
4,GO CALCIUM MEDIATED SIGNALING,0.0057817,0.097807,0.083627,1,1
4,GO REGULATION OF MACROPHAGE MIGRATION,0.043763,0.097524,0.10211,1,1
4,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.023205,0.097491,0.16682,1,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.037747,0.097377,0.11632,1,1
4,GO POLYSACCHARIDE CATABOLIC PROCESS,0.013139,0.096996,0.19734,1,1
4,GO POSITIVE REGULATION OF MAPK CASCADE,0.0060989,0.096974,0.1121,1,1
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0085714,0.096524,0.10234,1,1
4,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0040578,0.096222,0.11764,1,1
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0032441,0.096139,0.1252,1,1
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0090226,0.095939,0.086167,1,1
4,GO PROTEIN STABILIZATION,0.021165,0.095842,0.086806,1,1
4,GO POSITIVE REGULATION OF CELL DEATH,0.041967,0.095617,0.071063,1,1
4,GO REGULATION OF PROTEIN STABILITY,0.0021689,0.09466,0.10893,1,1
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.017137,0.094041,0.091483,1,1
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0059384,0.094026,0.11716,1,1
4,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0039469,0.093467,0.13775,1,1
4,GO CYTOSOLIC TRANSPORT,0.001872,0.093246,0.11338,1,1
4,GO MACROMOLECULE CATABOLIC PROCESS,0.0083534,0.093034,0.070728,1,1
4,GO VESICLE LOCALIZATION,0.020205,0.092571,0.099445,1,1
4,GO NEGATIVE REGULATION OF AUTOPHAGY,0.04854,0.09178,0.08824,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.022165,0.091174,0.071233,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.042857,0.090807,0.068878,1,1
4,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0049174,0.090574,0.094822,1,1
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.022165,0.090371,0.07821,1,1
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0097392,0.089968,0.085164,1,1
4,GO PROTEIN CATABOLIC PROCESS,0.0027346,0.089758,0.095315,1,1
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.018398,0.089694,0.080419,1,1
4,GO REGULATION OF HISTONE DEACETYLATION,0.033894,0.089531,0.11516,1,1
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.0087944,0.089201,0.10471,1,1
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.0014738,0.088711,0.10019,1,1
4,GO REGULATION OF HYDROLASE ACTIVITY,0.017549,0.088533,0.085532,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.033894,0.088331,0.083727,1,1
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.0057817,0.0882,0.12377,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.031059,0.087674,0.14349,1,1
4,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.011904,0.087444,0.066085,1,1
4,GO PROTEIN POLYUBIQUITINATION,0.0013872,0.085808,0.097735,1,1
4,GO SIGNAL RELEASE,0.011904,0.085658,0.10416,1,1
4,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.02843,0.085215,0.084214,1,1
4,GO POLYOL METABOLIC PROCESS,0.026586,0.084901,0.10983,1,1
4,GO CELLULAR COMPONENT DISASSEMBLY,0.01282,0.084021,0.081808,1,1
4,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.031748,0.083243,0.08609,1,1
4,GO HOMEOSTASIS OF NUMBER OF CELLS,0.02068,0.080492,0.077291,1,1
4,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.045624,0.080006,0.058645,1,1
4,GO JNK CASCADE,0.033166,0.079852,0.076137,1,1
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.013139,0.079799,0.081906,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.009256,0.079585,0.091402,1,1
4,GO RESPONSE TO MONOSACCHARIDE,0.0054795,0.077427,0.11938,1,1
4,GO REGULATION OF REPRODUCTIVE PROCESS,0.029068,0.077215,0.084825,1,1
4,GO REGULATION OF PHOSPHORYLATION,0.017969,0.077203,0.07407,1,1
4,GO ANATOMICAL STRUCTURE MATURATION,0.041967,0.07713,0.070331,1,1
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.036164,0.0768,0.070414,1,1
4,GO DIVALENT INORGANIC CATION TRANSPORT,0.045624,0.076613,0.087166,1,1
4,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.031748,0.076001,0.077896,1,1
4,GO MITOCHONDRION ORGANIZATION,0.0017641,0.075479,0.11437,1,1
4,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.025994,0.075103,0.09528,1,1
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.024846,0.074835,0.071649,1,1
4,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.01282,0.074406,0.14099,1,1
4,GO GOLGI VESICLE TRANSPORT,0.0087944,0.07412,0.10632,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.016734,0.072745,0.10169,1,1
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.022165,0.072717,0.075978,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.011047,0.072705,0.096373,1,1
4,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.029068,0.072536,0.05601,1,1
4,GO LYSOSOMAL TRANSPORT,0.013798,0.070567,0.13631,1,1
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.013465,0.070225,0.082022,1,1
4,GO INTRACELLULAR TRANSPORT,0.0024367,0.069899,0.076814,1,1
4,GO INTRACELLULAR PROTEIN TRANSPORT,0.0075304,0.069456,0.061873,1,1
4,GO RESPONSE TO CARBOHYDRATE,0.0087944,0.068224,0.11419,1,1
4,GO DNA CATABOLIC PROCESS,0.0083534,0.067745,0.09866,1,1
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.043763,0.066688,0.060887,1,1
4,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.030383,0.065299,0.052518,1,1
4,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.024288,0.061138,0.075727,1,1
4,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.036948,0.057576,0.067237,1,1
4,GO REGULATION OF AUTOPHAGY,0.0031536,0.056563,0.10819,1,1
4,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.016734,0.055271,0.077597,1,1
4,GO REGULATION OF CATABOLIC PROCESS,0.020205,0.054076,0.068903,1,1
4,GO MACROAUTOPHAGY,0.001228,0.05403,0.12383,1,1
4,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.022165,0.05313,0.079814,1,1
4,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.015574,0.051948,0.069725,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.016734,0.04982,0.053616,1,1
4,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.017549,0.047617,0.070807,1,1
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0094949,0.046732,0.071985,1,1
4,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.025414,0.045244,0.081049,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.044685,0.032504,0.044,1,1
4,GO REGULATION OF MACROAUTOPHAGY,0.02268,0.03143,0.092292,1,1
5,GO FOREBRAIN NEURON FATE COMMITMENT,0.00029782,0.63972,0.72353,1,1
5,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.001872,0.59075,0.49246,1,1
5,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.001191,0.52831,0.41554,1,1
5,GO CARDIOBLAST PROLIFERATION,0.013139,0.48758,0.39833,1,1
5,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0049174,0.46479,0.41436,1,1
5,GO NEURON FATE SPECIFICATION,0.0013457,0.44934,0.43382,1,1
5,GO ATRIAL SEPTUM MORPHOGENESIS,0.0059384,0.44781,0.33487,1,1
5,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.02268,0.38267,0.28982,1,1
5,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00023468,0.36551,0.4253,1,1
5,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0054795,0.34681,0.25477,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0012662,0.32464,0.32441,1,1
5,GO RESPONSE TO FORSKOLIN,0.015953,0.31071,0.25346,1,1
5,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.0069616,0.30015,0.26851,1,1
5,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.0033369,0.29878,0.40974,1,1
5,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,5.8301e-05,0.29214,0.47913,1,1
5,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0059384,0.29212,0.29368,1,1
5,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.024288,0.28486,0.30399,1,1
5,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.012203,0.27135,0.19788,1,1
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0021062,0.26909,0.22949,1,1
5,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00028792,0.26842,0.35946,1,1
5,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.0017123,0.2588,0.26159,1,1
5,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.036948,0.25419,0.26388,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0069616,0.25035,0.31857,1,1
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.019739,0.24802,0.16689,1,1
5,GO DENDRITE SELF AVOIDANCE,0.014486,0.24466,0.19709,1,1
5,GO GAMMA DELTA T CELL DIFFERENTIATION,0.010506,0.23542,0.36471,1,1
5,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.00065623,0.23254,0.19127,1,1
5,GO CELL FATE SPECIFICATION,0.0025083,0.22738,0.19452,1,1
5,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.0066042,0.22172,0.16914,1,1
5,GO ESTROUS CYCLE,0.016339,0.22046,0.20727,1,1
5,GO DNA DEMETHYLATION,0.0067808,0.21511,0.14664,1,1
5,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.021165,0.20781,0.12937,1,1
5,GO REGULATION OF SISTER CHROMATID COHESION,0.0062634,0.20264,0.14578,1,1
5,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0014738,0.19545,0.21862,1,1
5,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.025414,0.19484,0.16678,1,1
5,GO MITOTIC SISTER CHROMATID COHESION,0.0017123,0.19186,0.19797,1,1
5,GO NEGATIVE REGULATION OF GLIOGENESIS,0.02166,0.19088,0.14301,1,1
5,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.014486,0.18229,0.184,1,1
5,GO KINETOCHORE ORGANIZATION,0.033166,0.18131,0.12841,1,1
5,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.013465,0.18096,0.34992,1,1
5,GO DENDRITIC TRANSPORT,0.04854,0.1809,0.16223,1,1
5,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.02068,0.17772,0.18498,1,1
5,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.0034322,0.17095,0.18824,1,1
5,GO GENETIC IMPRINTING,0.01282,0.16805,0.16445,1,1
5,GO COPULATION,0.041967,0.16469,0.13843,1,1
5,GO HISTONE H2A MONOUBIQUITINATION,0.001228,0.16297,0.19019,1,1
5,GO ACROSOME ASSEMBLY,0.016734,0.16188,0.14107,1,1
5,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.025994,0.15909,0.13094,1,1
5,GO DOSAGE COMPENSATION,0.0024367,0.15508,0.13231,1,1
5,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.0015189,0.15453,0.14521,1,1
5,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0047853,0.15219,0.23593,1,1
5,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.012508,0.1514,0.1997,1,1
5,GO DNA DEALKYLATION,0.047551,0.14866,0.090425,1,1
5,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0059384,0.14669,0.13595,1,1
5,GO NEGATIVE REGULATION OF DNA BINDING,0.023741,0.14386,0.109,1,1
5,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.01282,0.14369,0.1184,1,1
5,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.016734,0.14185,0.16698,1,1
5,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.03939,0.13992,0.097637,1,1
5,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.021165,0.13967,0.16339,1,1
5,GO ASTRAL MICROTUBULE ORGANIZATION,0.0090226,0.13521,0.15376,1,1
5,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.015953,0.13463,0.12212,1,1
5,GO HISTONE H2A UBIQUITINATION,0.0099891,0.1331,0.12152,1,1
5,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.0079323,0.13153,0.1494,1,1
5,GO HISTONE H2A ACETYLATION,0.011612,0.13087,0.13462,1,1
5,GO HISTONE H4 K16 ACETYLATION,0.0026572,0.12732,0.16261,1,1
5,GO MITOTIC CHROMOSOME CONDENSATION,0.0047853,0.12707,0.14285,1,1
5,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.0023671,0.12356,0.12344,1,1
5,GO CENTROSOME DUPLICATION,0.0057817,0.12346,0.12194,1,1
5,GO MEIOTIC SPINDLE ORGANIZATION,0.019283,0.11981,0.10804,1,1
5,GO NEURAL PRECURSOR CELL PROLIFERATION,0.0041716,0.11603,0.11345,1,1
5,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.04854,0.11293,0.071084,1,1
5,GO RETROGRADE AXONAL TRANSPORT,0.044685,0.10968,0.14007,1,1
5,GO HISTONE MONOUBIQUITINATION,0.0039469,0.10776,0.11149,1,1
5,GO CHROMATIN REMODELING AT CENTROMERE,0.029719,0.10501,0.12465,1,1
5,GO HISTONE UBIQUITINATION,0.017969,0.10044,0.074395,1,1
5,GO SYNAPTIC VESICLE LOCALIZATION,0.036164,0.098571,0.16326,1,1
5,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.034637,0.094694,0.075117,1,1
5,GO MITOTIC SPINDLE ORGANIZATION,0.036164,0.093783,0.063565,1,1
5,GO DEMETHYLATION,0.016734,0.083583,0.072182,1,1
5,GO HISTONE H4 ACETYLATION,0.0071468,0.081818,0.096623,1,1
5,GO RESPONSE TO NERVE GROWTH FACTOR,0.018836,0.072224,0.11331,1,1
5,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.026586,0.071678,0.066401,1,1
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.034637,0.070893,0.052678,1,1
5,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.0067808,0.070258,0.094585,1,1
5,GO MITOTIC SISTER CHROMATID SEGREGATION,0.03939,0.067949,0.062674,1,1
5,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.041093,0.066251,0.088991,1,1
5,GO SPINDLE ORGANIZATION,0.041967,0.061988,0.049083,1,1
